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Preface 
 
“It is generally accepted that the biologic sciences are 
absolutely splendid. In just the past decade they have 
uncovered a huge mass of brand-new information, and there 
is plenty more ahead; the biologic revolution is evidently still 
in its early stages.”  
(Thomas Lewis, 1974) 
iological research is indeed splendid (Lewis, 1974); the more information about 
the cell in general or a particular cell type we discover, the more this discovery 
reveals new possible functions, which this cell type may exert. This concept applies to mast 
cells (MCs); the still progressing exploration of these cells and their (patho)physiological role 
is a longer than a century-lasting investigation which still, and especially during the last 
decade, reveals novel roles for MCs in health and disease.  
When Paul Ehrlich as a 24-year-old student presenting his doctoral thesis in 1878, 
described a type of ‘‘granular cells of the connective tissue’’, which he named ‘‘Mastzellen’’ 
(Ehrlich, 1878), a vivid, multidirectional research to explore the development, phenotype, 
physiology and pathology of these cells was starting. Since then, the universe of MC biology 
has been ever extending and the deeper we explore the biology of these cells, the more 
functions we discover, including some that shatter long-held beliefs on their nature and 
limitations (Maurer et al., 2003; Maurer and Metz, 2005).  
In an attempt to contribute to the unraveling of the (patho)physiological role of these 
fascinating cells, this study was focused on their involvement in the initiation of an antigen-
specific adaptive immune response and their ability to modulate CD8+ T cell responses.  
B 
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1. Introduction 
 
1.1. General introduction 
 
ife is a dynamic, sophisticated process achieved through various, amazingly   
organized and interconnected mechanisms, each of which involves several 
biological pathways. The complexity of this process is attributed to the number of functions 
the living organism must effectively perform in order to survive. Apart from the apparent 
need to obtain and successfully process the necessary environmental elements (nutrition, 
water, air) for its growth and reproduction, a living organism must additionally cope with the 
challenges of the constantly evolving environment. It is a common phenomenon that the 
needs of one organism overlap or contradict the needs of another. Thus, a system of 
protective mechanisms has evolved that secure life from the attack of other organisms. In 
consistency with the evolution of the organisms, these protective mechanisms have evolved 
from simple protein secretion and enzymatic digestive pathways, to the development of 
highly specialized cells and a whole system of complex, still not fully identified interactions 
between those cells. This defense system that has evolved to protect organisms from the 
invading pathogens is called the immune system (Goldsby et al., 2003). The first ever 
observation of an existing immune system is considered to be the one mentioned by the 
Greek historical Thucydides in 430 BC, as he stated that during an epidemic disease in 
Athens, the patients could be nursed only by those who had recovered from the disease, since 
they were protected from developing the disease again (Thucydides).  
 Thus, already during the first observation of its existence, the human immune system 
was attributed with its two major characteristics: protection and memory. Indeed, the immune 
system has developed efficient mechanisms not only for inhibiting most kinds of 
microorganisms, such as viruses, bacteria, protozoa and other parasites to infect the human 
body (immunological protection), but also for recognizing the same antigens upon a 
subsequent encounter (immunological memory). Despite the indispensable role of the 
immune system in protection against pathogens, dysfunction of the immune system may 
often lead to undesirable pathological situations, such as an undue reaction against non-
pathogenic agents (allergy) or even against self-antigens (autoimmunity).  
L 
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 The immune system is sub-divided into two categories: the innate and the adaptive 
immune system. Each of them includes a series of mechanisms exerted by different cell 
types, in order to achieve optimal results. Innate and adaptive immunity cooperate with each 
other and are interconnected by specific cell types and soluble mediators.  
 
1.1.1. Innate immunity 
Innate immune responses are identified as unspecific, short-term protective immune 
responses, present not only in higher evolved organisms, but also in invertebrates and, 
partially, in plants (Jones and Dangl, 2006; Iriti and Faoro, 2007). They include the secretion 
of antimicrobial peptides and enzymes, which damage or destroy the membranes of invading 
microorganisms. In animals, specialized cells, the phagocytes, eradicate foreign 
microorganisms by internalizing and digesting them with intracellular enzymes. Elimination 
of invading microorganisms is additionally facilitated by a group of soluble proteins 
comprising the complement system. Proteins of the complement system recruit phagocytes to 
the site of infection, damage the membrane of the foreign microorganisms and coat the 
pathogens, facilitating their uptake by phagocytes. Another important aspect of the innate 
immune system is the induction of inflammation. Inflammation consists of the release of 
chemoattractive factors at the site of infection as well as increased blood flow and capillary 
permeability, which result in increased cell migration to the site of infection and effective 
clearance of the pathogens. However, dysregulation of the inflammatory response often leads 
to pathological situations such as chronic inflammation and allergy (Goldsby et al., 2003).  
Although the innate and the adaptive immunity are not strictly separated mechanisms, 
different cell types have been characterized as the main executors of the one or the other 
response. Thus, the mammalian innate immune responses are primarily carried out by 
phagocytic cells (such as monocytes, macrophages, neutrophils), as well as eosinophils, 
platelets, NK cells, basophils and MCs (Roitt et al., 2002).  
In the center of the detection mechanisms for invading microorganisms in vertebrates 
lies the family of Toll-like receptors (TLRs). Similar to the Toll proteins of Drosophila and 
highly conserved during evolution, the TLR family has been extensively studied both in 
human and mice (Gay and Keith, 1991; Medzhitov et al., 1997; Rock et al., 1998). Until now, 
10 members (TLRs 1-10) in human and 12 members in mice (TLRs 1-9 and 11-13) have been 
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described. TLRs recognize common molecular structures detected in certain groups of 
microorganisms, called pathogen associated molecular patterns (PAMPs). They are mainly 
expressed by antigen-presenting cells (APCs) and upon binding to their ligands, induce 
activation of the APCs and initiation of immune responses leading to the elimination of the 
invading microorganisms (Kaisho and Akira, 2006).  
In general, the innate immune system can successfully cope with infections at a first 
stage; however, it cannot guarantee a complete and long-term protection against all 
infections, since it lacks the equipment for an antigen-specific interaction with pathogens as 
well as the potential to recognize the pathogenic molecules upon a subsequent encounter.  
 
1.1.2. Adaptive immunity 
The encounter of pathogenic microorganisms in our environment is inevitable. The 
innate immune system provides a prompt defense mechanism, however its lack of specificity 
towards the pathogens renders it inadequate for efficient elimination of the pathogen upon 
subsequent encounter. The evolution of the adaptive immune system has provided additional 
advantages to the vertebrates; specific elimination of the invaders with high efficiency and 
even, display of efficient equipment for their elimination upon a second encounter.  
Adaptive immune responses are carried out by lymphocytes, which derive from a 
common lymphoid progenitor in the bone marrow. There are two major populations of 
lymphocytes: B lymphocytes (B cells) which mature in the bone marrow and T lymphocytes 
(T cells) which mature in the thymus. The main function of B cells is to recognize antigens 
through membrane-bound antibodies (B cell receptor) and subsequently differentiate into 
effector plasma cells which secrete antigen-specific antibodies. Therefore, B cells are the 
main participants of the so-called humoral immunity. On the other hand, T cells recognize 
antigens which are associated with major histocompatibility molecules (MHC) on the 
membrane of APCs. Upon activation, T cells exert their effector functions and regulate a 
cellular immune response (Goldsby et al., 2003).  
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1.1.2.1.  T cells and the regulation of adaptive immunity 
During their maturation in the thymus, T cells express a membrane-bound T cell-
receptor (TCR), which has a unique specificity for antigen. T cells are sub-divided into two 
classes: CD4+ T cells and CD8+ T cells, according to surface expression of CD4 or CD8 
antigens respectively. CD4+ T cells recognize MHC class II-associated antigens, while CD8+ 
T cells recognize MHC class I-associated antigens (Goldsby et al., 2003).  
CD4+ T cells mainly modulate the subsequent immune response by the production of 
cytokines (therefore called T helper cells: Th). Depending on the exposure on cytokines, 
naïve CD4+ T cells differentiate into IFN-γ-, IL-2- and TNF-α-secreting Th1 cells, IL-4-, IL-
5 and IL-13-secreting Th2 cells or IL-17-, IL-6-secreting Th17 cells (Weaver et al., 2006). 
On the other hand, regulatory CD4+ T cells (Treg) suppress the immune response by 
secretion of TGF-β as well as by direct cell-cell contact (von Boehmer, 2005).  
CD8+ T cells are primarily associated with the elimination of virus- or bacteria-
infected cells or tumor cells. Upon interaction with an MHC class I-bound antigen on the 
surface of APCs, CD8+ T cells become activated, proliferate and either mature to effector 
cytotoxic CD8+ T cells or to long-living memory CD8+ T cells. Cytotoxic CD8+ T cells 
eliminate virus- or bacteria-infected cells as well as tumor cells, while memory CD8+ T cells 
preserve the immunological memory for a subsequent encounter with the same antigen 
(Jabbari and Harty, 2006).  
Cytotoxic CD8+ T cells play a central role in the control of microbial and viral 
infections (Wong and Pamer 2003). The TCR on cytotoxic CD8+ T cell recognize and 
interact with MHC class I-antigen complexes on the surface of infected cells. Subsequently, 
cytotoxicity is performed indirectly by the release of cytokines and directly by two different 
pathways; the Fas-FasL pathway and the granule-exocytosis pathway. The secretion of 
cytokines such as IFN-γ and TNF-α induces apoptosis of the target cell without requiring 
direct cell-cell contact (Andersen et al., 2006). On the other hand, the interaction of the 
surface-expressed Fas-Ligand (FasL) on cytotoxic CD8+ T cells with the surface-expressed 
Fas on target cells induces aggregation of intracellular death domains and results in apoptosis 
of the target cell (Hanabuchi et al., 1994). In addition, the granule-exocytosis pathway 
involves the release of cytotoxic mediators, which are pre-stored in cytolytic granules in the 
cytoplasm of CD8+ T cells and are released upon degranulation of the CD8+ T cells 
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(Lieberman, 2003). The best studied cytotoxic mediators of CD8+ T cells are perforin, which 
forms pores in the cell membrane of the target cell, and granzymes, which induce the 
caspase-dependent pathway of apoptosis in the target cell. The mechanisms of CD8+ T cell-
induced cytotoxicity are schematically depicted in Fig. 1.1.  
 
Fig. 1.1. Pathways of CD8+ T cell-induced cytotoxicity. a) Indirectly induced apoptosis of 
target cells by cytokines (IFN-γ and TNF-α) released by cytotoxic CD8+ T cell (CTL) b) Cell 
contact-dependent induced apoptosis of the target cell through the Fas-FasL pathway c) 
Apoptosis of target cell induced by the release of cytotoxic mediators (granzyme B and 
perforin) from the CTL (from Andersen et al., 2006, with permission). 
 
1.1.2.2.  Antigen presentation 
Naïve B and T lymphocytes can respond to antigens with high specificity and 
efficiency, initiating an adaptive immune response. The key step for achieving an antigen-
specific adaptive immune response is the presentation of antigens by antigen presenting cells 
(APCs) to B and T lymphocytes.  
APCs degrade antigens into peptides (antigen processing) and present them on their 
surface, associated with MHC molecules and co-stimulatory molecules (antigen 
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presentation) (Brodsky and Guagliardi, 1991). Several factors such as the physical form of 
the antigen, the site of antigen delivery, the presence of adjuvant, as well as the nature of the 
APC can influence the processing and presentation of antigens (Trombetta and Mellman, 
2005).  
Exogenous proteins are internalized by APCs and degraded in endocytic 
compartments (early endosomes, late endosomes and lysosomes) by hydrolytic enzymes and 
acidic pH. The assembly of the MHC class II complex occurs in the endoplasmic reticulum 
(ER), where pairs of MHC class II αβ chains associate with a trimeric protein, the invariant 
chain (Ii). While the MHC class II complex trafficks from the ER through Golgi to the 
endocytic compartments, the Ii chain is degraded. However, the degradation of Ii is not 
complete; a fragment, called CLIP, is left occupying the peptide-binding groove of the MHC 
class II, thus preventing any immature binding of peptides to the MHC class II. Degradation 
of CLIP occurs in endosomal compartments by a non-classical MHC molecule called HLA-
DM. Thus, the peptide-binding groove becomes available to binding peptides derived from 
exogenous proteins that have been degraded in endosomes. Finally, the MHC class II-peptide 
complex is transported to the plasma membrane (Goldsby et al., 2003; Watts, 1997) 
In contrast to MHC class II, the loading of the MHC class I complex with the peptide 
occurs in the ER lumen. Intracellular antigenic proteins (that could be synthesized by virus- 
or bacteria-infected cells) are degraded into peptides by the proteasome in the cytosol. These 
peptides are subsequently transported into the ER by the transporter associated with antigen 
processing (TAP), which is associated with the transmembrane glycoprotein tapasin. Tapasin, 
on the other hand, associates with the heavy chain of MHC class I molecule, which 
constitutively forms heterodimers with the beta-2-microglobulin chain (β2m). The 
association of the MHC class I heterodimers with tapasin enables the loading of the peptides 
onto the MHC class I, which, in turn, stabilizes the MHC class I complex and initiates its 
dissociation from tapasin. Subsequently, the loaded MHC class I trafficks to the cell 
membrane via the Golgi network (Flutter and Gao, 2004; Cresswell et al., 2005; Pamer and 
Cresswell, 1998). A schematic representation of the MHC class I assembly and loading is 
shown in Fig. 1.2.  
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Fig. 1.2. Schematic view of MHC class I assembly and loading pathway. Peptides derived 
from the processing of proteins in the cytosol by the proteasome are transported into the ER 
by TAP. Tapasin provides a link between TAP and the heavy chain of MHC class I molecule, 
which constitutively forms heterodimers with the β2m chain. The association of the heavy 
chain-β2m heterodimers with tapasin results in the loading of the peptides onto the MHC 
class I, which, in turn, stabilizes the MHC class I complex and initiates its dissociation from 
tapasin (from Cresswell et al., 2005, with permission). 
Despite the well-defined borders between MHC class I and MHC class II route of 
antigen presentation, both pathways can be crossed in certain cases (Trombetta and Mellman, 
2005). Thus, exogenous antigens may escape the dominant route to MHC class II-restricted 
presentation, access the MHC class I pathway of antigen presentation and induce cytotoxic 
CD8+ T cell responses. This route of alternative presentation, referred to as cross-
presentation or cross-priming, can be induced by several, not yet fully understood 
mechanisms (Groothuis and Neefjes, 2005). Although many different cell types can present 
antigens through the classical MHC pathways, only DCs and macrophages are so far 
described as cells cross-presenting exogenous antigens (Trombetta and Mellman, 2005).  
DCs are the most highly appreciated APCs, due to their high efficiency in 
internalizing antigens and presenting them in vitro and in vivo to both CD4+ and CD8+ T 
cells. However, several other cell types act as APCs with similar or less efficiency. Therefore, 
the discrimination between “professional” APCs, which generally include DCs, B cells and 
macrophages, and the “non-professional” or “amateur” APCs has been introduced. 
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Interestingly, the uptake and presentation of antigens by different cell types might result in 
distinct, APC-specific epitopes, which induce differential T cell responses (Robadey et al., 
1996; Schneider and Sercarz, 1997). Therefore, it is suggested that the presentation of the 
same antigen by different APCs may result in the induction of distinct T cell responses.   
A constructive tool to study antigen presentation is the generation of T cell receptor- 
(TCR)-transgenic mice. The T cell receptor is expressed on the surface of T cells and allows 
them to recognize antigens associated with MHC molecules. Transgenic mice for the TCR 
recognize and respond to a specific antigen presented in an MHC class I or class II way, 
depending on whether the transgenic TCR is expressed on CD8+ or CD4+ T cells, 
respectively. Since ovalbumin (OVA) comprises a very well characterized model antigenic 
protein extensively studied in murine models, TCR-transgenic mice have been generated 
against peptides derived from OVA protein. Thus, OT-I transgenic mice express transgenic 
TCR on CD8+ T cells, recognizing the OVA257-264 peptide (OT-I peptide) (Hogquist et al., 
1994), while OT-II transgenic mice express a transgenic TCR on CD4+ T cells, recognizing 
the OVA323-339 peptide (OT-II peptide) (Barnden et al., 1998). T cells isolated from those 
mice are used to investigate antigen-specific immune responses in vitro and in vivo.  
 
1.1.3. Crosstalk between innate and adaptive immunity 
Rather than being two separate systems, the innate and the adaptive immune system 
are functionally and anatomically linked to each other and synergize for the successful 
defense against pathogen invasion. Major executors of the innate-adaptive immunity 
crosstalk are cells that possess functional characteristics of both systems, therefore are able to 
detect innate signals and forward them to the adaptive immune cells (Getz, 2005).  
A key mechanism for the crosslink between the two branches of immunity is the 
recognition of pathogens by DCs through TLRs. First, DCs sense the presence of foreign 
microorganisms by TLRs. The TLR-PAMP interaction stimulates signal transduction 
pathways in DCs, which result in maturation of the DCs, up-regulation of co-stimulatory 
molecules and migration to the lymph nodes. Subsequently, the activated DCs present the 
pathogen-derived antigens to T cells, therefore initiate an antigen-dependent adaptive 
immune response. Thus, DCs act as central players at the interface between innate and 
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adaptive immunity by receiving innate immune signals and translating them into antigen-
dependent adaptive responses (Clark and Kupper, 2005; Pulendran, 2001).  
Apart from the DCs which provide the dominant bridge between innate and adaptive 
immunity, other innate immune cells have been reported to influence the adaptive immune 
response. Macrophages also express TLRs, as well as scavenger receptors that bind to and 
mediate phagocytosis of microbial pathogens (Mukhopadhyay and Gordon, 2004). Following 
phagocytosis of microbes, enhanced surface expression of co-stimulatory molecules is 
induced, which provides the macrophages with enhanced efficiency to deliver antigen-
specific signals to adaptive immune cells (Taylor et al., 2005). Moreover, it is proposed that 
NK cells, apart from their well-accepted role in promoting Th1 responses by IFN-γ 
production (Stein-Streilein et al., 2000) can also differentiate into Th2 cytokine-secreting NK 
cells, named NK2 cells (Kimura and Nakayama, 2005). Due to the number of 
immunologically relevant cytokines secreted by NK cells, it is proposed that NK cells may 
also serve as a crosslink between innate and adaptive immunity (Kos, 1998).  
Accumulating evidence suggest that MCs may act as key regulatory cells at the 
crossroads between innate and adaptive immunity. The functional characteristics that enable 
MCs to provide a link between innate and adaptive immunity are further discussed in this 
study.  
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1.2. Mast cells (MCs) 
MCs derive from hematopoietic stem cells (Kitamura et al., 1977; Nabel et al., 1981). 
MC progenitors are either committed to a distinct subtype and selectively recruited to the 
tissue, or get a tissue-specific character after epigenetic influence by environmental factors. 
After homing into different tissues, MC progenitors differentiate into mature, long-living, 
phenotypically diverse MCs (Tsai et al., 2005).  
MCs are categorized into two different subtypes: connective tissue MCs, mainly 
found in the skin, lung and peritoneal cavity and mucosal MCs, mainly found in the 
gastrointestinal mucosa. Mucosal MCs are smaller and contain less granula than the 
connective tissue MCs (Bienenstock et al., 1982; Miller and Schwartz, 1989). The flexibility 
of the MC progenitors to give rise to distinct MC subpopulations depending on the 
environment, may possibly be an explanation for the MC capacity to respond optimally to 
various stimuli in different environments and be implicated in many biological processes 
(Galli et al., 2005a).  
MC differentiation and proliferation is supported by various cytokines and soluble 
factors, such as stem cell factor (SCF), IL-3, IL-4, IL-9, IL-10 and NGF (Metcalfe et al., 
1997), as well as by adhesion to extracellular matrix components, such as laminin (Thompson 
et al., 1989), vitronectin (Bianchine et al., 1992) and fibronectin (Dastych et al., 1991). 
Among these factors, IL-3 is the absolutely necessary and sufficient one to induce murine 
MC differentiation in vitro. Therefore, in vitro differentiation of murine MCs is commonly 
achieved by culturing bone marrow cells in the presence of IL-3 for 4-5 weeks (Razin et al., 
1981; Razin et al., 1984). Such IL-3-dependent bone marrow-derived MCs (BMMCs) contain 
histamine and exhibit the characteristic red-purple appearance of their metachromatic granula 
after staining with toluidine blue (Schueller et al., 1967). A toluidine blue staining of cultured 
MCs is shown in Fig. 1.3A. SCF, the ligand for the c-kit (CD117) receptor, also plays a 
major role in MC differentiation, and induces MC maturation, activation and proliferation in 
vitro and in vivo (Zsebo et al., 1990; Tsai et al., 1991a; Tsai et al., 1991b; Wershil et al., 
1992). Therefore, SCF is used in combination with IL-3 for the in vitro differentiation of 
murine BMMCs (Tsai et al., 1991b).  
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Fig. 1.3. Morphological characteristics of MCs. A. Toluidine blue staining of a cultured 
human MC line showing the characteristic appearance of granula (from Samoszuk et al., 
2005). B. Transmission electron micrograph of rat peritoneal MCs depicting the presence of 
many electron-dense ganula (from Dileepan and Stechschulte, 2006, with kind permission of 
Springer Science and Business Media).  
A unique characteristic of MCs, possibly a fundamental reason explaining their multi-
directional (patho)physiological role, is the large number of their cytoplasmic granula (Riley 
and West, 1952). These electron-dense granules in peritoneal MCs are shown in a 
transmission electron micrograph in Fig. 1.3B. Having been the main issue of MC-related 
research for decades after MCs were first described, MC-granula contain a large stock of pre-
formed soluble mediators; histamine, heparin, proteases, acid hydrolases, chymase and other 
enzymes (Schwartz and Austen, 1980), occupy the majority of MC-cytoplasmic volume until 
an appropriate signal will trigger their prompt release in the surrounding microenvironment. 
Degranulation of MCs, the process of rapid release of pre-stored mediators by fusion of the 
granula membrane with the plasma membrane, is the quick response of MCs to activating 
signals. Sometimes beneficial, sometimes detrimental; when pathogens are being attacked, 
MC degranulation acts as a “first aid” to the threatened organism, when an “innocent” 
allergen such as grass pollen is the cause, undesired inflammation and anaphylactic shock can 
be the undue result initiated by MC over-reaction.  
In addition to the ability of rapid degranulation and release of pre-stored mediators, 
MCs have the potential of synthesizing and releasing a large number of soluble mediators 
upon activation. As shown in Fig. 1.4, MCs have the capacity to secrete a variety of 
cytokines, growth factors, chemokines and other classes of newly synthesized soluble factors 
upon activation. 
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cytokines & growth factors
IFN-α, IFN-β, IFN-γ, IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8, IL-9, IL-10,
IL-11, IL-12, IL-13, IL-14, IL-15, IL-16, IL-17F, IL-18, IL-22, IL-25, LIF, LT-β,
M-CSF, MIF, SCF, TGF-β1, TNF, TSLP, EGF, NGF, β-FGF, IGF-1, VEGF,
GM-CSF chemokines
CCL1, CCL2, CCL3, CCL3L1, CCL4, CCL5 
(RANTES), CCL7 (MCP-3), CCL8 (MCP-2), 
CCL11 (eotaxin), CCL13 (MCP-4), CCL16, 
CCL17, CCL20 , CCL22, CXCL1, CXCL2, 
CXCL3,CXCL10, CXCL11, XCL1 
(lymphotactin) 
preformed mediators
histamine, heparin, cathepsin, protease, 
tryptase, chymase, carboxypeptidase-A, 
β-hexosaminidase
lipid mediators
LTB4, PAF, PGD2, PGE2
free radicals
nitric oxide, superoxide
 
Fig. 1.4. MC-released soluble mediators. A variety of soluble factors are stored in a 
preformed state in the MC cytoplasmic granula or are newly generated and secreted upon 
activation. (modified from Galli et al., 2005b). 
Activation of MCs is induced by various factors, the best studied of which is the 
crosslinking of the high affinity receptor of IgE (FcεRI) upon specific antigen-binding 
(Metzger, 1992; Turner and Kinet, 1999). Following FcεRI aggregation, increased 
mobilization of calcium (Ca2+) mediated by the signaling enzyme phospholipase Cγ (PLCγ), 
results in MC degranulation. On the other hand, FcεRI signaling also induces 
phosphorylation of the mitogen-activated protein kinases (MAPK) and extracellular-signal-
regulated kinases (ERK), therefore mediates activation of transcription factors (namely AP1, 
NFAT and NF-kB) which lead to the production of cytokines (Gilfillan and Tkaczyk, 2006). 
Apart from the antigen-dependent FcεRI-mediated activation of MCs, other stimuli induce 
MC activation through their interaction with specific receptors. Thus, SCF interacts with the 
c-kit receptor and induces cytokine and chemokine release and regulates MC growth, 
differentiation and adhesion to extracellular matrix components (Coleman et al., 1993; 
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Columbo et al., 1992; Lorentz et al., 2002). Moreover, neuropeptides activate MC 
degranulation as well as cytokine and chemokine production (Kulka et al., 2007). 
Interestingly, pathogen-associated molecular patterns (PAMPs) induce MC activation and the 
release of mediators, via interaction with specific TLRs (Stelekati et al., 2007).  
MC functions in vivo are studied using MC-deficient murine models. MC deficiency 
in those murine models is based on the concept that the receptor c-kit (CD117) plays a major 
role in MC differentiation and function. Therefore, mice with c-kit loss of function mutations 
(WBB6F1-KitW/KitW-v mice; Kitamura et al., 1978) or tissue-type specific dysregulation of c-
kit expression (KitW-sh/KitW-sh mice; Grimbaldeston et al., 2005) lack MCs. An additionally 
interesting tool using those strains is the possibility to generate “MC-knock-in” mice; after 
reconstitution with MCs obtained either from bone marrow or from embryonic stem cells or 
directly isolated, e.g. from peritoneal cavity, these mice can be used to investigate the role of 
MCs in vivo (Nakano et al., 1985). 
 
1.2.1. MCs as participants in allergic responses 
Allergy is the result of inappropriate and excessive immune response, often against 
common, “non-dangerous” antigens. The allergic responses either occur within minutes 
(acute allergic reactions) or within hours (late phase allergic reactions) of allergen exposure. 
In some cases, symptoms may decrease and revert over time (chronic allergic reactions). 
When the allergen is encountered systemically, the symptoms occur in several sites 
simultaneously (anaphylaxis reaction) (Golden, 2007).  
For more than a century after their first description by Paul Ehrlich, MCs were only 
characterized as the main “effector cells” in allergy. The initial role attributed to MCs was 
their involvement in anaphylactic reactions (Keller, 1962) and in acute allergic reactions. 
Upon antigen/IgE-induced degranulation, MCs release histamine, lipid mediators 
(prostaglandins, leukotrienes) and proinflammatory cytokines (TNF-α, IL-8) which trigger 
acute allergic inflammation. The importance of MCs in acute allergic immune responses has 
been demonstrated in vivo by the inability of MC-deficient mice to develop acute IgE-
dependent reactions in the skin, respiratory or intestinal tract (Williams and Galli, 2000).  
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However, the role of MCs in the late phase allergic reactions remains controversial 
and apparently dependent on the immunization procedure and adjuvant used. A commonly 
used method to study the late phase allergic reactions in mice is based on the intraperitoneal 
sensitization and airway challenge against ovalbumin (OVA). Consequent symptoms include 
airway hyperresponsiveness (AHR), increased eosinophilic infiltration in the bronchoalveolar 
lavage fluid (BAL) and development of OVA-specific serum antibodies (IgE, IgG1). Takeda 
et al. (1997) reported that eosinophilic inflammation and AHR in mice sensitized and 
challenged to OVA is not controlled by MCs. However, using a less potent sensitization 
protocol, Kobayashi et al. (2000) demonstrated an essential role for MCs in the development 
of AHR.  
 
1.2.2. MCs and innate immunity 
MCs are commonly found at sites exposed to the external environment (Galli et al., 
1999; Marshall, 2004). At such places, MCs are capable of encountering exogenous antigens, 
therefore participating in the innate immune response. So far, MCs are recognized mediators 
of host defense against parasitic worms, intracellular protozoan parasites and bacteria 
(Maurer et al., 2003). Less information is available regarding the role of MCs during viral 
infections.  
The crucial contribution of MCs in the defense against parasites was defined in the 
1980s (Woodbury et al., 1984) and for many years the protective function of MCs was only 
correlated with parasitic worm infections (Marshall, 2004). MCs also protect against 
intracellular protozoan parasite infections via degranulation and release of leukotriene B4 
(LTB4), which induces cytotoxicity against the parasite (Henderson and Chi, 1998; Ben-
Rashed et al., 2003).  
The recognition of MCs as key players in innate immunity against bacteria was 
promoted by landmark studies of Echtenacher et al. (1996) and Malaviya et al. (1996a). 
These studies indicated that the presence of MCs is essential for host survival after bacterial 
infection. MC-deficient mice were shown to be less efficient both in clearing enterobacteria 
and surviving in the cecal ligation and puncture (CLP)-induced acute septic peritonitis model 
- the gold standard for sepsis research (Buras et al., 2005). 
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The role of MCs in viral infections is less studied. The synthetic compound 
polyinosinic-polycytidylic acid (poly[I:C], pIC) is used as a model to study viral infections, 
since it mimicks dsRNA, which is synthesized by various types of viruses (Der et al., 1997). 
Upon activation with pIC or virus, MCs release type I IFNs (Kulka, et al., 2004). Moreover, 
human MCs can be infected by dengue virus, which induces production of chemokines, 
namely RANTES, MIP-1a and MIP-1b (King et al., 2002). In addition, encephalomyocarditis 
virus infection results in MC chymase and tryptase production in vivo (Kitaura-Inenaga, K., 
2003). Interestingly, human MC progenitors, developed from cord blood stem cells of HIV-
infected patients, are susceptible to HIV infection (Sundstrom et al., 2004). After maturation 
in peripheral tissues, HIV-infected MC progenitors mature into latently infected MCs, which 
comprise a long-living reservoir of the virus in peripheral tissues (Sundstrom et al., 2007). 
However, the role of MCs in antiviral host defense mechanisms in vivo has not been 
thoroughly investigated.  
Lately, functional expression of TLRs has also been detected in human and rodent 
MCs. Table 1.1 summarizes the expression of TLRs on MCs and the result of TLR-induced 
MCs activation. The expression of TLRs by MCs suggests that MCs are capable of 
recognizing innate immune signals and initiating a protective immune response. An 
interesting question arising from the discovery of TLR-expression on MCs is whether TLR-
mediated activation of MCs modulate their ability to direct an adaptive immune response, in 
a way similar to that of the TLR-mediated activation of DCs.  
[1. Introduction] 
 
- 25 - 
 
 
TLR Ligand Result of TLR-induced MC activation References 
in vitro in vivo 
TLR1 lipopeptide not studied Matsushima et al., 2004 
TLR2 peptidoglycan 
activation of 
transcription factors, 
pro-inflammatory 
cytokine production 
increased 
vasodilatation, 
accumulation of 
neutrophils 
Supajatura et al., 2002; 
McCurdy et al., 2001; 
Ushio et al., 2004 
TLR3 dsRNA 
transcription of primary 
response genes, pro-
inflammatory cytokine 
production 
up-regulation of co-
stimulatory molecules, 
chemotaxis of CD8+ T 
cells 
Matsushima et al., 2004; 
Orinska et al., 2005 
TLR4 LPS,  lipid A 
activation of 
transcription factors, 
MAPK activation, pro-
inflammatory cytokine 
production 
neutrophil recruitment, 
enhanced OVA-induced 
eosinophilic infiltration 
Ikeda & Funaba, 2003;  
Masuda et al., 2002; 
Matsushima et al., 2004; 
McCurdy et al., 2001; 
Supajatura et al., 2001;  
Nigo et al., 2006;  
Qiao et al., 2006  
TLR6 peptidoglycan, zymosan not studied 
Ikeda and Funaba, 2003; 
Matsushima et al., 2004; 
McCurdy et al., 2001; 
Supajatura et al., 2001  
TLR7 R-848 pro-inflammatory cytokine production 
 Matsushima et al., 2004 
TLR8 R-848 not studied Supajatura et al., 2001 
TLR9 CpG pro-inflammatory cytokine production 
 Matsushima et al., 2004 
Table 1.1. TLR expression patterns in MCs and their effect on MC activation. dsRNA: 
double-stranded RNA; LPS: lipopolysaccharide; R-848: synthetic imidazoquin-like molecule 
resiquimod R-848; CpG: unmethylated DNA CpG motifs (modified from Stelekati et al., 
2007). 
 
1.2.3. Emerging role of MCs in adaptive immunity 
It is only during the last two decades, that continuously accumulating data suggest a 
dominant role of MCs in the regulation of adaptive immune responses, by controlling the 
phenotype and function of the adaptive immunity players (B cells, DCs and T cells), therefore 
transforming the appreciation of MCs from the pure protagonists of the effector phase of 
allergy to key regulatory cells at the crossroads between innate and adaptive immunity. 
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MCs modulate B cell responses either via direct cell-cell contact or indirectly via the 
release of cytokines. Direct cell contact between MCs and B cells occurs via CD40-CD40L 
interaction and induces IgE production by B cells (Gauchat et al., 1993; Pawankar et al., 
1997). Additionally, MCs influence the B cell development and proliferation, as well as the 
production of immunoglobulins through release of cytokines, namely IL-4, IL-9, IL-13, as 
well as proteases (Yoshikawa et al., 2001; Stassen et al., 2001;  Tkaczyk et al., 1996; 
Tkaczyk et al., 2000).  
Furthermore, MCs influence the DC biology. Several MCs products, such as  IL-1β, 
IL-18, RANTES, TNF-α and prostaglandin E2 have been reported to promote DC migration 
(Yamazaki et al., 1998; Cumberbatch et al., 2001; Kabashima et al., 2003; Suto et al., 2006), 
while IgE-mediated activation of MCs directly induces Langerhans cell migration in vivo 
(Jawdat et al., 2004). In addition, MCs regulate the functional maturation of DCs by up-
regulating integrin and co-stimulatory molecule expression (Caron et al., 2001b; Skokos et 
al., 2003). A key function of MCs in regulating DC-mediated immune responses is their 
ability to down-regulate IL-12 production by DCs via histamine and prostaglandins release 
and therefore promote a Th-2 T cell response (Caron et al., 2001a; Mazzoni et al., 2006). 
A highly effective, most recently studied mechanism, by which MCs exhibit their 
regulatory effect on B cells and DCs, is dependent on the release of exosomes. 
Heterogeneous in size and shape and stored inside the cytoplasmic granules, MC-derived 
exosomes contain a pool of MHC class II-, costimulatory- and adhesion-related molecules 
and are released during the process of exocytosis (Raposo et al., 1997; Skokos et al., 2001a). 
Exosomes can be transferred between cells of the immune system (Denzer et al., 2000), thus 
interact with B cells or DCs in an adhesion molecule-dependent way (Skokos et al., 2001b; 
Skokos et al., 2001c), induce maturation of DCs and initiate adaptive immune responses 
(Skokos et al., 2003).  
An optimal T cell response is the center of an antigen-specific cell-mediated immune 
response. MCs have been shown to modulate CD4+ T cell responses either directly (Fig. 1.5i) 
or indirectly (Fig. 1.5ii). MCs release Th-2-related cytokines such as IL-4, which induce Th-2 
polarization of naïve T cells (Mekori and Metcalfe, 1999). In contrast, exosome release by 
MCs has been correlated with Th-1 differentiation of naïve T cells in vitro (Skokos et al., 
2001a). On the other hand, the MC-B cell interaction promotes a Th-1 differentiation of naïve 
T cells (Tkaczyk et al., 2000; Skokos et al., 2001b; Skokos et al., 2001c), while MC-DC 
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interaction, resulting in down-regulation of IL-12 production by DCs promotes a Th-2 
polarization of naïve T cells (Caron et a., 2001b; Mazzoni et al., 2006). These interactions 
suggest that there is a dual role for MCs in regulating the Th1/Th2 equilibrium, depending on 
the encounter of different cells in every microenvironment (Stelekati et al., 2007).  
 
Fig. 1.5. Antigen-independent, MC-mediated modulation of T cell responses. MCs 
modulate T cell responses either (i) directly or (ii) indirectly. (i) The release of IL-4 by MCs 
favours Th-2 polarization of naïve T cells, while exosome release induces Th-1 
differentiation. (ii) MCs interact with B cells either directly (e.g. via CD40-CD40L 
interaction) or via exosome release and this interaction promotes Th-1 differentiation of 
naïve T cells. On the other hand, MCs interact with DCs via histamine and prostaglandins 
release, resulting in down-regulation of IL-12 production by DCs and subsequent Th-2 
polarization of naïve T cell (from Stelekati et al., 2007).  
A critical question arising after the exciting discovery that MCs influence T cell 
responses is whether MCs have the potential to encounter with T cells in vivo. Indeed, MCs 
have been detected in close proximity to T cells at sites of allergic inflammation (Mekori, 
2004; Nakae et al., 2005). On one hand, a variety of MC-derived chemokines induce T cell 
migration towards the site of inflammation (Mekori and Metcalfe, 1999). Furthermore, MC-
derived TNF-α induces recruitment of circulating T cells into the draining lymph nodes 
during bacterial infection (McLachlan et al., 2003). In addition, FcεRI-mediated 
degranulation of MCs results in chemotaxis of effector but not central memory CD8+ T cells 
via leukotriene B4 (LTB4) secretion (Ott et al., 2003). CD8+ T cell recruitment is also induced 
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by TLR-3-dependent activation of MCs in vivo (Orinska et al., 2005). On the other hand, 
MCs have been also reported to migrate from the site of allergen encounter to the draining 
lymph nodes, where they recruit T lymphocytes (Wang et al., 1998). This evidence suggests 
that MCs actively regulate T cell migration, therefore a potential MC-T cell interaction in 
vivo is speculated. 
 
1.2.4. MCs and antigen presentation 
Presentation of antigens is of major importance for the initiation of an appropriate 
adaptive immune response, which will lead to the successful elimination of pathogens as well 
as to the induction of immunological memory. Antigen presentation in every 
microenvironment is dependent on the presence and function of the corresponding APCs 
(Unanue, 2007). DCs, B cells and macrophages are regarded as “professional” APCs, 
however constantly more cell types are suggested to execute similar function. Several hints of 
MCs exerting such a physiological role have emerged during the last decade; however the 
admission of MCs as “antigen presenting cells” has not yet been entirely approved by the 
scientific community.  
The first suggestion that MCs may act as APCs arouse after the observation that 
cultured MC progenitors (Wong et al., 1982) as well as primary rat MCs (Banovac et al., 
1989) express MHC class II. Thereafter, MHC class II and co-stimulatory molecule 
expression has been detected on mouse (Frandji, et al., 1993), rat (Fox et al., 1994; Warbrick 
et al., 1995) and human (Love et al., 1996; Poncet et al., 1999) MCs. Further studies 
investigated the ability of MCs to present MHC class II-restricted antigens to T cells in vitro: 
mouse BMMCs (Frandji, et al., 1993) as well as rat (Fox et al., 1994) and human (Poncet et 
al., 1999) primary MCs can efficiently induce antigen-specific proliferation of CD4+ T cell 
lines in vitro. Despite the reports demonstrating the ability of MCs to induce antigen-specific 
CD4+ T cell responses by presentation of MHC class II-restricted antigens, less information 
has been obtained so far regarding the ability of MCs to modulate CD8+ T cell responses. A 
valuable report in this direction by Malaviya et al., demonstrates that BMMCs present 
bacterial antigens and induce proliferation of a CD8+ T cell line after phagocytosis of living 
bacteria (Malaviya et al., 1996b). Nevertheless, neither the mechanism of the antigen-specific 
interaction between MCs and CD8+ T cells, nor its relevance in vivo has been investigated so 
far. 
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1.3. The goal of this study 
Increasing evidence of MCs playing an important regulatory role in adaptive 
immunity suggests a re-evaluation of their designation as pure innate immune participants 
and a detailed investigation of their diverse physiological and pathological role. It has been 
reported that MCs induce CD8+ T cell chemotaxis, however little is known about the 
potential of MCs to induce further CD8+ T cell responses. The crucial contribution of CD8+ T 
cells in the defense against intracellular pathogen infections as well as their dominant role in 
allergic reaction renders essential the detailed examination of the mechanisms that induce 
their effector functions. A possible crosstalk between MCs and CD8+ T cells could be a key 
regulatory mechanism to modulate the activities of both MCs and CD8+ T cells in various 
pathophysiological situations. For this reason, the purpose of this study was to investigate the 
ability of MCs to interact with CD8+ T cells, present an MHC class I-restricted antigen and 
initiate antigen-specific primary CD8+ T cell responses in vitro and in vivo. Furthermore, 
since MCs are resident cells in the periphery, therefore have the potential to contact activated 
T cells, the effect of MC interactions with activated CD8+ T cells was studied. Finally, the 
investigation of the regulatory effects that a MC-CD8+ T cell interaction has on the MCs was 
pursued.  
 
In summary, the questions addressed during this study were the following:  
1. Are MCs able to modulate primary CD8+ T cell responses in an antigen-independent 
manner? 
2. Can MCs initiate antigen-specific CD8+ T cell responses? 
• What are the outcomes (e.g. activation, proliferation, cytokine production, 
cytotoxicity) of a MC-CD8+ T cell antigen-specific interaction?  
• What is the mechanism of a MC-CD8+ T cell antigen-specific interaction? 
3. Do MCs regulate CD8+ T cell responses in antigen-driven manner in vivo? 
• Do MCs contribute to the modulation of CD8+ T cell activities in an allergic murine 
model? 
4. Do MCs tune the activities of effector CD8+ T cells? 
5. Do CD8+ T cells after the MC encounter affect the activities of their MC partners?  
 
The questions aroused during this study are schematically depicted in Fig. 1.6. 
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Fig. 1.6. Questions aroused during the present study. MCs have been shown to induce 
chemotaxis of CD8+ T cells, however little is known about their further interaction with 
CD8+ T cells. Therefore, this study investigated the ability of MCs to induce CD8+ T cell 
responses in an antigen-dependent and antigen-independent manner as well as the ability of 
CD8+ T cells to modulate MC activities.  
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2. Materials and Methods 
2.1. Materials 
2.1.1.  Animals 
C57BL/6 mice were purchased from Charles River (Sulzfeld, Germany). TCR-transgenic 
OT-I mice (Hogquist et al., 1994) were bred in the Animal Care Facility of the Research 
Center Borstel, Germany. Beta-2-microglobulin-deficient mice (β2m-/-) (Koller et al., 1989) 
were kindly provided by F. Winau (MPI for Infection Biology, Berlin, Germany). Mast cell 
(MC)-deficient WBB6F1-KitW/KitW-v mice (Kitamura et al., 1978) were kindly provided by 
Prof. M. Maurer (Charite, Berlin, Germany) and bred in FEM Berlin.  
 
2.1.2. Chemicals and other reagents 
Reagent:     Purchased from: 
Accutase      PAA Laboratories, Pasching, Austria 
Agarose     Invitrogen, Paisley, U.K. 
Alum Imject (Al(OH)3)          Pierce Biotechnology, Rockford, U.S.A. 
Ammonium chloride (NH4Cl)   Merck, Darmstadt, Germany 
Aqua B. Braun H2O    Melsungen, Germany 
Bio-Plex Cytokine Assay  
(10-plex, mouse Th1/Th2)     Bio-Rad Laboratories, Munich, Germany 
Boric acid (H3BO3)    Merck, Darmstadt, Germany 
Bovine serum albumin (BSA)  Sigma-Aldrich, Steinheim, Germany 
Brefeldin A     Sigma-Aldrich, Steinheim, Germany 
CFDA SE Cell Tracer Kit (CFSE)         Molecular Probes, Leiden, The Netherlands 
Chloroform (CHCl3)     Merck, Darmstadt, Germany 
Ciprofloxacinhydrochlorid            Wald-Apotheke, Wahlstedt, Germany 
Collagenase Type IV  
(from Clostridium histolyticum)   Sigma-Aldrich, Steinheim, Germany 
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Deoxyribonuclease I            Sigma-Aldrich, Steinheim, Germany 
Diethylpyrocarbonate (DEPC)-H2O   Sigma-Aldrich, Steinheim, Germany 
Dimethyl sulfoxide (DMSO)    Sigma-Aldrich, Steinheim, Germany 
Disodium hydrogen phosphate (Na2HPO4)  Merck, Darmstadt, Germany 
dNTP  (10 mM)            Roche, Mannheim, Germany 
DuoSet ELISA Development Kit (IFN-γ) R&D Systems, Wiesbaden, Germany 
DuoSet ELISA Development Kit (IL-2) R&D Systems, Wiesbaden, Germany 
Ethanol (C2H5OH)    Merck, Darmstadt, Germany 
Ethidium bromide     Merck, Darmstadt, Germany  
Ethylene diamine tetraacetic acid (EDTA) Merck, Darmstadt, Germany 
Fetal calf serum (FCS)           Biochrom, Berlin, Germany 
Fluorescein Isothiocyanate Isomer I (FITC)  Sigma-Aldrich, Steinheim, Germany 
Hydrochloric acid (HCl)   Merck, Darmstadt, Germany 
Hydrogen peroxide (H2O2)   Merck, Darmstadt, Germany  
Hematoxylin            Merck, Darmstadt, Germany 
Hydrogen citrate (citric acid)  (C6H8O7)       Merck, Darmstadt, Germany 
IMDM             PAA Laboratories, Pasching, Austria 
Isopropanol (C3H8O)           Gibco, Rockville, USA 
L-glutamine with penicillin/streptomycin  PAA Laboratories, Pasching, Austria 
Loading dye (6-fold)     MBI Fermentas, St.Leon-Rot, Germany 
LPS (from Salmonella enterica)         provided by H. Brade, Borstel 
Lysine      Merck, Darmstadt, Germany 
Magnesium chloride (MgCl2)   Merck, Darmstadt, Germany 
Microarray (Maus MG 430 2.0)  Affymetrix, Santa Clara, U.S.A. 
Microbeads (anti-FITC)         Miltenyi Biotec, Bergisch Gladbach, Germany 
Microbeads (streptavidin)         Miltenyi Biotec, Bergisch Gladbach, Germany 
Mitomycin C            Sigma-Aldrich, Steinheim, Germany 
Molecular weight marker    MBI Fermentas, St.Leon-Rot, Germany 
Newborn calf serum (NCS)          Gibco, Rockville, USA 
Non-essential amino acids          Gibco, Rockville, USA  
Ovalbumin (OVA) grade V         Sigma-Aldrich, Steinheim, Germany 
Ovalbumin (OVA) grade VI         Sigma-Aldrich, Steinheim, Germany 
OVA257-264 (SIINFEKL)         NeoMPS, Strasbourg, France 
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Paraformaldehyde           Fluka, Steinheim, Germany 
PBS for cell culture  
(without Magnesium, without Calcium) PAN Biotec, Aidenbach, Germany 
Polyinosinic-polycytidylic acid (pIC) Sigma-Aldrich, Steinheim, Germany 
Potassium chloride (KCl)    Merck, Darmstadt, Germany 
Potassium phosphate (KH2PO4)   Merck, Darmstadt, Germany 
Propidium iodide (PI)           Sigma-Aldrich, Steinheim, Germany 
Random Primer            New England Biolabs, Frankfurt, Germany 
Ribonuclease Inhibitor           MBI Fermentas, St.Leon-Rot, Germany 
RPMI-1640      Biochrom, Berlin, Germany 
Sephadex G50     GE Healthcare, Freiburg, Germany 
Sodium azide (NaN3)          Merck, Darmstadt, Germany 
Sodium carbonate (Na2CO3)   Merck, Darmstadt, Germany 
Sodium chloride (NaCl)         Merck, Darmstadt, Germany 
Sodium pyruvat (C3H3NaO3)          Gibco, Rockville, U.S.A. 
Streptavidin-HRP     R&D Systems, Wiesbaden, Germany 
Succrose      Sigma-Aldrich, Steinheim, Germany 
Sulfuric acid (H2SO4)    Merck, Darmstadt, Germany 
Superscript II Reverse Transcriptase Kit        Invitrogen, Paisley, U.K. 
Taq-DNA-Polymerase (SAWADY)  Peqlab Biotechnologie, Erlangen, Germany 
Tetramethylbenzidin           Fluka, Steinheim, Germany 
Toluidine blue            Sigma-Aldrich, Steinheim, Germany 
Tris       Serva GmbH, Heidelberg, Germany 
Trizol-Reagent            Invitrogen, Paisley, U.K. 
Trypan blue  
(0.5% w/v in physiological saline)  Biochrom, Berlin, Germany 
Tween 20      Sigma-Aldrich, Steinheim, Germany 
Vitamin             Gibco, Rockville, U.S.A. 
β-mercaptoethanol            Gibco, Rockville, U.S.A. 
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2.1.3. Cytokines 
Cytokine:     Purchased from: 
Recombinant mouse IL-3    R&D Systems, Wiesbaden, Germany 
Recombinant mouse SCF    R&D Systems, Wiesbaden, Germany 
Recombinant mouse GM-CSF   Peprotec, London, U.K. 
 
2.1.4. Monoclonal antibodies and detection reagents for FACS 
Antibody (specific for mouse):  Purchased from: 
CD117 (c-Kit, 2B8)     BD PharMingen, Heidelberg, Germany 
CD11b (Integrin αM chain, M1/70)         BD PharMingen, Heidelberg, Germany  
CD11c  (Integrin αx chain, HL3)         BD PharMingen, Heidelberg, Germany 
CD16/32 (Fcγ III/II, 2.4G2)           BD PharMingen, Heidelberg, Germany 
CD25 (IL-2 receptor α chain, p55)   BD PharMingen, Heidelberg, Germany 
CD3ε (CD3 ε chain, 145−2C11)        BD PharMingen, Heidelberg, Germany 
CD4 (L3T4, RM4-5)               BD PharMingen, Heidelberg, Germany 
CD44 (Pgp-1, Ly-24, IM7)    BD PharMingen, Heidelberg, Germany 
CD45R/B220 (RA3-6B2)   BD PharMingen, Heidelberg, Germany 
CD49b/Pan-NK Cells (DX5)    BD PharMingen, Heidelberg, Germany 
CD62L  
(L-selectin, LECAM-1, Ly-22, MEL-14) BD PharMingen, Heidelberg, Germany 
CD69  
(very early activation antigen, H1.2F3)  BD PharMingen, Heidelberg, Germany 
CD80 (B7.1, 16-10A1)          BD PharMingen, Heidelberg, Germany 
CD86 (B7.2, GL1)           Southern Biotechnology, Alabama, U.S.A. 
CD8α (Ly-2, 53-6.7)           BD PharMingen, Heidelberg, Germany 
F(ab´)2 anti-rat IgG     AbD Serotec, Dusseldorf, Germany 
F4/80 antigen (MCA497FB)   AbD Serotec, Dusseldorf, Germany 
FcεRI alpha (MAR-1)    eBioscience, Frankfurt, Germany   
Gr-1 (Ly-6C and G, 53-6.7)         BD PharMingen, Heidelberg, Germany 
Granzyme B (16G6)     eBioscience, Frankfurt, Germany 
H2-kb (MHC class I) (AF6-88.5)  BD PharMingen, Heidelberg, Germany 
[2. Materials and Methods] 
 
- 35 - 
 
I-A/I-E (MHC class II) (M5/114.15.2)      BD PharMingen, Heidelberg, Germany 
IFN-γ       BD PharMingen, Heidelberg, Germany 
IL-2       BD PharMingen, Heidelberg, Germany 
Isotype controls     BD PharMingen, Heidelberg, Germany 
LAMP-1     DSHB, Iowa, U.S.A. 
Streptavidin-APC    BD PharMingen, Heidelberg, Germany 
Streptavidin-FITC     Genzyme, Cambridge 
Streptavidin-PE     Dianova, Hamburg, Germany 
T1/ST2 (DJ8)           Morwell Diagnostics, Switzerland  
 
2.1.5. Primers 
 
Primers for PCR were purchased from Metabion (Martinsried, Germany) at stock 
concentration of 100 μM. Following primer pairs were used: 
mouse Lzp-s-F: 5´-AGA ATG CCT GTG GGA TCA AT- 3´ 
mouse Lzp-s-R: 5´-CTG GGA CAG ATC TCG GTT TT- 3´ 
 
mouse 4-1BB-F: 5´-AGT GTC CTG TGC ATG TGA- 3´ 
mouse 4-1BB-R: 5´-AGT TAT CAC AGG AGT TCT GC- 3´ 
 
mouse 4-1BBL-F: 5´-CGC TTT GGT TTT GCT GCT TCT G- 3´ 
mouse 4-1BBL-R: 5´-CAT CTA CCT GAG GCT TTG CTT GC- 3´ 
 
mouse Tgm-2-F: 5´-TCA GCC AGC AGC CTC TAG AC- 3´ 
mouse Tgm-2-R: 5´-CCT ACT GCC TGC TTG GAA CC- 3´ 
 
mouse IFN-γ-F: 5´-AGC GGC TGA CTG AAC TCA GAT TGT AG- 3´ 
mouse IFN-γ-R: 5´-GTC ACA GTT TTC AGC TGT ATA GGG- 3´ 
 
mouse β-actin-F: 5´-CTC CTT AAT GTC ACG CAC GAT TTC- 3´ 
mouse β-actin-R: 5´-GTG GGG CGC CCC AGG CAC CA- 3´ 
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2.1.6. Buffers 
 
2.1.6.1.  Buffers for cell culture 
Phosphate buffered saline (PBS) (PAN Biotec, Aidenbach, Germany) 
 
IMDM complete medium    =  Iscove´s modified DMEM (IMDM) + 10% heat-inactivated 
FCS + 50 µM β-mercaptoethanol + 2 mM L-glutamine + 
100 U/mL penicillin + 100 µg/mL streptomycin + 1-fold 
non-essential amino acids + 1 mM sodium pyruvat  
RPMI complete medium = RPMI-1640 + 10% heat-inactivated FCS + 50 µM β-
mercaptoethanol + 2 mM L-glutamine + 100 U/mL 
penicillin + 100 µg/mL streptomycin  
 Erythrocyte lysis buffer     =   H2O + 0.83% NH4Cl + 0.168% Na2CO3 + 1 mM EDTA, 
pH=7.3, sterile filtrated 
 
2.1.6.2.  Buffers for cell isolation 
MACS buffer  =  PBS + 5% heat-inactivated FCS  
 
2.1.6.3.  Buffers for flow cytometry 
FACS buffer  =   PBS + 2% NCS + 0.1% NaN3 + 2 mM EDTA, pH=7.4 - 7.5 
Phosphate buffered saline (PBS) = H2O + 3.2 mM Na2HPO4 + 0.5 mM KH2PO4+ 1.3 mM    
KCl + 135 mM NaCl, pH = 7.4 
For intracellular FACS staining:  
IC Fixation buffer (eBioscience, Frankfurt, Germany), containing 4% paraformaldehyde  
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10-fold Permeabilization buffer (eBioscience, Frankfurt, Germany), diluted 1:10 with Aqua 
B. Braun H20 (working solution), containing 0.1% saponin and 0.09% sodium azide at the 1-
fold final working solution 
Flow cytometry staining buffer (eBioscience, Frankfurt, Germany), containing fetal bovine 
serum and sodium azide 
 
2.1.6.4.  Buffers for ELISA 
Blocking buffer = PBS + 1% BSA + 5% sucrose + 0.05% sodium azide 
Washing buffer  = PBS + 0.05% Tween 20, pH=7.2-7.4 
Reagent diluent buffer  =  Tris-buffered saline (20 mM Tris, 150 mM NaCl) + 0.1% BSA+ 
0.05% Tween 20, pH=7.2-7.4 
 
2.1.6.5.  Buffers for molecular biological techniques 
Reaction buffer for cDNA synthesis = 5.0 µl 5-fold Strand-Buffer + 2.5 µl DTT-Buffer (0.1 
M) + 5.0 µl dNTP´s (10 mM) + 0.75 µl Ribonuclease 
Inhibitor + 4.5 µl DEPC-H2O 
5-fold strand-buffer (Invitrogen, Paisley, U.K.), containing  250 mM Tris-HCl, 375 mM 
KCl, 15 mM MgCl2, pH=8.3 at room temperature (RT) 
DTT-Buffer (Invitrogen, Paisley, U.K.) 
10-fold  PCR-buffer  for SAWADY Taq-DNA-polymerase (Peqlab Biotechnologie, 
Erlangen, Germany), containing 100 mM Tris-HCl, 500 mM KCl, 0.1% Tween 20, 15 mM 
MgCl2, pH = 8.8 
Reaction mix for PCR = 2 µl 10-fold PCR-Buffer + 1 µl forward primer + 1 µl reverse 
primer  + 0.3 µl dNTP´s (10 mM) + 0.2 µl Taq Polymerase + 
14.5 µl Aqua B. Braun H2O 
Electrophoresis buffer  (Tris/boric acid/EDTA; TBE)  =  89 mM Tris  +  89  mM boric acid  
+ 2 mM EDTA, pH = 8.0 
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2.1.7. Laboratory supplies 
Supply:     Purchased from: 
Anopore membrane (0.02 μm, 10 μm)   Nunc, Roskilde, Dennmark 
Anopore membrane (0.2 μm, 10 μm)       Nunc, Roskilde, Dennmark 
Gel casting tray     Bio-Rad Laboratories, Munich, Germany 
Microcentrifuge tubes (1.5 ml, 2 ml)      Sarstedt, Nümbrecht, Germany 
Microscope cover slips (24 x 40 mm) Gerhard Menzel Glasbearbeitungswerk, 
Braunschweig, Germany 
Microscope slides (76 x 26 mm)  Waldemar Knittel Glasbearbeitung, 
Braunschweig, Germany 
Multidish with 24 wells    Nunc, Roskilde, Dennmark 
Multidish with 48 wells    Nunc, Roskilde, Dennmark 
Multidish with 96 wells (flat-bottom) Nunc, Roskilde, Dennmark 
Needles (23 G, 27 G)     Becton Dickinson S.A., Madrid, Spain 
Neubauer counting chamber    Paul Marienfeld, Königshofen, Germany 
Petri dish (100 x 15 mm, sterile)  Becton Dickinson Labware, Franklin Lakes,  
U.S.A. 
Plastic pipette tips   Sarstedt, Nümbrecht, Germany 
Plastic pipettes (5 ml, 10 ml, 25 ml)  Greiner bio-one, Frickenhausen, Germany 
Plastic tubes (15 ml, 50 ml)      Sarstedt, Nümbrecht, Germany 
Syringe (1 ml, 5 ml, 10 ml)   Becton Dickinson S.A., Madrid, Spain 
Tissue culture flask  
(non-pyrogenic, 250 ml, 75 cm2, sterile) Greiner bio-one, Frickenhausen, Germany 
Tubes for FACS (5 ml, 75 x 12 mm)  Sarstedt, Nümbrecht, Germany 
               
 
2.1.8. Laboratory equipment 
Equipment:     Purchased from: 
Automacs      Miltenyi Biotec, Bergisch Gladbach, Germany 
Bench       Kojair, Vilppula, Finland 
Bio-Plex array reader     Bio-Rad Laboratories, Munich, Germany 
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Centrifuge Mikro 22      Hettich Zentrifugen, Tuttlingen, Germany 
Centrifuge Rotina 46 R     Hettich Zentrifugen, Tuttlingen, Germany 
Cytocentrifuge (Cytospin3)     Shandon, Frankfurt, Germany 
ELISA reader       Tecan, Salzburg, Austria 
ELISA washer      Tecan, Salzburg, Austria 
FACS Calibur flow cytometer    BD Biosciences, Heidelberg, Germany 
Fluorescence microscope (Diaphot 300)  Nikon, Japan 
Glassware      Duran Group, Mainz, Germany 
Incubator                                                          Kendro Laboratory Products, Langenselbold, 
Germany 
Microplate shaker  Laborbedarf Hassa, Lübeck, Germany 
Microwave oven (1026L) Privileg, Korea 
Microscope       Olympus Optical, Japan 
pH Meter       Baack Laborbedarf, Schwerin, Germany 
Photometer (automatic)    Eppendorf, Hamburg, Germany 
Pipettes       Eppendorf, Hamburg, Germany 
Power supply (Power PAC300)   Bio-Rad Laboratories, Munich, Germany 
Precision Balance      A&D Instruments, Japan 
Thermoblock       Biometra, Goettingen, Germany 
Thermocycler       Eppendorf, Hamburg, Germany 
Transluminator with camera     Biometra, Goettingen, Germany 
Vortex (Minishaker MS2)     IKA Works, Wilmington, USA 
Waterbath       Medingen, Germany 
 
 
2.1.9. Software 
Bio-Plex Manager Software    Bio-Rad Laboratories, Munich, Germany 
Cell Quest  Becton Dickinson, Immunocytometry Systems,   
California, U.S.A. 
Magellan      Tecan, Salzburg, Austria 
Microsoft Office 2007   Microsoft Cooperation, CA, U.S.A. 
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2.2. Methods 
 
2.2.1.   Cell culture techniques 
 
2.2.1.1. Cell counting 
Counting of cells was performed with exclusion of dead cells by trypan blue. Trypan 
blue permeates the membrane of only dead cells, therefore dead cells appear blue. Working 
solution of trypan blue was prepared by diluting trypan blue 1:10 in 0.9% NaCl. The cell 
suspension to be counted was diluted 1:10 in the working solution of trypan blue and cells 
were counted using a Neubauer counting chamber under optical microscope.  
 
2.2.1.2. Generation and cultivation of BMMCs 
As a model of studying mast cell (MC) phenotype and function, bone marrow-derived 
mast cells (BMMCs) were used. BMMCs were obtained as described previously (Razin et al., 
1984; Dvorak et al., 1994) with some modifications. Bone marrow was isolated from femurs 
and tibia of C57BL/6 wild-type mice or of β2m-/- mice. The bone marrow was flushed with 
phosphate buffered saline (PBS) and washed once with PBS. All cell washing steps were 
carried out in centrifuge at 270 x g for 10 min at 4° C. Erythrocytes were lysed by incubation 
in erythrocyte lysis buffer for 15 min at room temperature (RT). Next, cells were washed 
with IMDM complete medium and cultured in a 75 cm2 tissue culture flask. Cells were 
maintained in IMDM complete medium supplemented with 5 ng/ml murine recombinant IL-3 
and 10 ng/ml murine recombinant SCF. Once per week, cells were collected from the flask, 
centrifugated, resuspended in fresh IMDM complete medium supplemented with 5 ng/ml   
IL-3 and 10 ng/ml SCF and plated in a new flask. During the first 2 weeks of culture, 
ciprofloxacinhydrochlorid was added at a concentration of 10 μg/ml. The cells were 
maintained in incubator with 7.5% CO2 at 37° C. Five weeks after the initiation of the 
culture, the maturation and purity of BMMCs were tested with toluidine blue/hematoxylin 
staining (2.2.1.3) and FACS analysis (2.2.4.1) for cell surface expression of CD117 (c-Kit), 
FcεRI, CD11c, CD11b, CD45R/B220 and F4/80 .  
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2.2.1.3. Toluidine blue/hematoxylin staining of BMMCs 
Toluidine blue staining of MCs was performed in order to test MC maturation. 
Toluidine blue is a metachromatic dye, which binds to biologically active mediators in MC 
granula. Cytospins of MCs were prepared using a cytocentrifuge on 76 x 26 mm microscope 
slides. Cells were fixed in 50% ethanol for 15 min at RT and then transferred into toluidine 
blue working solution, consisting of 0.2% toluidine blue and 1.92% hydrogen citrate in 50% 
ethanol. Cells were stained with toluidine blue for 30 min at RT and subsequently washed 
with distilled water. Afterwards, cells were stained with hematoxylin for 3 min at RT and 
then washed with water. Slides were left to dry on air and covered with microscope cover 
slips before being examined using a microscope.  
 
2.2.1.4. Generation of BMDCs 
As a positive control for antigen presentation experiments, bone marrow-derived 
dendritic cells (BMDCs) were used. BMDCs were derived as previously described (Scheicher 
et al., 1992; Inaba et al., 1992). Bone marrow isolated from femurs and tibia of C57BL/6 
wild-type mice was flushed with phosphate buffered saline (PBS) and washed once with 
PBS. All cell washing steps were performed at 270 x g for 10 min at 4° C. Erythrocytes were 
lysed by incubation in erythrocyte lysis buffer for 15 min at RT. Next, cells were washed 
with RPMI complete medium and viable cells were counted after staining with trypan blue. A 
number of 3 x 106 bone marrow cells were seeded in a 100 x 15 mm petri dish in 10 ml 
complete RPMI medium supplemented with 20 ng/ml murine recombinant GM-CSF. The 
cells were maintained in incubator with 5% CO2 at 37° C. On day 3, 10 ml RPMI complete 
medium supplemented with 20 ng/ml GM-CSF were added to the cells. On day 6, 10 ml of 
the cells were removed in a plastic sterile tube, centrifugated, resuspended in fresh 10 ml 
RPMI complete medium supplemented with 10 ng/ml GM-CSF and added to the rest of the 
cells in the petri dish. On day 8, the maturation of BMDCs was tested by FACS analysis 
(2.2.4.1) for surface expression of CD11c, CD80 and MHC class II expression.  
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2.2.1.5. Detachement of BMDCs 
BMDCs are adherent cells at the bottom of the petri dish. On day 8 of BMDC 
differentiation, cells were detached from the bottom of the petri dish with the use of accutase. 
The medium of the cell culture was removed into a plastic sterile 50 ml tube. 5 ml PBS were 
used to wash the petri dish and subsequently added to the tube with the rest of the cells. 3 ml 
of pre-warmed accutase were added into the petri dish and incubated for 20 min at 5% CO2 in 
37° C in an incubator. Next, the petri dish was washed with PBS until the cells were 
detached. The supernatant was given to the rest of the cells in the plastic tube and the petri 
dish was washed twice with 5 ml RPMI complete medium. Finally, the collected cells were 
added to the rest of the cells in the plastic tube and centrifugated at 270 x g for 10 min, at     
4° C. 
 
2.2.2.   Cell purification 
 
2.2.2.1. CD8+ T cell separation  
CD8+ T cells were obtained from TCR-transgenic (OT-I) mice using magnetic-
associated cell sorting (MACS). Mice were euthanized with CO2 inhalation and inguinal, 
cervical, axillary, brachial, mesenteric and lumbar lymph nodes were excised and 
homogenized in PBS by forcing them through a metallic mesh. All cell washing steps were 
carried out at 270 x g for 10 min, at 4° C. Erythrocytes were lysed by incubation in 
erythrocyte lysis buffer for 15 min at RT. Afterwards, cells were washed with RPMI 
complete medium, counted and resuspended in MACS buffer at a concentration of 108 
cells/ml.  
Negative selection of CD8+ T cells from the lymph node cell suspension was 
performed according to a standard protocol provided by Miltenyi Biotec 
(www.miltenyibiotec.com). The cells were incubated with 1 μg/ml FITC-labeled monoclonal 
antibodies against CD4, CD45R/B220, CD49b/Pan-NK, CD11c and F4/80 for 20 min on ice, 
in the dark. After a washing step with MACS buffer, cells were incubated with anti-FITC 
microbeads for 15 min at 4° C in the dark, according to the manufacturer´s instructions. 
Finally, magnetic associated cell sorting using the program “DEPLETES” (for increased 
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purity) of automacs was performed, resulting in two separate fractions: a negative fraction 
containing the unlabeled CD8+ T cells and a positive fraction containing the rest of the lymph 
node cells (FITC-labeled). The purity of the CD8+ T cell fraction was tested by FACS 
analysis (2.2.4.1).  
 
2.2.2.2. Purification of MCs 
In some experiments, MCs were purified after co-culture with CD8+ T cells in vitro. 
For purification of MCs, positive selection with MACS was used. Cells were washed with 
MACS buffer, counted and resuspended at a concentration of 108 cells/ml. Cells were 
incubated with 2.5 μg/ml biotin-labeled monoclonal antibody against CD117 for 20 min on 
ice, in the dark. After a washing step with MACS buffer, cells were incubated with 
streptavidin-micobeads for 15 min at 4° C in the dark, according to the manufacturer´s 
instructions. Magnetic associated cell sorting using the program “POSSEL” (for increased 
purity) of automacs resulted in two separate fractions: a negative fraction containing the 
unlabeled CD8+ T cells and a positive fraction containing the labeled MCs. To increase the 
purity of MCs, the positive fraction was re-labeled with streptavidin-microbeads and sorted 
with automacs for a second time. The purity of the MC fraction was tested by FACS analysis 
(2.2.4.1). 
 
2.2.3.    In vitro activation of CD8+ T cells by MCs 
 
2.2.3.1. Pulsing of BMMCs with OVA257-264peptide 
In order to test the ability of MCs to induce antigen-specific CD8+ T cell responses, 
BMMCs were pulsed with the OT-I specific OVA257-264 peptide. The pulsing of BMMCs with 
the OVA257-264 peptide was performed according to standard protocols used for DCs 
(Kukutsch et al., 2000; Rückert et al., 2003). BMMCs were resuspended in IMDM complete 
medium at a concentration of 107 cells/ml. The OVA257-264 peptide was added to the cell 
suspension at a final concentration of 4 μg/ml and cells were incubated for 3 hrs in a 
waterbath at 37° C. Cells were gently shaken every 30 min. Afterwards, cells were washed 4 
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times with 5 ml IMDM complete medium, resuspended in IMDM complete medium and 
counted after staining with trypan blue.  
In some experiments, the cytokine release from BMMCs was inhibited by mitomycin 
C or paraformaldehyde treatment of the BMMCs. For this reason, following the pulsing with 
OVA257-264 peptide, BMMCs were treated with 10 μg/ml mitomycin C for 30 min in a 
waterbath at 37° C or with 1% paraformaldehyde for 3 hrs at RT, in the dark. After 
mitomycin C or paraformaldehyde treatment, the BMMCs, as well as their untreated controls, 
were washed 3 times with 5 ml IMDM complete medium. Finally, cells were counted and 
resuspended in IMDM complete medium.  
 
2.2.3.2. In vitro MC-CD8+ T cell co-culture 
Purified CD8+ T cells were plated in the wells of a 48-well multidish plate at a 
concentration of 1 x 106 cells/ml. In parallel, 0.01 x 106 - 0.5 x 106 of OVA257-264 -pulsed or 
control unpulsed BMMCs were added to the CD8+ T cells, as indicated in each experiment. 1 
μg/ml murine recombinant IL-3 was added to the wells and the final volume was brought to 
500 μl by addition of IMDM complete medium.  
In some experiments, the direct cell-cell contact between CD8+ T cells and BMMCs 
was inhibited by placing a 0.2 μm or a 0.02 μm anopore membrane in a 24-well multidish 
plate. In this case, CD8+ T cells were plated at the bottom part of the wells, while BMMCs 
were placed inside the upper chamber of the transwell.  
Unless otherwise stated, the MC-CD8+ T cell co-culture lasted for 48 hrs. However, 
for measuring the CD8+ T cell proliferation by CFSE (2.2.5.1), the MC-CD8+ T cell co-
culture lasted for 72 hrs. In either case, supernatants were collected for measurement of 
secreted cytokines (2.2.6) and cells were analyzed by flow cytometry (2.2.4.). A schematic 
representation of the in vitro MC-CD8+ T cell co-culture experimental setup is depicted in 
Fig. 2.1.  
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c) Intracellular FACS staining (cytokines)
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Negative selection of CD8+ T cells
OT-I 
transgenic mice
C57/BL6 mice
β2m -/- mice
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+ IL-3, SCF 
48 / 72 hrs
Bone marrow-derived mast cell
(BMMC) differentiation lymphocyte purification
 
Fig. 2.1. Experimental setup for studying the interactions between MCs and CD8+ T 
cells in vitro. 
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2.2.4. Flow cytometry 
 
2.2.4.1. Surface staining 
For surface FACS staining, 2 x 105 – 5 x 105 cells were washed once, resuspended in 
100 μl FACS buffer and stained with phycoerythrin-(PE), allophycocyanin-(APC), or 
fluorescein isothyocyanate-(FITC) conjugated monoclonal antibodies. The antibodies used 
for surface FACS staining are shown in 2.1.4. Cells were distributed into 5 ml FACS tubes 
and each sample was stained with a maximum of three antibodies: FITC-, PE- or APC- 
conjugated. Unstained cells or isotype-control stained cells served as a negative control, as 
indicated in each experiment. Unless otherwise specified, the antibodies for FACS staining 
were added to the cells at a concentration of 0.2 μg/ml. Cells were incubated for 20 min at 4° 
C in the dark and subsequently washed with 1µg/ml propidium iodide in FACS buffer, in 
order to stain for dead cells.  
In some experiments, biotin-labeled antibodies were used for surface FACS staining. 
These samples were stained with 0.2 μg/ml biotin-labeled antibodies for 20 min, at 4° C in 
the dark and subsequently washed with FACS buffer. Cells were then stained with a 
secondary antibody, namely FITC-, PE- or APC- conjugated streptavidin for 20 min, at 4° C 
in the dark and finally washed with 1µg/ml propidium iodide in FACS buffer.  
For analysis of MC phenotype, the unspecific binding of antibodies to the Fc receptor 
of MCs was blocked by the use of purified anti-mouse CD16/32 antibody. MCs were 
incubated with 10 μg/ml purified anti-CD16/32, for 15 min at 4° C. The antibodies for 
surface staining of MCs were added without washing the anti-CD16/32 antibodies away. 
Samples were incubated for 20 min at 4° C in the dark and subsequently washed with 1µg/ml 
propidium iodide in FACS buffer.  
All samples were analyzed using a FACS Calibur flow cytometer. Gate on viable cells 
was set according to exclusion of propidium iodide staining. Further gates were set on 
forward- sideward- scatter, or a particular stained population, as indicated in each 
experiment. Data were analyzed with CellQuest software.  
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2.2.4.2. Intracellular staining 
In order to examine the presence of cytokines in a particular cell population, 
intracellular FACS staining was performed according to a standard protocol provided by 
eBioscience (www.eBioscience.com). To inhibit the release of cytokines from the cells, 
brefeldin A was added in the cell suspension at a concentration of 10 μg/ml during the last 7-
9 hrs of cell culture. Cells were then washed once in IMDM complete medium and surface 
FACS staining was performed for phenotypical discrimination of the different cell types in 
the culture. Surface staining was performed in IMDM complete medium by addition of 0.4 
μg/ml monoclonal antibodies (2.1.4) for 20 min, at 4° C in the dark. Next, cells were washed 
with IMDM complete medium and fixed with 100 μl IC fixation buffer for 30 min at RT, in 
the dark. Cells were washed with 500 μl of 1-fold permeabilization buffer and resuspended in 
100 μl of permeabilization buffer. Intracellular staining was performed by incubating the 
cells with 1 μg/ml monoclonal antibodies against the cytokines of interest (FITC-conjugated 
IL-2, IFN-γ or granzyme B) for 30 min at RT, in the dark. After a washing step with 
permeabilization buffer, cells were resuspended in 200 μl of flow cytometry staining buffer. 
Samples were analyzed in a FACS Calibur flow cytometer using the software CellQuest.  
 
2.2.4.3. Assessment of CD8+ T cell degranulation  
Degranulation of CD8+ T cells after activation with MCs was assessed by FACS 
analysis for surface expression of lysosomal-associated membrane protein 1, LAMP-1 
(CD107a) (Alter et al. 2004). Cells were washed and resuspended in FACS buffer and stained 
with 0.4 μg/ml APC-conjugated anti-CD3ε monoclonal antibody for discrimination between 
CD8+ T cells and MCs. Simultaneously, cells were stained with rat anti-mouse LAMP-1 
antibody, according to the manufacturer´s instructions. Staining was performed for 20 min, at 
4° C in the dark. Subsequently, the cells were washed with FACS buffer and stained with 
F(ab´)2 anti-rat IgG for 20 min, at 4° C in the dark. Finally, cells were washed with 1µg/ml 
propidium iodide in FACS buffer, resuspended in FACS buffer and analyzed in a FACS 
Calibur flow cytometer. For evaluation of CD8+ T cell degranulation, gates were set on viable 
cells according to exclusion of propidium iodide staining, on lymphocytes according to 
forward- sideward- scatterplot analysis and on CD3+ cells.  
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2.2.5. Quantification of cell proliferation 
 
2.2.5.1. CFSE labeling 
For assessment of CD8+ T cell proliferation, the method of CFSE labeling of CD8+ T 
cells was used. CFSE labeling was performed before the co-culture of CD8+ T cells with 
MCs. Purified CD8+ T cells were resuspended in PBS at concentration of 8 x 107 cells/ml and 
an equal volume of 6 μM CFDA SE in PBS was added. Cells were continuously vortexed for 
6 min at RT and an equal volume of ice-cold FCS was added to stop the reaction of CFSE 
labeling. This was followed by a centrifugation step at 270 x g for 10 min at 4° C and two 
washing steps in PBS. The efficiency of the CFSE labeling was determined by FACS. CFSE-
labeled CD8+ T cells were co-cultured with MCs (2.2.3.2) and proliferation of CD8+ T cells 
was measured by FACS after 72 hrs.  
 
2.2.6. Measurement of cytokines in culture supernatants 
 
2.2.6.1. Enzyme-Linked ImmunoSorbent Assay (ELISA) 
Supernatants of MC-CD8+ T cell co-cultures were kept frozen at -20° C. ELISA was 
performed using a DuoSet ELISA Development Kit according to the manufacturer´s 
instructions. 96-well, flat bottom plates were coated with 100 μl of 4 μg/ml capture antibody 
diluted in PBS and incubated overnight at 4° C. Next, the plates were washed and incubated 
overnight with 200 μl/well ELISA blocking buffer. All washing steps were performed by 
washing the plates three times with ELISA washing buffer in ELISA washer. Samples (100 
μl) and standard dilutions of the cytokines were diluted in reagent diluent buffer, were added 
in the wells and incubated for 2 hrs at RT. After a washing step, the detection antibody was 
diluted in reagent diluent buffer and added in the wells at a concentration of 400 ng/ml (100 
μl/well) for 2 hrs at RT. Plates were then washed and 100 μl/well  streptavidin-HRP were 
added for 20 min. Following a washing step, the reaction was visualized by addition of 100 
μl/well substrate solution, consisting of 1:1 H2O2:Tetramethylbenzidin. Finally, the reaction 
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was stopped by addition of 50 μl/well of 1 N H2SO4 and the optical density of each well was 
determined using ELISA reader set to 450 nm. 
 
2.2.6.2. Bioplex 
For screening of the cytokine content in the MC-CD8+ T cell co-culture supernatants, 
the Bio-Plex Cytokine Assay (10-plex, mouse Th1/Th2) was used according to the 
manufacturer´s instructions. Briefly, the wells of a 96-well flat-bottom microplate were 
prewet with 100 μl of Bio-Plex assay buffer and the buffer was removed by vacuum 
filtration. Next, 50 μl of the multiplex bead working solution were added into the wells and 
subsequently removed by vacuum filtration. 100 μl of Bio-Plex wash buffer were dispensed 
in each well and subsequently removed by vacuum filtration. Samples and pre-diluted 
standard dilutions of the cytokines were added at a final volume of 50 μl and incubated for 30 
min during continuous shaking of the plate on a microplate shaker. Next, the plate was 
washed three times with 100 μl of Bio-Plex wash buffer. The Bio-Plex detection antibody 
was added at a final volume of 25 μl and incubated for 30 min during continuous shaking of 
the plate on a microplate shaker. Following three washings with 100 μl of Bio-Plex wash 
buffer, 50 μl of streptavidin-PE were added for 10 min. Finally, after additional three 
washings with 100 μl of Bio-Plex wash buffer, the beads in each well were resuspended with 
100 μl Bio-Plex assay buffer. The absorbance of the wells was measured in the Bio-Plex 
array reader and the concentration of the cytokines was automatically calculated by Bio-Plex 
Manager Software.   
 
2.2.7.  Generation of OVA-FITC conjugates 
 
2.2.7.1. Labeling of OVA protein to FITC 
In order to visualize the uptake of ovalbumin (OVA) protein by MCs, OVA was 
coupled with fluorescein isothiocyanate (FITC). OVA grade V was diluted in 0.1 M sodium 
carbonate at a concentration of 2 mg/ml. FITC was dissolved in dimethyl sulfoxide (DMSO) 
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at a concentration of 1 mg/ml. For each 1 ml of protein solution, 50 μl of FITC solution were 
added. The FITC solution was added very slowly and the protein solution was continuously 
stirred during the addition. The reaction was left in the dark for 8 hrs at 4° C. The reaction 
was stopped by addition of 1.5 M lysine for 2 hrs at RT during continuous shaking.  
 
2.2.7.2. Column purification of OVA-FITC 
In order to purify the OVA-FITC protein from the unbound FITC, gel filtration was 
performed in Sephadex G50 Column (1.5 cm diameter, 50 cm length). The sample was 
carefully layered on top of the column and was allowed to flow into the column until it 
entered the column bed. PBS was used as elution buffer. The speed of the elution was set to 
1.5 ml / 10 min. The OVA-conjugated FITC was eluted first and could be easily 
distinguished under room light from the unbound FITC, which was eluted afterwards.  
The concentration of protein after the gel filtration was calculated by measuring the 
absorbance at 280 nm. The ratio of FITC to protein was calculated by measuring the 
absorbance at 495 (A495) nm and at 280 nm (A280). Fractions with a ratio of A495 / A280 
between 0.3 and 1 were considered optimal (Harlow and Lane, 1988) and were pooled 
together for further use. The degree of labeling in the final fraction was 0.92 according to the 
following formula: 
 
dye per protein molecule = (A495 x dilution factor) / (68000 x protein concentration (M)) 
 
2.2.8. Molecular biological techniques 
 
2.2.8.1. RNA isolation 
For preparation of RNA, cells were thoroughly resuspended in 1 ml Trizol-Reagent 
and frozen at -70° C. Shortly before the RNA isolation, samples were thawed slowly on ice. 
A volume of 200 µl chloroform was added and the cells were vortexed and centrifugated at 
16000 x g for 15 min, at 4° C. As a result of this centrifugation, three phases were obtained: 
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an upper, colourless phase containing the RNA, a middle phase containing proteins and DNA 
and a lower light red coloured phase, containing trizol and chloroform. The upper phase 
containing the RNA was transferred to a new microcentrifuge tube containing 500 µl 
isopropanol to induce RNA precipitation. Samples were vortexed, left at RT for 10 min and 
centrifugated at 16000 x g (4° C) for 15 min before the supernatant was removed. To wash 
the RNA pellets, 500 µl of 75% ethanol were carefully added without resuspending the 
pellets. Samples were centrifugated again at 16000 x g for 10 min and the supernatants were 
carefully decanted. Pellets were left to air-dry and then resuspended in 30-50 µl DEPC-H2O.  
Quantification of RNA was carried out using an automated photometer. Purity was 
determined by calculating the ratio of absorbance at 260 nm (A260) to absorbance at 280 nm 
(A280). Pure RNA should have an A260/A280 ratio of 2.   
 
2.2.8.2. cDNA synthesis 
Complementary DNA (cDNA) was synthesized from purified RNA using random 
oligonucleotides and Superscript II TM Kit. A volume of 1.5 µl (120 ng) random primer was 
added to 2.5 µg RNA and the total volume was brought to 11.5 µl with DEPC-H2O. The 
reaction was incubated for 10 min in a 70° C pre-heated thermoblock. Samples were briefly 
centrifugated and cDNA synthesis was performed by addition of 100 U (0.5 µl) Superscript II 
reverse transcriptase in reaction buffer. The reaction was incubated for 1 hr at 37° C and 
subsequently inactivated by 5 min incubation at 100° C in a pre-heated thermoblock. Finally, 
the samples were transferred into ice and PCR was performed for amplification of cDNA.  
 
2.2.8.3. Polymerase chain reaction (PCR) 
The sequences of the primers used for PCR are shown in 2.1.5. PCR was performed 
using 1 U (0.2 µl) of Taq DNA polymerase in a PCR-reaction mixture of 20 µl. Samples 
were amplified in a DNA Thermocycler for 30 cycles. Each cycle consisted of denaturation at 
95° C for 30 sec, annealing for 30 sec, and elongation at 72° C for 30 sec, preceded by initial 
denaturation at 95° C for 3 min and followed by a final extension step at 72° C for 10 min. 
Annealing temperature for each primer was experimentally produced by running the same 
reaction at different annealing temperatures using a gradient thermocycler.  
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Amplification of β-actin message was used to normalize the amount of cDNA. For β-
actin amplification, PCR was carried out for 25 cycles, each consisting of denaturation at 95° 
C for 25 sec, annealing at 60° C for 25 sec, and elongation at 72° C for 25 sec, preceded by 
initial denaturation at 95° C for 3 min and followed by a final extension step at 72° C for 10 
min. A mock PCR (without cDNA) was included to exclude contamination in all 
experiments. Aliquots of PCR products were electrophoresed on 1.5% agarose gel and 
visualized under UV light after ethidium bromide staining.  
 
2.2.8.4.  Electrophoresis  
Agarose gel (1.5%) was prepared by heat-dissolving agarose in Tris/boric acid/EDTA 
(TBE) using a microwave oven. Melted agarose was allowed to cool to 55° C before a 
volume of 40 ml was poured into a beaker. To this volume, 10 µl of 1 mg/ml ethidium 
bromide were added, gently swirled and poured into a small gel casting tray fitted with a 12 
well comb. Samples were loaded at volumes of 6 µl which contained 5 µl PCR product plus 1 
µl 6-fold loading dye along with 5 µl (0.1 µg) molecular weight marker. Gel electrophoresis 
was carried out in TBE buffer at 10 V/cm gel width (approximately 70 V) for 1 hr. 
Visualization and photography of the gel were done using a transluminator equipped with a 
camera.  
 
2.2.8.5. Microarray 
Microarray analysis was performed by Dr. Reinhardt Hoffmann and Dr. Jörg Mages 
in the facilities of the Institute for Medical Microbiology, Immunology and Hygiene, at the 
Technical University of Munich. The purified RNA samples were labeled and hybridized on 
a mouse (MG 430 2.0) DNA-microarray (Affymetrix, Santa Clara, U.S.A.), according to the 
manufacturer´s instructions.  
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2.2.9. Animal experiments 
  All in vivo animal experiments were approved by the “Ministerium für 
Landwirtschaft, Umwelt und ländliche Räume des Landes Schleswig-Holstein, Germany“.  
 
2.2.9.1. Adoptive transfer of BMMCs, BMDCs and CD8+ T cells 
BMMCs and BMDCs were pulsed with 4 μg/ml OVA257-264, as described in 2.2.3.1.   
5 x 106 of OVA257-264 -pulsed BMMCs or BMDCs or equal amount of unpulsed BMMCs 
(control) in 200 μl of PBS were injected into the peritoneum of C57BL/6 or β2m-/- mice. One 
day later, CD8+ T cells were purified from the lymph nodes of OT-I transgenic mice as 
described in 2.2.2.1 and labeled with CFSE (2.2.5.1.). A number of 8 x 106 CFSE-labeled 
CD8+ T cells in 200 μl PBS were injected into the peritoneum of the recipient mice. Four 
days after transfer of the CD8+ T cells, mice were euthanized with CO2 inhalation. Peritoneal 
lavage was obtained after injection of 10 ml ice-cold 0.9% NaCl in the peritoneal cavity. 
Inguinal and mesenteric lymph nodes, spleen and blood were isolated and analyzed for CFSE 
proliferation of transgenic CD8+ T cells by FACS. 
 
2.2.9.2. Allergic airway sensitization 
WBB6F1-KitW/KitW-v (MC-deficient) female mice, as well as their congeneic wild-
type mice (WBB6F1-KitW/KitW) were immunized against ovalbumin (OVA), according to an 
established protocol of sensitization against OVA (Rückert et al., 2005; Beisswenger et al., 
2006). Sensitization of mice was performed by three intraperitoneal injections of alum-
absorbed OVA. 20 μg OVA (grade VI) were diluted in 200 μl PBS containing 1.5 mg 
Al(OH)3 and the solution was injected in the peritoneum of the mice with a 27 G needle on 
day 0, day 14 and day 21. Mice were challenged by exposure to aerosolized OVA (1% OVA 
grade V in PBS) for 40 min and were left in the aerosol-chamber for additional 10 min. One 
day after the last OVA-aerosol challenge, mice were sacrificed by cervical dislocation.  
The lung and the draining lymph nodes of the lung were isolated after injection of 
PBS in the right ventricle of the heart, in order to remove the blood. Next, the lung and the 
draining lymph nodes of the lung were digested by incubation in collagenase / 
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deoxyribonuclease buffer (1 mg/ml collagenase and 0.2 mg/ml deoxyribonuclease in RPMI) 
for 30-60 min in incubator with 5% CO2, at 37° C. Subsequently, cells were washed with 
FACS buffer at 270 x g, for 10 min, at 4° C, counted and analyzed for the content and 
phenotype of CD8+ T cells by FACS (2.2.4.1).  
  
2.2.10. Statistical  analysis 
Results are represented as mean values ± standard deviation from pooled data of two 
to six independent experiments, as indicated. Statistical analysis of the results, unless 
otherwise stated, was performed by Student’s t test. A p value of <0.05 was considered 
statistically significant (*).  
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                    3.  Results 
ast cells (MCs) have been well characterized as main “effector” cells in the 
acute phase of allergic reactions and as participants of the innate immune 
response. Recent results, however, suggest that MCs also have a key role in the regulation of 
adaptive immunity, since they recruit and interact with B cells, dendritic cells (DCs) and T 
cells (Galli et al., 2005b). Moreover, bone marrow-derived MCs (BMMCs) have been shown 
to process bacterial antigens and induce proliferation of CD8+ T cell line in vitro (Malaviya et 
al., 1996b). A potential MC-CD8+ T cell interaction is also supported by the fact that MCs 
induce chemotaxis of CD8+ T cells in vivo (McLachlan et al., 2003; Ott et al., 2003; Orinska 
et al., 2005). However, the ability of MCs to modulate primary CD8+ T cell activation and 
effector functions, as well as the identification of the factors that regulate this interaction 
remain unknown. CD8+ T cells play a central role in the induction of a protective immune 
response against intracellular pathogens. Moreover, CD8+ T cells are important for the 
induction of allergic sensitization and atopic diseases (Haczku et al., 1995a; Haczku et al., 
1995b; Hamelmann et al., 1996). Therefore, a potential ability of MCs to regulate CD8+ T 
cell responses could be crucial for the modulation of host defense mechanisms as well as for 
the development of allergic diseases. For this reason, this study investigated the potential of 
MCs to interact with CD8+ T cells in vitro and in vivo, as well as the effects of this interaction 
on MCs.   
 
3.1. Obtaining a pure MC population from the bone marrow 
As a model to study the role of MCs, bone marrow-derived MCs (BMMCs) were 
used.  BMMCs were obtained after cultivating the bone marrow of C57/BL6 mice in the 
presence of IL-3 and SCF for 5 weeks (Dvorak et al., 1994). The maturation of the cells was 
tested with toluidine blue/hematoxylin staining, which results in appearance of the MC-
specific red-purple metachromatic granula (Fig. 3.1A). The morphology of the cells 
reproduced the typical MC-phenotype, as shown by the high granularity (sideward-scatter) 
and size (forward-scatter) of the cells, analyzed by FACS (Fig. 3.1B). The presence of dead 
cells in the cultures was measured by FACS after propidium iodide (PI) staining (Fig. 3.1C), 
which verified that the cultures contained only 1-5% dead cells (PI positive cells). The cells 
displayed the MC-specific surface expression of c-kit (CD117), FcεRI and T1/ST2, as shown 
M 
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by FACS analysis (Fig. 3.1D). In order to exclude the presence of other cell types in the 
cultures, that could possibly interact with T cells and affect the results of the following 
experiments, the cultures were tested for the presence of DCs, myeloid cells, B cells and 
macrophages by analyzing surface expression of CD11c, CD11b, B220 and F4/80 
respectively by FACS (Fig. 3.2). IL-3- and SCF- differentiated BMMCs displayed no 
significant surface expression of those markers, indicating that no other antigen presenting 
cells (APCs) were present in the culture. Therefore, the cells obtained after 5 weeks of in 
vitro culture were considered as pure BMMCs and used as a model to investigate the role of 
MCs in modulating CD8+ T cell responses.  
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Fig. 3.1. The in vitro culture of BMMCs results in a pure population dsiplaying the MC-
phenotype. Bone marrow cells of C57/BL6 mice were cultured in the presence of IL-3 (10 
ng/ml) and SCF (5 ng/ml) for 5 weeks. A. Maturation of BMMCs was tested with toluidine 
blue/hematoxylin staining. B. Morphology of BMMCs was analyzed by FACS. (FSC: 
forward-scatter, SSC: sideward-scatter) C. Viability of the cells was tested with propidium 
iodide (PI) staining D. Purity of BMMCs was analyzed by FACS staining for MC-related 
surface markers (c-kit, FcεRI and T1/ST2) (gated on viable cells). Cells stained with isotype 
control antibodies of irrelevant specificity served as negative control. Representative results 
of more than six independent experiments are shown.  
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Fig. 3.2. The in vitro cultures of BMMCs were not contaminated with “professional” 
antigen-presenting cells (APCs). Bone marrow cells of C57/BL6 mice were cultured in the 
presence of IL-3 (10 ng/ml) and SCF (5 ng/ml). Following 5 weeks of culture, the presence of 
potential APCs was tested with FACS after staining for CD11c, CD11b, B220 and F4/80 
(gated on viable cells). Staining of the cells with control isotype matched antibodies of 
irrelevant specificity is shown in bold black lines. Representative results of more than six 
independent experiments are shown.  
 
3.2. Obtaining a pure DC population from the bone marrow 
DCs are highly efficient APCs, capable of inducing CD4+ as well as CD8+ T cell 
responses. For this reason, DCs were used as a comparison to MCs in following experiments 
investigating the antigen-specific MC-CD8+ T cell interactions in vivo. Bone marrow-derived 
DCs (BMDCs) were obtained after cultivating the bone marrow of C57/BL6 mice in the 
presence of GM-CSF for 7-9 days, as previously described (Scheicher et al., 1992; Inaba et 
al., 1992). On day 7, the phenotype of DCs was analyzed by FACS for maturation and 
viability of the cells. The morphology of the cells reproduced the typical DC-phenotype, as 
shown by the low granularity (sideward-scatter) and moderate size (forward-scatter) of the 
cells (Fig. 3.3A). The presence of dead cells in the culture was measured by propidium iodide 
(PI) staining (Fig. 3.3B), which verified that the culture contained only 5-10% dead cells (PI 
positive cells). The cells displayed the DC-specific surface expression of CD11c, (Fig. 3.3C). 
The DCs obtained by this method were mature, since they expressed surface MHC class II (I-
A/I-E) and the co-stimulatory molecule CD80 (Fig. 3.3C). Therefore, the BMDCs obtained 
according to this protocol were used as potent APCs in comparison to MCs in following 
experiments.  
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Fig. 3.3. The in vitro culture of BMDCs results in a pure population displaying the DC-
phenotype. Bone marrow cells of C57/BL6 mice were cultured in the presence of GM-CSF 
for 7-9 days. A. Morphology of BMDCs was analyzed by FACS. (FSC: forward-scatter, SSC: 
sideward-scatter) B. Viability of the cells was measured by propidium iodide (PI) staining. C. 
Maturation of BMDCs was analyzed by FACS staining for surface markers (CD11c, I-A/I-E  
and CD80) (gated on viable cells). Staining of the cells with control isotype matched 
antibodies of irrelevant specificity is shown in bold black lines. Representative results of 
more than six independent experiments are shown.  
   
3.3. Obtaining a pure population of primary CD8+ T cells 
CD8+ T cells were purified from the lymph nodes of OT-I transgenic mice. These 
mice express a transgenic TCR on CD8+ T cells, which recognizes the OVA257-264 peptide in 
association with MHC class I molecules. The viability, purity and activation status of the 
isolated CD8+ T cells were tested by FACS analysis (Fig. 3.4). The isolated cells displayed 
the typical low size and low granularity of naïve lymphocytes according to forward-/ 
sideward-scatterplot analysis (Fig. 3.4A). The isolated CD8+ T cells were viable (97 ± 2% PI 
negative) (Fig. 3.4B), highly pure (96 ± 2% CD8+) (Fig. 3.4C) and not activated, as shown 
by the minimal surface expression of the activation markers CD69, CD25 and CD44 (Fig. 
3.4D) at the time of the isolation. 
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Fig. 3.4. The isolated CD8+ T cells comprise a pure population of naïve primary CD8+ T 
cells. Lymph nodes were excised from OT-I transgenic mice and CD8+ T cells were purified 
by negative selection with MACS. The phenotype of the CD8+ T cells was analyzed by FACS.  
A. Forward-/ sideward- scatterplot analysis of the purified CD8+ T cells shows that the 
isolated cells displayed the typical morphology of naïve lymphocytes. B. Propidium iodide 
(PI) staining was performed in order to test the viability of the cells. C. Purity of the cells was 
analyzed by surface expression of CD8 and the transgenic TCR β chain (Vβ5). D. Activation 
of the isolated CD8+ T cells was analyzed by surface expression of activation markers 
(CD69, CD25 and CD44) (gated on viable cells). Staining of the cells with control isotype 
matched antibodies of irrelevant specificity is shown in bold black lines. Representative 
results of more than six independent experiments are shown.  
In order to exclude the presence of any other possible APCs in the purified CD8+ T 
cell fraction, the cells were tested for the presence of B cells, DCs, macrophages and NK 
cells by analyzing the surface expression of B220, CD11c, F4/80 and NK1.1 respectively by 
FACS (Fig. 3.5). None of those markers displayed a significant expression, showing that the 
MACS depletion of contaminating cells was up to 96 ± 2% (n=6) efficient. Therefore, the 
CD8+ T cells isolated from the OT-I transgenic mice were considered a pure population of 
naïve primary CD8+ T cells and were used in the following experiments to study the 
interaction between MCs and CD8+ T cells.  
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Fig. 3.5. The isolated CD8+ T cell population was not contaminated with potential APCs.  
CD8+ T cells were isolated from lymph nodes of OT-I mice and purified by negative selection 
with MACS. The presence of APCs in the culture was tested with FACS staining for surface 
expression of B220, CD11c, F4/80 and NK1.1 (gated on viable cells). Staining of the cells 
with control isotype matched antibodies of irrelevant specificity is shown in bold black lines. 
Representative results of more than six independent experiments are shown.  
 
3.4. Antigen-independent effects of MCs on CD8+ T cells in vitro 
The interaction between APCs and T cells may occur both in an antigen-dependent 
and antigen-independent way. In the absence of a specific antigen, DCs have been shown to 
form functional synapses with T cells and induce a small Ca2+ response and weak 
proliferation, mainly on CD4+ and, to a minimal extent, on CD8+ T cells (Revy et al., 2001). 
Interestingly, DCs, but neither B cells nor monocytes, increase the survival of naïve T cells 
(both CD4+ and CD8+) in an antigen-independent manner (Revy et al., 2001; Kondo et al., 
2001). Since an antigen-independent interaction between APCs and T cells is potentially 
relevant for the homeostasis of the naïve T cell pool, the cells that participate in this 
interaction should be characterized in detail. Several investigators suggest that MCs modulate 
CD4+ T cell activities in an antigen-independent manner, by influencing the Th1/Th2 balance 
via release of soluble mediators (Stelekati et al., 2007). Therefore, it was suggested that the 
CD8+ T cell responses might also be influenced by MCs in an antigen-independent manner. 
For this reason, the survival as well as the activation of CD8+ T cells was tested in the 
presence of MCs and in the absence of a specific stimulus (namely the OVA257-264 peptide).  
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3.4.1. MCs support the survival of naïve CD8+ T cells 
MCs are able to release a variety of cytokines (Introduction, Fig.1.3). Some of the 
MC-released cytokines, namely IL-2, IL-7 and IL-15, support and regulate the survival of 
CD8+ T cells (Marrack and Kappler, 2004). Therefore, it was examined whether MCs are 
able to directly regulate the survival of CD8+ T cells. For this reason, the survival of naïve 
CD8+ T cells in the presence or absence of MCs was evaluated by propidium iodide (PI) 
staining of the CD8+ T cells. Indeed, the addition of MCs at a ratio 1:2 to CD8+ T cells 
increased the percentage of viable (PI-negative) CD8+ T cells by 32 ± 9% (n=7), while 
addition of MCs at a ratio 1:10 increased the survival of CD8+ T cells by 16 ± 3% (n=3) (Fig. 
3.6A).  
It has been previously reported that DCs promote the survival of naïve T cells in an 
antigen-independent and cell contact-dependent manner (Revy et al., 2001; Kondo et al., 
2001), suggesting that not only cytokine production but also physical cell-cell interactions are 
essential for the increased T cell survival. For this reason, the importance of direct cell 
contact between MCs and CD8+ T cells for the increased survival of CD8+ T cells was 
examined. Thus, CD8+ T cells were cultured with MCs in the presence of a membrane, which 
inhibited direct cell contact between MCs and CD8+ T cells. As shown in Fig. 3.6B, the 
presence of the membrane reduced the survival of CD8+ T cells by 25 ± 18% (n=4), 
suggesting that direct cell contact between MCs and CD8+ T cells is essential for the 
enhanced survival of CD8+ T cells.  
 
 
 
[3. Results] 
 
- 62 - 
 
A B
control 1:2 1:10 free contact membrane%
 a
liv
e
C
D
8+
T 
ce
lls
0
25
50
%
 a
liv
e
C
D
8+
T 
ce
lls
0
25
50
*
** *
 
Fig. 3.6. MCs enhance the survival of primary naïve CD8+ T cells. CD8+ T cells were 
purified from lymph nodes by negative MACS separation. A. 1 x 106 CD8+ T cells were 
cultured in the absence (“control”) or in the presence of 0.5 x 106 MCs (“1:2”) or 0.1 x 106 
MCs (“1:10”) in IMDM complete medium containing IL-3 (5 ng/ml) for 48 hours. B. 1 x 106 
CD8+ T cells were cultured with 0.5 x 106 MCs and the direct cell contact between MCs and 
CD8+ T cells was either allowed (“free contact”) or inhibited by the presence of a 0.2 μm 
anopore membrane (“membrane”). Cells were stained with propidium iodide (PI) and 
analyzed by FACS. Graphs show the percentage of PI-negative cells (% viable CD8+ T cells), 
gated on CD8+ T cells. Mean values with standard deviation of two to five independent 
experiments are shown (n=4-7). * p<0.05, ** p<0.01 
These data suggest that MCs promote the survival of CD8+ T cells in an antigen-
independent and cell-cell contact-dependent manner and propose that MCs contribute to the 
homeostasis of naïve CD8+ T cells.  
 
3.4.2. MCs do not induce CD8+ T cell activation in the absence of antigen 
The antigen-independent activation of T cells may be important for the establishment 
of protective immunity or play a role in autoimmune diseases (Kondo et al., 2001). Therefore, 
the question whether MCs regulate CD8+ T cell activation in an antigen-independent manner 
was addressed. For this reason, CD8+ T cells were isolated from lymph nodes by MACS and 
cultured in the presence of MCs for 48 hours. Subsequently, the cells were analyzed by 
FACS for surface expression of activation markers on CD8+ T cells. Surface expression of 
CD69 (very early activating antigen) has been shown to become rapidly up-regulated after 
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activation of T cells (Ziegler et al., 1994). CD25 (IL-2 receptor α) is also reported to be 
expressed on T cells upon activation (Santos et al., 1991), while CD44 (cell adhesion 
receptor) surface expression has been correlated not only with activation but also with 
memory differentiation of T cells (Budd et al., 1987). Therefore, the combination of these 
markers was chosen in order to provide a clear estimation of the activation status of the CD8+ 
T cells. In order to focus on the CD8+ T cell population during further analysis, gates were set 
on the lymphocyte population according to forward-/ sideward-scatterplot analysis (Fig. 
3.7A, left plot), alive cells, as demonstrated by exclusion of PI staining (Fig. 3.7A, middle 
histogram) and CD8+ cells, as shown by staining with specific CD8 antibody (Fig. 3.7A, left 
histogram). Further analysis on CD8+ T cells included the set of all these three gates. As 
shown in Fig. 3.7B, MCs did not induce any activation on naïve CD8+ T cells in the absence 
of a specific antigen, as depicted by the absence of surface expression of activation markers 
CD69, CD25 and CD44 on CD8+ T cells.   
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Fig. 3.7. MCs do not induce activation of naïve T cells in the absence of a specific antigen. 
CD8+ T cells were isolated from lymph nodes by MACS and cultured with MCs in the 
presence of IL-3 (5 ng/ml) for 48 hours. A. Gates were set in order to select the CD8+ T cell 
population for further analysis. Lymphocyte gate was set according to FSC/SSC localization 
of lymphocytes. Viability gate was set on the propidium iodide (PI) negative cells in order to 
exclude dead cells from further analysis. CD8+ gate was set according to surface expression 
of CD8. Further analysis was focused on the population selected according to these three 
gates. B. Histograms depict FACS staining for surface expression of CD69, CD25 and CD44, 
gated on viable CD8+ T cells. Staining of the cells with control isotype matched antibodies of 
irrelevant specificity is shown in bold black lines. Representative results of five independent 
experiments are shown.  
These results suggest that an antigen-independent interaction between MCs and CD8+ 
T cells occurs only in terms of enhanced CD8+ T cell survival, and not CD8+ T cell 
activation. Therefore it is proposed that MCs might contribute only to the homeostasis of 
naïve CD8+ T cells, but do not induce activation of naïve CD8+ T cells in the absence of a 
specific antigen.   
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3.5. Antigen-dependent effects of MCs on CD8+ T cells in vitro 
The presentation of antigens to T cells is the initiative step for an adaptive cellular 
immune response. APCs internalize proteins, degrade them into peptides and present them on 
their surface associated with MHC class I or MHC class II molecules for priming CD8+ or 
CD4+ T cells, respectively. Endogenous proteins are generally presented on an MHC class I-
restricted manner, while exogenous proteins are presented on an MHC class II-restricted 
manner. However, through the process of cross-presentation, exogenous antigens may also be 
presented on an MHC class I-dependent manner to induce CD8+ T cell responses (Trombetta 
and Mellman, 2005). MCs have been shown to present MHC class II-related antigens to 
CD4+ T cells (Frandji, et al., 1993). However, less is known about the antigen-specific 
interaction between MCs and CD8+ T cells; MCs induce in vitro proliferation of CD8+ T cell 
lines (Malaviya et al., 1996b), but neither the mechanism of MC-CD8+ T cell interaction nor 
its relevance in vivo has been investigated so far.  
 
3.5.1. MCs internalize the OVA protein 
The first step of presentation or cross-presentation of exogenous antigens consists of 
the internalization of antigenic proteins. In order to test the potential of MCs to interact with 
CD8+ T cells in an antigen-dependent manner, MCs were initially tested for their ability to 
internalize the ovalbumin (OVA) protein. OVA is a model antigenic protein (Herz et al., 
1996) and was chosen on the concept that the OT-I CD8+ T cells used in this study express 
the transgenic TCR for the peptide OVA257-264, derived from the OVA protein.  In order to 
visualize the possible uptake of the OVA protein by MCs, OVA protein was coupled to FITC 
and the OVA-unbound FITC was removed by column purification. First, MCs were either 
incubated with 20 μg/ml OVA-FITC for 4 hours or were left untreated, washed and FITC-
internalization was observed in a fluorescence microscope. As shown in Fig. 3.8A, MCs were 
able to internalize the protein. Next, the effect of the protein concentration on the 
internalization result was studied in the same experimental settings. MCs were incubated with 
different concentrations of OVA-FITC, subsequently washed and analyzed by FACS. As 
depicted in Fig. 3.8B, the internalization of the protein by MCs occured at protein 
concentrations of at least 20 μg/ml. These results suggest that MCs are capable of 
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internalizing antigenic proteins in a dose-dependent manner, therefore have the potential to 
act as APCs.  
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Fig. 3.8. MCs internalize the OVA protein in vitro. OVA protein was coupled with FITC and 
added to the MC culture. A. MCs were incubated with OVA-FITC (20 μg/ml) for 4 hours 
(“+OVA-FITC”) or left untreated (“control”), subsequently washed and visualized under 
fluorescence microscope. B. MCs were incubated with different concentrations of OVA-
FITC, as indicated or left untreated (“control”) for 4 hours and analyzed by FACS. 
Histogram (upper row) shows OVA-FITC staining of MCs (gated on viable, c-kit positive 
cells). Graph in lower row shows mean fluorescence intensity (MFI) of MCs after OVA-FITC 
treatment. Bars represent mean values of MFI with standard deviation of two independent 
experiments.  
 
3.5.2. MCs induce antigen-specific CD8+ T cell responses 
The fact that MCs internalize the OVA-protein supports the initial hypothesis that 
MCs may interact with CD8+ T cells in an antigen-dependent manner. In order to study the 
ability of MCs to induce antigen-dependent CD8+ T cell responses, BMMCs were pulsed 
with the OVA257-264 peptide and cultured with TCR-transgenic (OT-I) CD8+ T cells 
recognizing the peptide OVA257-264. Subsequently, the CD8+ T cell responses were measured 
in terms of activation, proliferation and cytokine production.  
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3.5.2.1. MCs induce antigen-specific CD8+ T cell activation 
In order to test the ability of MCs to induce antigen-dependent activation of CD8+ T 
cells, MCs were pulsed with OVA257-264 peptide and cultured with OT-I transgenic CD8+ T 
cells. After 48 hours of co-culture, CD8+ T cell activation was measured by surface 
expression of activation markers with FACS. Analysis was focused on the CD8+ T cells by 
setting of gates on the lymphocyte population, PI-negative (viable) cells and CD8-expressing 
cells (Fig. 3.9A).  A first hint that CD8+ T cells become activated after antigen-dependent 
contact with MCs was given by the fact that CD8+ T cells exhibited increased size (FSC) and 
granularity (SSC) (Fig. 3.9A, left plot) compared to the CD8+ T cells which experienced 
antigen-independent contact with MCs (Fig. 3.7A, left plot). Indeed, already after 18 hours 
(data not shown) and, to a greater extent, after 48 hours (Fig. 3.9B), antigen-pulsed MCs 
induced activation of CD8+ T cells, as shown by the marked up-regulation of the activation 
markers CD69 (very early activating antigen), CD25 (IL-2 receptor α) and CD44 (cell 
adhesion receptor) on CD8+ T cells, measured by FACS analysis. Since CD69 is a very 
sensitive marker of activation, rapidly induced upon T cell activation, it was used in 
combination with CD25 to estimate the activation status of the CD8+ T cells. The activation 
of CD8+ T cells was dependent on the numbers of OVA257-264-pulsed MCs. All three 
activation markers showed the maximal up-regulation at a ratio of MC:CD8 = 1:2. However, 
even at a much lower ratio of MC:CD8 = 1:10, CD8+ T cells displayed up to  90 ± 4% 
activation (n=6). As depicted in Fig. 3.9C, CD69 appeared to be a more sensitive activation 
marker, as shown by its higher up-regulation compared to CD25 and CD44, mainly at the 
lower MC:CD8 ratios. Thus, at the lowest ratio of MC:CD8 = 1:100, CD69 still exhibited an 
up-regulation of 45 ± 14% (n=6), while the corresponding up-regulation for CD25 and CD44 
were 29 ± 9% and 35 ± 5%, respectively.  
It is therefore concluded that MCs are indeed able to initiate an antigen-dependent 
activation of CD8+ T cells and induce up-regulation of CD69 and subsequently CD25 and 
CD44 surface expression.  
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Fig. 3.9. MCs induce antigen-specific CD8+ T cell activation in vitro. MCs were pulsed with 
OVA257-264 peptide (4 μg/ml), washed and cultured with naïve, purified OT-I transgenic CD8+ 
T cells. 1 x 106 CD8+ T cells were incubated with different numbers of antigen-pulsed MCs. 
A. Analysis of CD8+ T cell population was performed after setting appropriate gates on 
lymphocyte population (left plot), alive cells (middle histogram) and CD8-expressing cells 
(right histogram). Further analysis focused on the population selected according to these 
three gates. B. Activation of CD8+ T cells was determined by analysis of CD69 and CD25 
(upper row) and CD44 (second row) expression by FACS (gated on viable CD8+ T cells). 
Control isotype staining is shown in bold black lines. One representative of six independent 
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experiments is shown. C. Mean values of activated CD8+ T cells (according to CD69, CD25 
or CD44 surface expression) with standard deviation of six independent experiments are 
shown.  
To exclude a TCR-independent, unspecific activation of CD8+ T cells, naïve CD8+ T 
cells were purified from lymph nodes of C57BL/6 wild-type mice and cultured with OVA257-
264-pulsed MCs. After 48 hours of co-culture, no surface expression of CD69 and CD25 and 
minimal surface expression of CD44 were detected on the wild-type CD8+ T cells (Fig. 3.10). 
These results demonstrate that the antigen-specific activation of CD8+ T cells by MCs is 
TCR-dependent. 
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Fig. 3.10. The antigen-specific activation of CD8+ T cells by MCs is TCR-dependent. MCs 
were pulsed with OVA257-264 peptide and cultured with naïve CD8+ T cells purified from 
lymph nodes of OT-I transgenic mice (“OT-I CD8”) or C57BL/6 wild-type mice (“WT 
CD8”) at a ratio of 1:2. Activation of CD8+ T cells was determined by analysis of CD69 and 
CD25 (upper row) and CD44 (lower row) expression by FACS (gated on viable CD8+ T 
lymphocytes). Control isotype staining is shown in bold black line. Representative results of 
three independent experiments are shown. 
To verify that the antigen-specific activation of CD8+ T cells was dependent on the 
functional expression of MHC class I on MCs, BMMCs derived from beta-2-microglobulin 
deficient mice (β2m-/-), were used for co-culture with CD8+ T cells. Absence of β2m 
expression in these mice leads to the lack of a functional expression of MHC class I and 
therefore, to the inability to present in an MHC class I-dependent manner. β2m-/- MCs were 
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pulsed with    OVA257-264 and co-cultured with OT-I transgenic CD8+ T cells. As shown in 
Fig. 3.11, after 48 hours of co-culture, the β2m-/- MCs induced only a minimal activation of 
the CD8+ T cells, measured by surface expression of CD69, CD25 and CD44, as compared 
with wild-type MCs. Therefore, these data confirm that the bulk of CD8+ T cell activation 
induced by MCs is due to MHC class I-dependent antigen presentation.  
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Fig. 3.11. The antigen-specific activation of CD8+ T cells by MCs is MHC class I-
dependent. BMMCs were derived from the bone marrow of C57BL/6 wild-type mice (“WT 
MC”) or β2m-deficient mice (“β2m-/- MC”). MCs were pulsed with OVA257-264 peptide and 
cultured with naïve, purified, OT-I transgenic CD8+ T cells at a ratio of 1:2. Activation of 
CD8+ T cells was determined by analysis of CD69 and CD25 (upper row) and CD44 (lower 
row) expression by FACS (gated on viable CD8+ T cells). Control isotype staining is shown 
in bold black line. Representative results of three independent experiments are shown. 
 
3.5.2.2. MCs induce antigen-specific CD8+ T cell proliferation 
Antigen-specific activation of CD8+ T cells by “professional” APCs leads on the one 
hand to proliferation and clonal expansion, and on the other hand to their differentiation into 
effector cells or long-living memory cells (Roitt et al., 2002). In order to study the result of 
the MC-induced MHC class I-dependent antigen presentation, the proliferation of CD8+ T 
cells after antigen-specific contact with MCs was examined using the method of CFSE 
labeling of CD8+ T cells. CFSE is a cell tracking reagent, which passively diffuses into the 
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cells. Upon reaction with intracellular amines it forms fluorescent conjugates that are 
detectable by flow cytometry. The dye is distributed equally with the cytoplasmic proteins to 
the daughter cells after cell division. Therefore, cell division can be tracked by the sequential 
halving of CFSE fluorescence resulting in a fluorescence histogram in which the peaks 
represent successive generations of daughter cells. 
Thus, the MC-induced, antigen-specific proliferation of CD8+ T cells was examined 
by incubating OVA257-264-pulsed MCs with OT-I transgenic, CFSE-labeled CD8+ T cells. 
Peptide-pulsed MCs stimulated CD8+ T cells to undergo up to five cell divisions, as shown 
by the five successive peaks in the histogram plot of CFSE dilution (Fig. 3.12A), 
demonstrating that MCs are capable of inducing proliferation of naïve, primary CD8+ T cells. 
Maximal proliferation was detected at a ratio MC:CD8 = 1:20, with 92 ± 2% (n=3) of the 
CD8+ T cells proliferating. At the lowest tested ratio of MC:CD8 = 1:100, clearly less cells 
appeared in each cell division, however a total of 57 ± 16% (n=4) of the CD8+ T cell 
population proliferated.  No proliferation could be detected in the presence of unpulsed MCs 
(Fig. 3.12B, “control”) or with β2m-/-, peptide-pulsed MCs (Fig. 3.12B, “β2m-/-”). 
Therefore, it is concluded that MCs are able to induce antigen-specific proliferation of CD8+ 
T cells in a MHC class I-dependent manner.  
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Fig. 3.12. MCs induce antigen-specific CD8+ T cell proliferation in vitro. MCs were pulsed 
with OVA257-264 peptide and cultured with CFSE-labeled OT-I transgenic CD8+ T cells.  A. 1 
x 106 CD8+ T cells were incubated with different numbers of antigen-pulsed MCs.  B. 1 x 106 
CD8+ T cells were cultured with 0.5 x 106 unpulsed MCs (“control”) or with 0.5 x 106 β2m-/-, 
peptide-pulsed MCs (“β2m-/-”). Histograms depict CFSE dilution as measured by FACS 
(gated on viable CD8+ T cells). Representative results of five independent experiments are 
shown. C. Mean values of the percentages of proliferating CD8+ T cells with standard 
deviation of three to four independent experiments are shown.  
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3.5.2.3. MCs induce antigen-specific cytokine production by CD8+ T cells 
Effector functions of activated CD8+ T cells are exerted by secretion of cytokines, 
mainly IL-2 and IFN-γ (Roitt et al., 2002). Therefore, it was questioned whether the MC-
induced antigen-dependent activation of CD8+ T cells resulted also in differentiation of CD8+ 
T cells into effector, cytokine-producing cells. For this reason, the supernatants of the MC-
CD8+ T cell co-cultures were screened for their cytokine content with Bio-Plex assay. 
Cytokines known to be produced at high amounts after antigen-specific T cell activation   
(IL-2, IFN-γ), as well as cytokines that regulate T cell differentiation (IL-4, IL-10, IL-12) and 
cytokines that contribute to the inflammatory response (TNF-α, GM-CSF) were measured. 
High amounts of the T cell-related cytokines IL-2 [5.6 ± 0.9 ng/ml] (n=3) and                   
IFN-γ  [6.0 ± 0.2 ng/ml] (n=2) and lower amounts of TNF-α [312 ± 180 pg/ml] (n=3) and 
GM-CSF [400 ± 116 pg/ml] (n=3) were detected after antigen-specific MC-CD8+ T cell 
contact (n=3) (Fig. 3.13). In contrast, none, or hardly any, production of IL-4, IL-5, IL-10 
and IL-12 was detectable.  
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Fig. 3.13. Cytokines are released during antigen-specific MC-CD8+ T cell contact.  MCs 
were pulsed with OVA257-264 peptide or left untreated (“control”) and cultured with 1 x 106 
OT-I transgenic CD8+ T cells at different cell ratios for 48 hours. Supernatants of the co-
culture were analyzed for cytokine content with Bio-Plex assay. Mean values with standard 
deviation of two to three independent experiments are shown. 
In order to investigate whether the detected cytokines were produced by the activated 
CD8+ T cells, intracellular cytokine staining for the T cell-related cytokines IL-2 and IFN-γ 
was performed. Indeed, both IL-2 and IFN-γ were detected intracellularly in CD8+ T cells 
after the MC-mediated antigen-dependent activation (Fig. 3.14), at a percentage of 5.5 ± 
2.9% and 3.1 ± 1.5% (n=10) respectively. Thus, it was demonstrated that IL-2 and IFN-γ 
were produced by the activated CD8+ T cells, although their production by MCs as well was 
not excluded.  
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Fig. 3.14. MCs induce antigen-specific cytokine production by CD8+ T cells. 1 x 106 OT-I 
transgenic CD8+ T cells were incubated with 0.1 x 106 unpulsed MCs (“ - OVA257-264”) or 
with an equal number of antigen-pulsed MCs (“ + OVA257-264”) for 48 hours. Cells were 
stained for surface expression of CD8, subsequently stained for intracellular expression of 
IL-2 (A) or IFN-γ (B) and analyzed by FACS. Percentages show cytokine-positive CD8+ T 
cells. Dot plots show one representative of five independent experiments. Right panel shows 
mean values of cytokine-positive CD8+ T cells with standard deviation of five independent 
experiments (n=10). 
 ** p<0.01 
 
Conclusively, these results demonstrate that MCs are capable of inducing significant 
antigen-specific CD8+ T cell responses, as shown by the activation, proliferation and cytokine 
production by primary CD8+ T cells. Thus, MCs act as efficient antigen-presenting cells in 
vitro, by presenting MHC class I-related antigens and inducing effector CD8+ T cell 
responses.  
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3.5.3. MCs increase the cytotoxic potential of CD8+ T cells 
A key effector function of CD8+ T cells is their cytotoxic activity (e.g. against 
infected host cells) (Wong and Pamer, 2003). A crucial step in CD8+-mediated cytotoxicity is 
the exocytosis of specialized granules containing cytotoxic proteins, namely granzymes and 
perforin (Lieberman, 2003). Therefore, it was examined whether MCs were able to enhance 
the cytotoxic potential of the CD8+ T cells by increasing their intracellular content of 
granzyme B upon antigen-specific interaction. Indeed, as shown in Fig. 3.15, intracellular 
granzyme B expression was increased by 27 ± 9% (n=9) in CD8+ T cells after antigen-
mediated activation by MCs. 
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Fig. 3.15. MCs increase the cytotoxic potential of CD8+ T cells. 1 x 106 CD8+ T cells were 
incubated with 0.1 x 106 unpulsed MCs (“ - OVA257-264”) or with an equal number of antigen-
pulsed MCs (“ + OVA257-264”) for 48 hours. Cells were stained for surface expression of 
CD8, subsequently stained for intracellular expression of granzyme B and analyzed by FACS. 
Histograms show one representative of five independent experiments. Control isotype 
staining is shown in bold black lines. Graph in the right panel shows mean values of 
granzyme B-positive CD8+ T cells with standard deviation of five independent experiments 
(n=9). *** p<0.001 
Since an essential step for exhibiting cytolytic activity is the exocytosis of the 
preformed cytotoxic granules, it was further examined whether the CD8+ T cells degranulated 
after MC-dependent antigen-specific activation. A novel method for detecting cytotoxic 
CD8+ T cell degranulation has been developed based on the detection of cell surface 
expression of lysosomal associated membrane glycoproteins (LAMPs) on CD8+ T cells 
(Betts and Koup, 2004; Burkett et al., 2005). LAMPs are embedded in the membrane of the 
cytotoxic granules; upon activation and subsequent degranulation of cytotoxic CD8+ T cells, 
the granule membrane fuses with the plasma membrane, resulting in exposure of LAMPs on 
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the cell surface. Therefore, CD8+ T cell exocytosis was evaluated by measuring the 
expression of LAMP-1 (CD107a) on the surface of CD8+ T cells by FACS after MC-
mediated activation. Upon activation with antigen-pulsed MCs, the CD8+ T cells displayed 
increased surface LAMP-1 expression, which was dependent on the numbers of antigen-
pulsed MCs (Fig. 3.16).  
LAMP-1
co
un
ts
1:10
1:20
1:50
Ratio MC:CD8
A B 
100 101 102 103 104
control
control 1:10 1:20 1:50
0
4
8
12
*
M
FI
 
Fig. 3.16. MCs induce degranulation of CD8+ T cells. MCs were pulsed with OVA257-264 
peptide or left untreated and cultured with OT-I transgenic CD8+ T cells. 1 x 106 CD8+ T 
cells were incubated with unpulsed MCs (“control”) or with antigen-pulsed MCs at different 
cell ratios (1:10, 1:20 or 1:50). Cells were stained for surface expression of CD8 and LAMP-
1 and analyzed by FACS. Histogram shows one representative of three independent 
experiments for surface expression of LAMP-1 (gated on viable CD3+ T cells). Right graph 
shows mean values of mean fluorescence intensity (MFI) for LAMP-1 with standard deviation 
of two to three independent experiments. * p<0.05 
 
Thus, it is suggested that MCs modulate the effector functions of CD8+ T cells in an 
antigen-dependent manner by increasing their cytotoxic content, as well as by promoting the 
release of cytotoxic granula. For this reason, the MC-CD8+ T cell interaction should be taken 
into consideration when processes involving cytotoxicity, such as viral infections, are studied.  
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3.5.4. The antigen-specific interaction between MCs and CD8+ T cells is cell-   
cell contact-dependent 
The finding that MCs induce antigen-specific CD8+ T cell activities raises questions 
about the requirements involved in this interaction. The first step of interaction between 
“professional” APCs (DCs) and T cells consists of physical cell-cell contacts leading to long-
lasting stable conjugates between the two cell types, which allow the formation of 
immunological synapse (Gunzer et al., 2000; Mempel et al., 2004). It was therefore 
hypothesized that direct cell-cell contact is essential for the induction of CD8+ T cell 
activation by MCs.  
To examine this hypothesis, antigen-pulsed MCs were cultured with CD8+ T cells 
either allowing free cell-cell contact or in the presence of a semi-permeable membrane. The 
diverse size of mediators produced by MCs instructed the inhibition of the direct MC-CD8+ T 
cell contact with two different kinds of membrane: either one which allows the passive 
diffusion of any soluble factor produced by MCs (0.2 μm anopore membrane), or one which 
allows soluble factors of only less than 0.02 μm diameter to pass through (0.02 μm anopore 
membrane) and therefore excludes the diffusion of, e.g., exosomes. The inhibition of cell 
contact between MCs and CD8+ T cells by both membranes inhibited the subsequent 
activation, as shown by FACS analysis for activation markers (Fig. 3.17A) and proliferation, 
as shown by the CFSE dilution of the CD8+ T cells, measured with FACS (Fig. 3.17B). Thus, 
it was demonstrated that direct cell-cell contact between antigen-pulsed MCs and CD8+ T 
cells is essential for the induction of antigen-specific CD8+ T cell responses.   
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Fig. 3.17. The antigen-dependent activation and proliferation of CD8+ T cells induced by 
MCs are cell-cell contact-dependent. MCs were pulsed with OVA257-264 peptide or left 
untreated (“control”) and cultured with CD8+ T cells for 48 hours. Direct cell contact 
between MCs and CD8+ T cells was either allowed (“free contact”) or inhibited by the 
presence of a 0.2 μm or a 0.02 μm-anopore membrane, as indicated. A. Activation of CD8+ T 
cells was measured by analysis of CD69, CD25 (upper row) and CD44 (lower row) 
expression by FACS. Staining of the cells with control isotype matched antibodies of 
irrelevant specificity is shown in bold black lines.  B. Proliferation of CD8+ T cells was 
visualized by CFSE dilution. All graphs are gated on viable CD8+ T cells. Representative 
results of three independent experiments are shown. 
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3.5.5. The antigen-specific interaction between MCs and CD8+ T cells is 
dependent on cytokines released by MCs 
Since it was demonstrated that direct cell-cell contact is essential for the antigen-
specific interaction between MCs and CD8+ T cells, it was further enquired whether direct 
cell-cell contact is the only requirement for MCs to induce antigen-specific CD8+ T cell 
activation, or soluble factors produced by MCs contribute additionally to this activation. For 
this reason, the release of soluble factors by MCs was inhibited by treatment with mitomycin 
C.  
Initially, in order to exclude the possibility that the mitomycin C treatment of MCs 
induces activation of the CD8+ T cells in the absence of the OVA257-264 peptide, unpulsed 
MCs were left untreated or treated with mitomycin C and were subsequently co-cultured with 
CD8+ T cells. As shown in Fig. 3.18A, in the absence of the peptide, the CD8+ T cells did not 
exhibit any activation, whether MCs were pretreated with mitomycin C or not.  
Thus, it was further examined whether mitomycin C treatment of MCs would 
influence the ability of MCs to activate CD8+ T cells in an antigen-dependent manner. For 
this reason, MCs were treated with mitomycin C immediately after their pulsing with the 
OVA257-264 peptide. As compared with untreated antigen-pulsed MCs, the treatment of MCs 
with mitomycin C resulted in 54 ± 18% (n=3) decrease of their capacity to activate CD8+ T 
cells, as measured by the surface expression of activation markers (CD69+CD25+) on CD8+ 
T cells (Fig. 3.18B).  
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Fig. 3.18. Mitomycin C treatment of MCs reduces their ability to activate CD8+ T cells. 
Unpulsed MCs (A) or OVA257-264-pulsed MCs (B) were left untreated (“pos. control”) or 
were treated with mitomycin C (10 μg/ml) (“mit. C”) prior to their addition to OT-I 
transgenic CD8+ T cells. Activation of CD8+ T cells was measured 48 hours later by analysis 
of CD69 and CD25 expression (upper row) and CD44 expression (middle row) by FACS 
(gated on viable CD8+ T cells). Control isotype staining is shown in bold black lines. 
Representative results of one out of three independent experiments are shown. Graph in the 
lowest row (in B) shows mean values of activated (CD69+CD25+) CD8+ T cells with 
standard deviation of three independent experiments. * p<0.05 
 
 
 
[3. Results] 
 
- 82 - 
 
Mitomycin C inhibits nucleic acid synthesis, therefore blocks the synthesis of 
cytokines. However, MCs contain granula with many preformed cytokines and soluble 
factors, which are released upon MC degranulation. For this reason, the effect of blocking 
both the synthesis as well as the release of preformed soluble factors was examined by 
paraformaldehyde treatment of MCs.  
First, in order to exclude the possibility that the paraformaldehyde treatment of MCs 
would induce activation of the CD8+ T cells in the absence of the peptide, peptide-unpulsed 
MCs were left untreated or treated with paraformaldehyde and subsequently co-cultured with 
CD8+ T cells. In the absence of the peptide, the CD8+ T cells did not exhibit any activation, 
whether MCs were pre-treated with paraformaldehyde or not (Fig. 3.19A).  
Subsequently, MCs were treated with paraformaldehyde immediately after their 
pulsing with the antigen and were used to activate CD8+ T cells in an antigen-dependent 
manner. As shown in Fig. 3.19B, the paraformaldehyde treatment of MCs resulted in 69% ± 
16% (n=4) decrease of their capacity to activate CD8+ T cells, as measured by the surface 
expression of activation markers (CD69, CD25 and CD44) on CD8+ T cells.  
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Fig. 3.19. Paraformaldehyde treatment of MCs reduces their ability to activate CD8+ T 
cells. Unpulsed MCs (A) or peptide-pulsed MCs (B) were left untreated (“pos. control”) or 
were treated with paraformaldehyde (“PFA”), prior to their addition to the CD8+ T cells. 
Activation of CD8+ T cells was measured by analysis of CD69 and CD25 expression (upper 
row) and CD44 expression (middle row) by FACS (gated on viable CD8+ T cells). Control 
isotype staining is shown in bold black lines. Representative results of four independent 
experiments are shown. Graph in the lowest row (in B) shows mean values of activated 
(CD69+CD25+) CD8+ T cells with standard deviation of four independent experiments.     
** p<0.01 
Conclusively, the MC-mediated, antigen-specific CD8+ T cell activation is dependent 
both on direct cell-cell contact as well as on soluble factors released by MCs. It is therefore 
proposed that direct cell-cell contact between MC and CD8+ T cells is essential for the 
formation of cell conjugates and the presentation of MHC class I-bound antigen. Once this 
first step of interaction is achieved, pre-stored and newly generated soluble factors released 
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by MCs contribute additionally to the antigen-dependent activation of CD8+ T cells. 
However, the formation of cell conjugates between MCs and CD8+ T cells during MHC class 
I-dependent antigen presentation remains to be elucidated.  
 
3.5.6. TLR-ligand exposure of MCs enhances their potential to activate CD8+ 
T cells 
MCs are resident cells in peripheral tissues, especially at sites exposed to the external 
environment (skin, airways, gastrointestinal tract) (Marshall, 2004). At such places, MCs 
encounter invading pathogens, which they can recognize by TLRs. It has been shown that 
TLR3-induced stimulation of MCs mediates CD8+ T cell recruitment in vivo (Orinska et al., 
2005). Therefore, it was suggested that a potential TLR-ligand exposure of MCs might have a 
modulatory effect on the capacity of MCs to induce CD8+ T cell responses.  
To investigate this hypothesis, first it was examined whether TLR-activation of MCs 
enhances the surface expression of MHC class I molecules, since this is the case for MHC 
class II surface expression on MCs (Frandji et al., 1993). Therefore, the level of MC surface-
expressed MHC class I after stimulation with LPS (100 ng/ml) or pIC (10 μg/ml) was 
examined by FACS. As shown in Fig. 3.20, compared to untreated MCs, LPS-exposed MCs, 
exhibited significantly higher expression of surface MHC class I molecules. The surface 
expression of MHC class I on pIC-exposed MCs appeared to be slightly, but not significantly 
increased.  
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Fig. 3.20. TLR-activation of MCs enhances surface expression of MHC class I. MCs were 
stimulated with LPS (100 ng/ml) or pIC (10 μg/ml) or left untreated (“control”) for 48 hours. 
Surface expression of MHC class I on MCs was analyzed by FACS (gated on viable, c-kit 
positive MCs). A. Histogram shows one representative of four independent experiments 
(n=5). Control isotype staining is shown in bold black line. B. Mean values of mean 
fluorescence intensity (MFI) for MHC class I on MCs with standard deviation of four 
independent experiments are shown (n=5).  
The suggestion that MCs may regulate CD8+ T cell responses upon TLR-ligand 
exposure was supported by the up-regulation of MHC class I expression by MCs. Therefore, 
it was further examined whether the activation of MCs with TLR-ligands influenced their 
ability to induce CD8+ T cell responses. To investigate this hypothesis, MCs were cultured in 
the presence of LPS (100 ng/ml) or pIC (10 μg/ml) for 48 hours prior to their loading with 
OVA257-264 peptide. Subsequently, the antigen-pulsed MCs were incubated with OT-I 
transgenic CD8+ T cells. The activation of CD8+ T cells (surface CD69 and CD25 
expression), as well as the cytokines in the supernatants were measured. MCs that have been 
exposed to LPS or pIC exhibited a greater capacity to induce antigen-specific CD8+ T cell 
activation (Fig. 3.21A). At a ratio of MC:CD8 = 1:10, MCs exhibited the maximum capacity 
to activate CD8+ T cells, therefore the exposure to TLR-ligands did not significantly enhance 
the CD8+ T cell activation. However, at a lower ratio of 1:20, LPS- or pIC- activated MCs 
displayed an increased capacity to activate CD8+ T cells by 20 ± 8% or 20 ± 11% 
respectively. Moreover, secretion of IL-2 (Fig. 3.21B) was significantly enhanced upon TLR-
activation of MCs. Regarding IL-2 production, the effect of LPS-stimulation was more 
prominent at the highest ratio of MC:CD8 (1:2), while the effect of pIC-stimulation was more 
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prominent at the ratio of 1:10. In contrast to secretion of IL-2, IFN-γ secretion was not 
significantly enhanced upon TLR-ligand exposure of MCs (Fig. 3.21B).  
These results suggest that TLR-ligand exposure of MCs controls the antigen-dependent 
interaction between MCs and CD8+ T cells. Therefore, it is proposed that the encounter of 
PAMPs by MCs in peripheral tissues is an important factor modulating the contribution of 
MCs in the regulation of adaptive immune responses.  
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Fig. 3.21. TLR-ligand exposure of MCs enhances their capacity to activate CD8+ T cells.  
MCs were stimulated with LPS (100 ng/ml) or pIC (10 μg/ml) or left untreated (“control”) 
prior to their loading with OVA257-264 peptide and were cultured with OT-I transgenic CD8+ 
T cells. A. Activation of CD8+ T cells was measured by analysis of CD69 and CD25 
expression by FACS. Percentage of activated (double-positive CD69+CD25+) CD8+ T cells is 
shown. B. IL-2 production was measured in the supernatants of the co-cultures by ELISA. C. 
IFN-γ production was measured in the supernatants of the co-cultures by ELISA. Bars 
represent mean values with standard deviation of two to three independent experiments.        
* p < 0.05 
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3.6. Antigen-dependent effects of MCs on CD8+ T cells in vivo 
Since MCs were proven to be efficient activators of CD8+ T cell responses, the 
question whether this is only an in vitro observed effect or also an in vivo occurring 
phenomenon was raised. Therefore, the potential of MCs to interact with CD8+ T cells in an 
antigen-dependent manner in vivo was investigated. First, MCs were examined for their 
ability to induce antigen-dependent proliferation of primary CD8+ T cells in vivo. 
Furthermore, since MCs are well characterized cells during allergic reactions, the potential of 
MCs to modulate antigen-specific CD8+ T cell responses in an in vivo murine model of 
allergy was tested.  
 
3.6.1. MCs induce antigen-specific proliferation of CD8+ T cells in vivo 
In order to investigate whether MCs induce antigen-specific CD8+ T cell responses in 
vivo, adoptive transfer experiments were performed. First, 5 x 106 antigen-pulsed MCs were 
administered intraperitoneally in C57/BL6 wild-type mice. As positive control, an equal 
number of antigen-pulsed bone marrow-derived DCs were administered, while an equal 
number of unpulsed MCs served as negative control. One day later, recipient mice were 
injected intraperitoneally with 5 x 106 CFSE-labeled, primary CD8+ T cells purified from 
lymph nodes of OT-I transgenic mice. Proliferation of the transferred CD8+ T cells was 
examined by FACS analysis four days later. As shown in Fig. 3.22 MCs did not induce any 
antigen-independent proliferation of CD8+ T cells (“control”), while they were indeed able 
to induce the proliferation of CD8+ T cells in the presence of the OVA257-264 peptide (Fig. 
3.22, “MC”). The relative amount of CD8+ T cells in each of the successive peaks of CFSE 
dilution corresponds to the relative amount of CD8+ T cells in each cell division. Thus, it is 
shown that DCs pulsed with the OVA257-264 peptide induced higher proliferation of the CD8+ 
T cells, as compared with MCs, since the percentages of the CD8+ T cells in the later cell 
divisions are higher (Fig. 21, “DC”).  
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Fig. 3.22. MCs induce antigen-specific proliferation of CD8+ T cells in vivo.  5 x 106 MCs 
were left untreated (“control”) or were pulsed with the OVA257-264 peptide (“MC”) and 
injected intraperitoneally in C57BL/6 recipients. As positive control, 5 x 106 DCs were 
pulsed with the OVA257-264 peptide (“DC”) and injected intraperitoneally in C57BL/6 
recipients. 24 hours later, 8 x 106 purified CFSE-labeled CD8+ OT-I transgenic T cells were 
transferred intraperitoneally.  4 days later, lymph node cells were isolated and analyzed for 
proliferation of the CFSE-labeled CD8+ T cells by the dilution of CFSE (gated on viable 
lymphocytes). Representative results of three independent experiments with at least seven 
mice per group are shown (n=7-9).  
In order to prove that the antigen presentation was performed exclusively by the 
antigen-pulsed, transferred MCs, and not by other resident APCs, the same adoptive transfer 
experiment was performed in β2m-/- mice. These mice do not possess the β2m chain of MHC 
class I, therefore lack the ability to efficiently present MHC class I-related antigens. A 
comparable stimulation of CD8+ T cell proliferation by the transfer of antigen-pulsed MCs 
was observed in wild-type (Fig. 3.23, “WT”) and in β2m-/- mice (Fig. 3.23, “β2m-/-”), 
excluding the possibility that other resident cells which present MHC class I-dependent 
antigens significantly influenced the CD8+ T cell proliferative response.  
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Fig. 3.23. MCs induce antigen-specific CD8+ T cell proliferation in β2m-/- mice.  5 x 106 
MCs were left untreated (“control”) or pulsed with the OVA257-264 peptide (“+ OVA257-264”) 
and injected intraperitoneally in C57BL/6 (“WT”) or in β2m-/- (“β2m-/-”) recipients. 24 
hours later, 8 x 106 purified, CFSE-labeled, OT-I transgenic CD8+ T cells were transferred 
intraperitoneally.  4 days later, lymph node cells were isolated and analyzed for proliferation 
of the CD8+ T cells by the dilution of CFSE (gated on viable lymphocytes). Representative 
results of three independent experiments with at least seven mice per group are shown. Bars 
in the right graph represent mean values for the percentages of proliferating CFSE-labeled 
CD8+ T cells with standard deviation of three independent experiments with at least seven 
mice per group (n=7-9). n.s.:not significant 
 
With those experiments, showing that MCs induce proliferation of CD8+ T cells in 
wild-type as well as in β2m-/- mice, it was determined that MCs are efficient APCs, capable 
of interacting with CD8+ T cells upon presentation of MHC class I-related antigens in vivo.  
 
3.6.2. MCs do not significantly influence CD8+ T cell responses in a murine 
model of allergic airway sensitization 
Since MCs were proven to induce antigen-specific CD8+ T cell responses in vitro and 
in vivo, an in vivo pathological situation was investigated, in which the MC-CD8+ T cell 
interaction could be relevant. MCs are well characterized as main participants of an allergic 
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immune response. In addition, evidence in different models suggests that CD8+ T cells are 
also important for the induction of allergic sensitization (Haczku et al., 1995a; Haczku et al., 
1995b). Several parameters of allergic sensitization have been shown to be directly dependent 
on the presence of CD8+ T cells (Hamelmann et al., 1996). For this reason, the effect of MCs 
in inducing antigen-specific CD8+ T cell responses during a well established murine model of 
allergic sensitization against OVA was examined.  
To investigate this question, MC-deficient mice (Kit-W/Wv) as well as their 
congeneic wild-type mice (Kit-W/W) were immunized against ovalbumin (OVA), according 
to a well established protocol of sensitization against OVA, schematically represented in Fig. 
3.24. Mice were sensitized with three intraperitoneal injections of OVA (20 μg/mouse) and 
subsequently challenged with OVA aerosol (1% OVA in PBS). One day after the last OVA-
aerosol challenge, the lung and the draining lymph nodes of the lung were analyzed for the 
content and phenotype of CD8+ T cells.  
 
 
SENSITIZATION
OVA  intraperitoneal
29
ANALYSIS
0 14 21 26 27
CHALLENGE
OVA aerosol
28
sensitized mice
control mice
 
Fig. 3.24. Protocol for inducing allergic immune response against ovalbumin (OVA). MC-
deficient mice (Kit-W/Wv) as well as their congeneic wild-type mice (Kit-W/W) received 
intraperitoneal injection of OVA (20 μg/mouse) on days 0, 14 and 21. Subsequently, mice 
were challenged with inhalation (aerosol) of 1% OVA in PBS for 40 min on days 26, 27 and 
28. Control mice were only treated with OVA aerosol. Mice were analyzed for the CD8+ 
immune response in the lung and in the draining lymph nodes on day 29.  
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Using the above protocol of OVA immunizations in wild-type and MC-deficient 
mice, four groups of mice were formed: “control” (= unimmunized) wild-type and MC-
deficient mice as well as “sensitized” (= sensitized and challenged with OVA) wild-type and 
MC-deficient mice (Fig. 3.25). Thus, initially the CD8+ T cell response was compared 
between “control” wild-type and MC-deficient mice, in order to examine whether the absence 
of MCs results in an altered CD8+ T cell phenotype in naïve mice. Subsequently, the CD8+ T 
cell response was compared between “sensitized” wild-type and MC-deficient, in order to 
further investigate whether the CD8+ T cell response during an allergic sensitization is 
dependent on the presence of MCs.  
control WT control MC-deficient
sensitized WT sensitized MC-deficient
 
Fig. 3.25. The groups of mice that were formed and compared after OVA immunizations. 
Unimmunized (“control”) wildtype (WT) mice were compared to their congeneic MC-
deficient mice (W/Wv) to examine if the CD8+ T cell phenotype in naïve mice is dependent on 
the presence of MCs. OVA-sensitized and -challenged mice (“sensitized”) WT mice were 
compared to MC-deficient mice to examine whether the CD8+ T cell response during a 
murine model of allergic sensitization is dependent on the presence of MCs.  
First, the percentage as well as the total number of CD8+ T cells in the lung and in the 
draining lymph nodes of the lung was determined by FACS analysis. MC-deficient “control” 
mice exhibited a reduced percentage and reduced number of CD8+ T cells in the lung, but not 
in the draining lymph nodes of the lung (Fig. 3.26, left columns). However, these differences 
were not visible after sensitization and challenge against OVA (Fig. 3.26, right columns). 
This evidence suggests that MCs may regulate the amount of CD8+ T cells in the lung of 
naïve mice. However, it should be taken into consideration that the lack of c-kit function in 
Kit-W/Wv mice causes additional abnormalities in these mice, such as macrocytic anemia, 
lack of melanocytes, intestinal TCRγδ intraepithelial lymphocytes and interstitial cells of 
Cajal. Therefore, results in terms of MC-mediated effects obtained from comparisons 
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between Kit-W/Wv and their congeneic wild-type mice should be interpreted carefully. For 
this reason, the amount of CD8+ T cells in Kit-W/Wv mice reconstituted with BMMCs 
should be examined, in order to distinguish whether the above demonstrated decreased 
number of CD8+ T cells in the MC-deficient mice is exclusively a MC-dependent 
phenomenon, or results from a dysregulated T cell development in the Kit-W/Wv mice.  
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Fig. 3.26. MCs do not regulate the number of CD8+ T cells in an in vivo model of allergic 
airway sensitization against OVA. MC-deficient mice (Kit-W/Wv, blue bars), and their 
congeneic wild-type mice (Kit-W/W, white bars), were sensitized and challenged 
(“sensitized”) or only challenged (“control”) against OVA according to the protocol shown 
in Fig. 3.24. Lung and the draining lymph nodes of the lung were analyzed by FACS. A. 
Percentage of CD8+ T cells is shown (gated on viable cells) (n=7-9). B. Total number of 
viable CD8+ T cells is shown (n=3-5). * p<0.05, n.s.:not significant 
Furthermore, the potential of MCs to modulate the activation or memory 
differentiation of CD8+ T cells in this allergic model was analyzed.  Activation of CD8+ T 
cells was measured by surface expression of CD69 and CD25, while effector memory 
differentiated CD8+ T cells were characterized as CD44+CD62L- by FACS. As shown in Fig. 
[3. Results] 
 
- 94 - 
 
3.27, MC-deficient mice did not exhibit a significant difference in the activation of CD8+ T 
cells (Fig. 3.27A) or in the development of effector memory CD8+ T cells (Fig. 3.27B) after 
sensitization against OVA.  
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Fig. 3.27. MCs do not modulate the CD8+ T cell response in an in vivo model of allergic 
airway sensitization against OVA. MC-deficient mice (Kit-W/Wv, blue bars), as well as their 
congeneic wild-type mice (Kit-W/W, white bars), were sensitized and challenged 
(“sensitized”) or only challenged (“control”) against OVA according to the protocol shown 
in Fig. 3.24. Lung and the draining lymph nodes of the lung were analyzed by FACS. A. 
Percentage of CD69+CD25+ on viable CD8+ T cells is shown. B. Percentage of 
CD44+CD62L- on viable CD8+ T cells is shown. Bars represent mean values with standard 
deviation of three independent experiments with at least seven mice per group (n=7-9). 
n.s.:not significant 
This data indicate that, although MCs are able to induce antigen-specific proliferation 
of primary CD8+ T cells in vitro and in vivo, this antigen-specific interaction between MCs 
and CD8+ T cells does not have a significant impact on the outcome of the murine allergic 
model studied here. However, MC-CD8+ T cell interactions could play an important role in 
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other in vivo situations, for example viral infections. The role of MC-CD8+ T cell crosstalk in 
such pathological situations remains to be investigated.  
 
3.7. The effect of MCs on pre-activated CD8+ T cells 
MCs are long-lived, resident cells in the peripheral tissues (Marshall, 2004). 
Therefore, the next hypothesis formulated here was that MCs can influence CD8+ T cells that 
have been primed and pre-activated by the migrating DCs in the lymph nodes. Thus, MCs 
may play a role also in a secondary immune response, by regulating the activities of DC-
mediated pre-activated CD8+ T cells. To investigate the effect of MCs on pre-activated CD8+ 
T cells two different approaches were used. First, the effect of the presence of MCs during 
the DC-mediated activation of CD8+ T cells and second, the role of MCs in regulating the 
proliferation of pre-activated CD8+ T cells were examined.  
 
3.7.1. MCs reduce the ability of DCs to activate CD8+ T cells in vitro 
DCs are “professional” APCs capable of inducing optimal CD8+ T cell responses in 
an antigen-dependent manner. MCs have been shown to interact with DCs and induce their 
functional maturation by induction of integrins and co-stimulatory molecule expression (Galli  
et al., 2005b). In order to understand whether MCs also modulate the capacity of DCs to 
prime CD8+ T cells, the DC-induced activation of CD8+ T cells was studied in the presence 
or absence of MCs. For this reason, OVA257-264-pulsed DCs were used to stimulate naïve, 
OT-I transgenic CD8+ T cells in the absence of MCs or in the presence of different amounts 
of MCs in the culture. As read-out, the surface expression of CD69 and CD25 was measured 
by FACS analysis. The result indicated that the presence of MCs in the culture inhibited the 
antigen-dependent, DC-induced CD8+ T cell activation. This effect occurred in a MC dose-
dependent way. Low numbers (1 x 104 – 5 x 104) of MCs did not significantly influence the 
DC-mediated CD8+ T cell activation. However, 1 x 105 MCs reduced the activation of CD8+ 
T cells, as shown by the 12.5% ± 3.5% (n=2) reduced surface expression of activation 
markers CD69 and CD25, measured by FACS (Fig. 3.28).  
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Fig. 3.28. The presence of MCs reduces the antigen-dependent, DC-mediated CD8+ T cell 
activation. DCs were pulsed with OVA257-264 peptide and co-cultured with naïve, OT-I 
transgenic CD8+ T cells without MCs or in addition of 1 x 105, 5 x 104 or 1 x 104 MCs, as 
indicated. After 48 hours, cells were analyzed by FACS for their activation status. Dot plots 
show surface expression of activation markers (CD69 and CD25) on CD8+ T cells (gated on 
viable CD8+ T cells) (n=2). Graph in lower row shows mean values of activated 
(CD69+CD25+) CD8+ T cells with standard deviation of two independent experiments.  
 
3.7.2. MCs inhibit the proliferation of pre-activated CD8+ T cells in vitro 
Furthermore, it was investigated whether MCs modulate the proliferation of DC-
mediated, pre-activated CD8+ T cells. Therefore, CD8+ T cells were antigen-dependently 
activated by OVA257-264-pulsed DCs. Subsequently, the CD8+ T cells were isolated from the 
co-culture by MACS, and co-cultured with MCs at different cell ratios. The presence of MCs 
in the culture inhibited the proliferation of CD8+ T cells, as shown by the reduced CFSE 
dilution of the CD8+ T cells (Fig. 3.29).  
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Fig. 3.29. MCs reduce the proliferation of pre-activated CD8+ T cells. OVA257-264--pulsed 
DCs were cultured with OT-I transgenic lymph node cells for 24 hours. Following, CD8+ T 
cells were isolated by negative selection with MACS and labeled with CFSE. Purified 
activated CD8+ T cells were cultured in the presence of MCs at a MC:CD8 ratio of 1: 2 
(dark blue line) or 1:10 (light blue line) or in the absence of MCs (grey filled histogram). 
Proliferation was analyzed by CFSE dilution of CD8+ T cells, 48 hours after the addition of 
MCs, as measured by FACS (gated on viable CD8+ T cells). Representative results of two 
independent experiments are shown.  
These results suggest that MCs might regulate the CD8+ T cell responses during a 
secondary immune response, by down-regulating the DC-mediated CD8+ T cell activation as 
well as by reducing the proliferation of pre-activated CD8+ T cells. Thus, MCs may act as 
regulatory cells during adaptive immune responses: when encounter with naïve CD8+ T cells 
occurs, MHC class I-dependent presentation of antigens results in antigen-specific CD8+ T 
cell responses; however when MCs encounter pre-activated CD8+ T cells, reduced CD8+ T 
cell activation and proliferation occurs.  
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3.8. The effect of CD8+ T cells on MCs 
With the above demonstrated experiments, it was proven that MCs modulate CD8+ T 
cell responses in an antigen-dependent manner in vitro and in vivo. The contact with activated 
CD8+ T cells could, in turn, modulate the phenotype of MCs, as it is the case for DCs 
(Bernhard et al., 2000). In particular, activated T cells have been shown to induce maturation 
of DCs by enhancing surface expression of MHC and co-stimulatory molecules (Bernhard et 
al., 2000). Moreover, the CD8+ T cell response detected in our settings comprised the 
secretion of cytokines, such as IFN-γ and GM-CSF, which are reported to affect MC 
differentiation and phenotype (Frandji et al., 1995). Therefore, it was suggested that the MC 
phenotype was also regulated by the contact with CD8+ T cells. The modulation of MC 
activities upon contact with activated CD8+ T cells could have a feedback in the MC-
mediated regulation of adaptive immune responses. For this reason, it was further 
investigated whether CD8+ T cells are able to modulate MC activities in an antigen-
independent or antigen-dependent manner.  
 
3.8.1. CD8+ T cells regulate MHC class I protein expression on MCs 
Activated T cells induce up-regulation of surface expressed MHC molecules on DCs 
(Bernhard et al., 2000). Since a surface expression of MHC class I molecules is important for 
the presentation of antigens to CD8+ T cells, the ability to CD8+ T cells to induce surface 
MHC class I on MCs was examined. For this reason, unpulsed or OVA257-264 -pulsed MCs 
were cultured with CD8+ T cells. As negative control, OVA257-264 -pulsed MCs that did not 
contact CD8+ T cells were used. After 48 hours of co-culture, MCs were analyzed for surface 
MHC class I expression by FACS. As shown in Fig. 3.30, antigen-dependent contact with 
CD8+ T cells induced surface expression of MHC class I on MCs. Thus, it is proposed that 
CD8+ T cells upon antigen-dependent, MC-mediated activation, increase the expression of 
MHC class I molecules on MCs, therefore enhance their potential for further interaction with 
CD8+ T cells.  
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Fig. 3.30. CD8+ T cells induce MHC class I surface protein expression on MCs. Unpulsed 
MCs (blue line) or OVA257-264 -pulsed MCs (red line) were cultured with CD8+ T cells. As 
negative control, OVA257-264 -pulsed MCs that did not contact CD8+ T cells were used (black 
line). After 48 hours of co-culture, MCs were analyzed for surface expression of MHC class I 
by FACS. Control isotype staining is shown by the grey filled histogram. A. Expression of 
MHC class I in one representative of three independent experiments is shown. B. Mean 
values of MFI for MHC class I with standard deviation of two independent experiments are 
shown.  
 
3.8.2. CD8+ T cells modulate the gene expression profile of MCs 
The enhanced MHC class I expression by MCs after antigen-dependent contact with 
CD8+ T cells suggests that activated CD8+ T  cells are able to modulate MC activities. To 
further investigate the impact of CD8+ T cells on MCs, first the gene expression profile of 
MCs after antigen-independent or antigen-dependent contact with CD8+ T cells was 
compared to the one of MCs not having contacted CD8+ T cells. Therefore, untreated or 
OVA257-264-pulsed MCs were co-cultured with CD8+ T cells for 48 hours and subsequently 
purified by MACS separation. As negative control, OVA257-264-pulsed MCs not having 
encountered CD8+ T cells were used. The purity of MCs after double MACS separation was 
tested with FACS staining for surface expression of c-kit (CD117) and FcεRI. As shown in 
Fig. 3.31, MCs after MACS purification were 96.8 ± 1.8% (n=3) pure for the case of OVA257-
264-pulsed MCs co-cultured with CD8+ T cells, 97.9 ± 0.5% (n=3) for the case of unpulsed 
MCs co-cultured with CD8+ T cells and 95.7 ± 0.1% (n=2) for the case of OVA257-264-pulsed 
MCs not co-cultured with CD8+ T cells. 
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Fig. 3.31. Purity of MCs after MACS separation following co-culture with CD8+ T cells. 
OVA257-264-pulsed MCs or unpulsed MCs were co-cultured with CD8+ T cells for 48 hours 
and subsequently purified by two successive MACS separations. As negative control, OVA257-
264-pulsed MCs not having encountered CD8+ T cells were used. A. Gate was set on all viable 
cells excluding cell debris and fractions of dead cells by FSC/SSC analysis. B. The purity of 
MCs after MACS separation was tested with FACS staining for surface expression of c-kit 
and FcεRI. Dot plots show representative results of two to three independent experiments. 
The experiment was performed three times and RNA was isolated from the purified 
MCs. Microarray analysis was performed in order to detect genes in MCs which were 
differentially expressed upon contact with CD8+ T cells. The experimental design for this part 
of the study is schematically represented in Fig. 3.32.   
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Fig. 3.32. Schematic representation of the experimental design for analyzing the 
differential gene expression in MCs after contact with CD8+ T cells.  
The labeling and hybridization of the MC RNA in Affymetrix GeneChips, as well as 
the evaluation of the primary data obtained from the microarray experiment, were performed 
by Dr. Reinhardt Hoffmann and Dr. Jörg Mages in the Technische Universität München. 
Statistical analysis was performed by limma analysis (Smyth, 2005), in which each condition 
was compared with each other. The F.p.-value derived from a summarization of the all these 
tests, similarly to a one-way ANOVA analysis. p-values derived from the comparison of pairs 
of MC sets. All p-values derived from the limma analysis were subsequently corrected for 
multiple testing using Benjamini Hochberg correction (Benjamini and Hochberg, 1995). 
Further evaluation of the results was focused only on the genes that revealed a significant 
differential expression between the different sets of MCs (F.p.-value < 0.05). The experiment 
was performed three times and the mean values of each set of MCs were used for further 
analysis.  
The genes that displayed differential expression (more than 5 times) in the different 
sets of MCs are summarized in Table 3.1. Briefly, 29 genes appeared to be more than 5 times 
differentially expressed in MCs after contact with CD8+ T cells. Of these, only 3 (Table 3.1, 
green colour) were down-regulated after contact with CD8+ T cells. These results 
demonstrate that CD8+ T cells direct a potent MCs response.  
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Gene 
symbol Gene title
MC+     
OVA257-264 
(Mean)
MC+  
CD8 
(Mean)
MC+OVA257-264 
+CD8      
(Mean)
max/m
in 
means
F.p.- 
value
Entrez.
Gene
Rtp4 receptor transporter protein 4 12,96 560,55 546,74 43,25 0,03 67775
LOC630509 
/// 
LOC674192
similar to H-2 class I 
histocompatibility antigen, Q7 
alpha chain precursor (QA-2 
34,17 213,82 1387,46 40,60 0,00
Ifng interferon gamma 5,93 12,25 143,20 24,15 0,00 15978
Mpa2l macrophage activation 2 like 11,18 132,18 240,09 21,48 0,01
Ak3l1 adenylate kinase 3 alpha-like 1 8,87 18,70 174,42 19,67 0,01 11639
AI451557 expressed sequence AI451557 10,76 182,40 210,13 19,54 0,01 102084
Tnfrsf9 tumor necrosis factor receptor 
superfamily, member 9
70,37 68,91 1238,48 17,97 0,00 21942
Lzp-s P lysozyme structural 356,11 247,35 34,18 10,42 0,00 17110
H2-Q1 /// 
0610037M1
histocompatibility 2, Q region 
locus 1 /// RIKEN cDNA 
3,94 6,98 39,73 10,08 0,00
Rsad2 radical S-adenosyl methionine 
domain containing 2
14,21 132,36 136,58 9,61 0,05 58185
Tgm2 transglutaminase 2, C 22,95 39,95 202,67 8,83 0,00 21817
Lpl lipoprotein lipase 79,47 27,20 9,17 8,67 0,00 16956
Zbp1 Z-DNA binding protein 1 10,77 59,06 92,90 8,63 0,02 58203
Stat1 signal transducer and activator 
of transcription 1
74,80 509,32 643,01 8,60 0,01 20846
Irf7 interferon regulatory factor 7 32,56 277,03 200,01 8,51 0,03 54123
Iigp1 interferon inducible GTPase 1 7,67 33,85 60,67 7,91 0,04 60440
Ms4a6b membrane-spanning 4-domains, subfamily A, member 6B 12,25 16,36 90,87 7,42 0,05 69774
AW112010 expressed sequence AW112010 22,26 80,97 162,29 7,29 0,01 107350
Mcf2l mcf.2 transforming sequence- 56,96 46,85 305,35 6,52 0,00 17207
Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 40,28 41,96 259,84 6,45 0,00 26432
Irgm immunity-related GTPase family, 122,08 589,89 761,01 6,23 0,04 15944
Rgs11 regulator of G-protein signaling 17,16 35,83 105,81 6,17 0,04 50782
Socs3 suppressor of cytokine 401,19 243,35 1470,84 6,04 0,00 12702
H2-Ab1 histocompatibility 2, class II antigen A, beta 1 45,36 66,46 261,66 5,77 0,00 14961
Tgfbi transforming growth factor, beta 
induced
23,12 7,28 4,24 5,45 0,01 21810
Igtp interferon gamma induced 226,87 1041,43 1195,15 5,27 0,03 16145
H2-Q8 histocompatibility 2, Q region 17,22 24,29 90,11 5,23 0,00 15019
Pdk1 pyruvate dehydrogenase kinase, isoenzyme 1 47,65 69,48 246,26 5,17 0,02 228026
Irf1 interferon regulatory factor 1 217,34 756,57 1087,75 5,00 0,01 16362  
Table 3.1. Differential gene expression in MCs after contact with CD8+ T cells in an 
antigen-dependent or antigen-independent manner.  OVA257-264-pulsed MCs were left 
untreated (MC + OVA257-264) or were co-cultured with OT-I transgenic CD8+ T cells (MC + 
CD8 + OVA257-264). In parallel, unpulsed MCs were co-cultured with OT-I transgenic CD8+ 
T cells (MC + CD8). After 48 hours MCs were isolated by positive selection with MACS and 
RNA was isolated. Microarray analysis (Affymetrix, Mouse MG 430 2.0) was performed. 
Statistical analysis was performed by limma analysis. Table summarizes the genes that were 
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more than 5 times down-regulated (green colour) or up-regulated (red colour) with F.p.-
value <0.05. Mean values of gene expression from three independent experiments are shown. 
 
3.8.2.1. CD8+ T cells modulate the gene expression profile of MCs in an antigen-
independent manner 
In an attempt to understand the relevance of the CD8+ T cell-induced gene regulation 
in MCs, the differentially expressed genes were analyzed according to whether their 
differential expression was induced in an antigen-independent or antigen-dependent manner. 
First, CD8+ T cells were tested for their ability to modulate the expression of genes in MCs in 
the absence of a specific antigen. As shown in Fig. 3.33, MCs isolated after antigen-
independent contact with CD8+ T cells (MC + CD8) displayed an up-regulated expression of 
several genes, each of them represented by a separate dot in the upper left triangle of the plot. 
Therefore, it is suggested that CD8+  T cells are able to induce a MC response in an antigen-
independent manner.  
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Fig. 3.33. CD8+ T cells induce differential gene expression in MCs in an antigen-
independent manner. MCs were co-cultured with OT-I transgenic CD8+ T cells (MC + 
CD8). In parallel, OVA257-264-pulsed MCs were cultured alone (MC + OVA257-264). After 48 
hours, MCs were isolated by positive selection with MACS and RNA was isolated. 
Microarray analysis (Affymetrix, Mouse MG 430 2.0) was performed. Statistical analysis was 
performed by limma analysis. Scatterplot shows the differential expression of genes with 
F.p.-value of <0.05. Mean values of gene expression from three independent experiments are 
shown. Genes appearing in the upper left triangle of the plot displayed an up-regulation in 
the set of MCs having experienced contact with CD8+ T cells (MC + CD8), while genes 
appearing in the low right triangle of the plot displayed an up-regulation in the set of MCs 
not having contacted CD8+ T cells.  
Examination of the genes that were up-regulated after CD8+ T cell contact revealed 
that several IFN-related genes, such as the receptor transporter protein 4 (Rtp4), IFN 
regulatory factor 7 (IRF7), signal transducer and activator of transcription 1 (STAT1) and 
IFN-γ induced GTPase (Igtp) were induced in MCs in an antigen-independent manner. In 
addition, radical S-adenosyl methionine domain containing 2 (Rsad2), an IFN-inducible gene 
encoding for the antiviral protein viperin (Chin and Cresswell, 2001), was in average 9 times 
up-regulated in MCs upon contact with CD8+ T cells. Therefore, the suggestion that CD8+ T 
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cells induce an IFN signal transduction pathway in MCs, leading to a possible protective 
antiviral response is proposed. A summary of the genes that were induced in MCs upon 
antigen-independent contact with CD8+ T cells is shown in Table 3.2.  
 
Gene 
symbol Gene title 
MC+     
OVA257-264 
(Mean) 
MC+  
CD8 
(Mean) 
max/min 
means 
p-
value 
Entrez 
Gene 
Rtp4 receptor transporter protein 4 12.96 560.55 43.25 0.04 67775 
AI451557 expressed sequence AI451557 10.76 182.40 16.96 0.01 102084 
Mpa2l  macrophage activation 2 like 11.18 132.18 11.83 0.02   
Rsad2 
radical S-adenosyl 
methionine domain 
containing 2 
14.21 132.36 9.32 0.05 58185 
Irf7 interferon regulatory factor 7 32.56 277.03 8.51 0.02 54123 
Stat1 signal transducer and activator of transcription 1 74.80 509.32 6.81 0.01 20846 
LOC630509 
/// 
LOC674192 
similar to H-2 class I 
histocompatibility antigen, 
Q7 alpha chain precursor 
(QA-2 antigen)  
34.17 213.82 6.26 0.02   
Zbp1 Z-DNA binding protein 1 10.77 59.06 5.48 0.04 58203 
Igtp interferon gamma induced GTPase 226.87 1041.43 4.59 0.04 16145 
 
Table 3.2. CD8+ T cells induce differential gene expression in MCs in an antigen-
independent manner. MCs were co-cultured with OT-I transgenic CD8+ T cells (MC + 
CD8). In parallel, OVA257-264-pulsed MCs were left untreated (MC + OVA257-264). After 48 
hours, MCs were isolated by positive selection with MACS and RNA was isolated. 
Microarray analysis (Affymetrix, Mouse MG 430 2.0) was performed. Statistical analysis was 
performed by limma analysis. Table summarizes the differential expression of genes with p-
value of <0.05 and differential expression (max/min averages) of >4.5. Mean values of gene 
expression from three independent experiments are shown.  
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3.8.2.2. CD8+ T cells modulate the gene expression profile of MCs in an antigen-
dependent manner 
Since the antigen-independent effect of CD8+ T cells on MCs was analyzed, it was 
further examined whether the presence of a specific MHC class I-related antigen (OVA257-264) 
inducing CD8+ T cell responses upon presentation by MCs, would have a different effect on 
the gene expression profile of MCs. For this reason, the gene expression profile of OVA257-
264-pulsed MCs after contact with CD8+ T cells (Fig. 3.34A, MC + CD8 + OVA257-264) was 
compared to the gene expression profile of unpulsed MCs after contact with CD8+ T cells 
(Fig. 3.34A, MC + CD8). As shown in Fig. 3.34, MCs isolated after antigen-dependent 
contact with CD8+ T cells (MC + CD8 + OVA257-264) displayed an up-regulation of gene 
expression of several genes, each of them represented by a separate dot in the low right 
triangle of the plot, as compared to MCs isolated after antigen-independent contact with 
CD8+ T cells (MC + CD8).  
In order to exclude the possibility that the presence of the peptide induces gene up-
regulation in MCs independently of CD8+ T cells, the gene expression profile of OVA257-264-
pulsed MCs (Fig. 3.34B, MC + OVA257-264) was compared to the gene expression profile of 
OVA257-264-pulsed MCs after co-culture with CD8+ T cells (Fig. 3.34B, MC + CD8 +       
OVA257-264). It was shown that the MC response was indeed dependent on the presence of 
CD8+ T cells and not induced by the pulsing with the OVA257-264 peptide. Therefore, it is 
suggested that CD8+ T cells induce a MC response in an antigen-dependent manner.  
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Fig. 3.34. CD8+ T cells induce differential gene expression in MCs in an antigen-
dependent manner. OT-I transgenic CD8+ T cells were cultured with OVA257-264-pulsed MCs 
(MC + CD8 + OVA257-264) or with untreated MCs (MC + CD8). As control, OVA257-264-pulsed 
MCs were left untreated (MC + OVA257-264). After 48 hours, MCs were isolated by positive 
selection with MACS and RNA was isolated. Microarray analysis (Affymetrix, Mouse MG 
430 2.0) was performed. Statistical analysis was performed by limma analysis. Scatterplot 
shows the differential expression of genes with F.p.-value of <0.05. Mean values of gene 
expression from three independent experiments are shown. A. Comparison of the gene 
expression profile of MCs after antigen-dependent or antigen-independent contact with CD8+ 
T cells is shown. B. Comparison of the gene expression profile of OVA257-264 -pulsed MCs 
after contact or not with CD8+ T cells is shown.  
A summary of the genes that were induced in MCs upon antigen-dependent contact 
with CD8+ T cells is shown in Table 3.3. Noteworthy is the fact that several genes related 
with the induction of adaptive immune response were up-regulated. Thus, the co-stimulatory 
molecule tumour necrosis factor receptor superfamily member 9 (Tnfrsf9) and antigens 
related to major histocompatibility complex (MHC) class I and II (Qa-2 antigen, H2-Q1, H2-
Ab1 and H2-Q8) displayed enhanced expression upon antigen-dependent contact with CD8+ 
T cells. MHC class molecules act in collaboration with co-stimulatory molecules on the 
surface of APCs in order to induce antigen-specific immune responses. It is therefore 
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proposed that the role of MCs in adaptive immunity is instructed by antigen-dependent 
contact with CD8+ T cells.  
Gene 
symbol Gene title 
MC+     
OVA257-264 
(Mean) 
MC+  
CD8 
(Mean) 
MC+OVA257-264 
+CD8      
(Mean) 
max/min 
means 
F.p.- 
value 
Entrez
Gene 
LOC630
509 /// 
LOC674
192 
similar to H-2 class I 
histocompatibility 
antigen, Q7 alpha chain 
precursor (QA-2 
antigen)  
34.17 213.82 1387.46 40.60 0.00   
Ifng interferon gamma 5.93 12.25 143.20 24.15 0.00 15978 
Mpa2l  macrophage activation 2 like  11.18 132.18 240.09 21.48 0.01   
Ak3l1 adenylate kinase 3 alpha-like 1 8.87 18.70 174.42 19.67 0.01 11639 
Tnfrsf9 
tumor necrosis factor 
receptor superfamily, 
member 9 
70.37 68.91 1238.48 17.97 0.00 21942 
H2-Q1 /// 
0610037
M15Rik 
histocompatibility 2, Q 
region locus 1 /// RIKEN 
cDNA 0610037M15 
gene 
3.94 6.98 39.73 10.08 0.00   
Tgm2 transglutaminase 2, C polypeptide 22.95 39.95 202.67 8.83 0.00 21817 
Zbp1 Z-DNA binding protein 1 10.77 59.06 92.90 8.63 0.02 58203 
Iigp1 interferon inducible GTPase 1 7.67 33.85 60.67 7.91 0.04 60440 
Ms4a6b 
membrane-spanning 4-
domains, subfamily A, 
member 6B 
12.25 16.36 90.87 7.42 0.05 69774 
AW1120
10 
expressed sequence 
AW112010 22.26 80.97 162.29 7.29 0.01 107350
Mcf2l mcf.2 transforming sequence-like 56.96 46.85 305.35 6.52 0.00 17207 
Plod2 
procollagen lysine, 2-
oxoglutarate 5-
dioxygenase 2 
40.28 41.96 259.84 6.45 0.00 26432 
Rgs11 regulator of G-protein signaling 11 17.16 35.83 105.81 6.17 0.04 50782 
Socs3 suppressor of cytokine signaling 3 401.19 243.35 1470.84 6.04 0.00 12702 
H2-Ab1 
histocompatibility 2, 
class II antigen A, beta 
1 
45.36 66.46 261.66 5.77 0.00 14961 
H2-Q8 histocompatibility 2, Q region locus 8 17.22 24.29 90.11 5.23 0.00 15019 
Pdk1 
pyruvate 
dehydrogenase kinase, 
isoenzyme 1 
47.65 69.48 246.26 5.17 0.02 228026
Table 3.3. CD8+ T cells induce differential gene expression in MCs in an antigen-
dependent manner. OT-I transgenic CD8+ T cells were cultured with OVA257-264-pulsed MCs 
(MC + CD8 + OVA257-264) or with untreated MCs (MC + CD8). As control, OVA257-264-pulsed 
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MCs were left untreated (MC + OVA257-264). After 48 hours, MCs were isolated by positive 
selection with MACS and RNA was isolated. Microarray analysis (Affymetrix, Mouse MG 
430 2.0) was performed. Statistical analysis was performed by limma analysis. Table 
summarizes the  differential expression of genes with F.p.-value <0.05 and differential 
expression (max/min averages) of >5. Mean values of gene expression from three 
independent experiments are shown.  
These results demonstrated that CD8+ T cells direct a strong MC response both in an 
antigen-dependent as well as in an antigen-independent manner. Therefore, the crosstalk 
between MCs and CD8+ T cells is bidirectional, consisting of both the MC-induced 
presentation of MHC class I-related antigens to CD8+ T cells, and of the CD8+ T cell-induced 
up-regulation of gene expression in MCs. Taken into consideration that many of these genes 
are IFN-related, the previously formulated hypothesis that the MC-CD8+ T cell contact plays 
a significant role in the defense against virus is highly strengthened.  
 
3.8.2.3. Confirmation of the microarray results 
The microarray analysis has revealed a significantly differential (>5 times) expression 
of 29 genes in MCs after contact with CD8+ T cells. In order to verify some of these results, 
PCR analysis for the cDNA of the MACS-purified MCs was performed. The results of the 
PCR analysis confirmed the corresponding data of the microarray experiment. Thus, 
transglutaminase 2 (TGM-2) was up-regulated in MCs after contact with CD8+ T cells, as 
shown both by the microarray experiment as well as by the PCR verification (Fig. 3.35). In 
addition, p-lysozyme structural was one of the three genes that were down-regulated in the 
microarray experiment after antigen-independent contact with CD8+ T cells and the same 
result was obtained with PCR analysis (Fig. 3.35). IFN-γ was significantly up-regulated in 
MCs after contact with CD8+ T cells, as shown by the microarray analysis. As shown in Fig. 
3.35, the PCR analysis showed the same tendency of increased IFN-γ in MCs upon contact 
with CD8+ T cells, however this result was not statistically significant.  
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Fig. 3.35. PCR analysis confirmed part of the data obtained by microarray analysis. 
OVA257-264 -pulsed MCs (red bars) or unpulsed MCs (blue bars) were cultured with CD8+ T 
cells. As negative control, OVA257-264 -pulsed MCs that did not contact CD8+ T cells were 
used (black line). After 48 hours, MCs were isolated by positive selection with MACS, RNA 
was isolated and cDNA was synthesized. PCR analysis revealed the expression of genes of 
interest in MCs, in comparison to β-actin control expression. Graphs show mean values of 
arbitrary units (a.u.) as measured with Optimas Software, with standard deviation of three 
independent experiments. Lzp: p-lysozyme structural, TGM-2: transglutaminase-2. * p<0.05, 
** p<0.01, n.s.:not significant 
A prominent up-regulation of the co-stimulatory molecule tnfrsf9 (4-1BB) was 
revealed from the microarray analysis. Next to its role as co-stimulatory molecule during 
APC-T cell interaction, 4-1BB/4-1BBL interaction also mediates DC as well as MC 
activities. Interestingly enough, DCs (Futagawa et al., 2002) as well as MCs (Nishimoto et 
al., 2005) express both 4-1BB and its ligand, 4-1BBL, and 4-1BB/4-1BBL interactions 
mediate activation and cytokine production by both DCs and MCs. These data inspired a 
further investigation of 4-1BBL expression on MCs after co-culture with CD8+ T cells. For 
this reason, PCR analysis was performed on the cDNA of the purified MCs after co-culture 
with CD8+ T cells. As shown in Fig. 3.36, 4-1BB displayed a significant up-regulation in 
MCs upon antigen-dependent contact with CD8+ T cells; a result which verified the data 
obtained by the microarray analysis. In addition, 4-1BBL expression was slightly but not 
significantly up-regulated in MCs after antigen-dependent contact with CD8+ T cells.  
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Fig. 3.36. Expression of 4-1BB but not 4-1BBL in MCs is up-regulated after antigen-
dependent contact with CD8+ T cells. OVA257-264 -pulsed MCs (red bars) or unpulsed MCs 
(blue bars) were cultured with CD8+ T cells. As negative control, OVA257-264 -pulsed MCs 
that did not contact CD8+ T cells were used (black line). After 48 hours MCs were isolated 
by positive selection with MACS, RNA was isolated and cDNA was synthesized. Expression of 
4-1BB and 4-1BBL was tested by PCR. Graphs show mean values of arbitrary units (a.u.) as 
measured by Optimas Software, with standard deviation of three independent experiments.  
4-1BB: tumour necrosis factor receptor superfamily member 9 (tnfrsf9, 4-1BB), 4-1BBL:       
4-1BB-ligand. * p<0.05, n.s.: not significant 
In conclusion, this part of the study demonstrated that the interaction between MCs 
and CD8+ T cells is bidirectional. Thus, CD8+ T cells instruct a potent MC response in an 
antigen-dependent as well as in an antigen-independent manner. The contact with CD8+ T 
cells stimulates MCs to activate the IFN-related pathway and presumably contribute to an 
antiviral response. Moreover, upon antigen-dependent activation, CD8+ T cells induce MHC 
and co-stimulatory molecule expression on MCs, therefore potentially facilitate the MC 
contribution in adaptive immune responses. Thus, MCs may act as key regulatory cells at the 
crossroads between innate and adaptive immunity.   
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                 4.  Discussion 
n optimal CD8+ T cell response is essential for the defense against pathogens, 
such as viral, intracellular bacterial or protozoal infections (Wong and Pamer, 
2003).  Moreover, several pathological situations, including allergic responses (Haczku et al., 
1995a; Haczku et al., 1995b; Hamelmann et al., 1996) and autoimmune reactions (Huseby et 
al., 2001; Sun et al., 2001) implicate antigen-specific CD8+ T cell activities. An antigen-
specific CD8+ T cell response is clearly initiated by “professional” antigen presenting cells 
(APCs), namely dendritic cells (DCs), B cells and macrophages. However, recent results 
suggest that mast cells (MCs) communicate with CD8+ T cells, by inducing CD8+ T cell 
chemotaxis upon activation in vivo (McLachlan et al., 2003; Ott et al., 2003; Orinska et al., 
2005). Moreover, it has been demonstrated that MCs phagocytose living bacteria, process 
bacterial antigens and induce antigen-specific proliferation of CD8+ T cell lines upon 
presentation of bacterial-expressed proteins in vitro (Malaviya et al., 1996a; Malaviya et al., 
1996b). However, the consequences of this crosstalk between MCs and CD8+ T cells, as well 
as the requirements for this interaction, have not been further investigated. Therefore, the 
main purpose of this study was to provide a better understanding of the antigen-dependent, as 
well as the antigen-independent MCs-CD8+ T cell interactions. 
 
4.1. The use of BMMCs for studying MC functions in vitro 
In order to investigate MC activities and their potential interaction with CD8+ T cells, 
the model of in vitro-differentiated murine bone marrow-derived MCs (BMMCs) was used. 
An essential requirement for the further experiments of this study was the high purity of the 
MC cultures and the absence of potential APCs in the MC cultures. Adequate numbers of 
highly pure MC populations were technically difficult to obtain by isolating primary MCs 
from the mouse skin, lung or peritoneal cavity. Therefore, highly pure, homogeneous BMMC 
cultures were chosen as the suitable model to study MC functions in this study.  
The differentiation of BMMCs in vitro was performed in the presence of IL-3 and 
SCF for 5 weeks. Although IL-3 is dispensable for the generation of murine MCs in vivo 
under physiological conditions (Lantz et al., 1998) as well as for the in vitro-generation of 
human MCs from bone marrow cells, peripheral blood mononuclear cells or cord blood cells 
A
[4. Discussion] 
 
- 113 - 
 
(Valent et al., 1992; Mitsui et al., 1992), it is the absolutely essential factor to support murine 
MC survival in vitro (Mekori et al., 1993). Moreover, IL-3 promotes, at least partially, the 
maturation of mouse MCs, in contrast to human MCs (Valent et al., 1989; Valent et al., 
1990). The addition of SCF in BMMCs in vitro results in a synergistic effect in the 
maturation of MCs, since it enhances the expression of MC proteases and proteoglycans (Tsai 
et al., 1991a; Tsai et al., 1991b; Gurish et al., 1992) and promotes the formation of 
cytoplasmic granules (Dvorak et al., 1994). For this reason, mouse BMMCs in this study 
were differentiated in the presence of both IL-3 and SCF.  
MC maturation is routinely tested by the specific staining of their metachromatic 
granula. The BMMC cultures used in this study displayed the typical appearance of the MC 
metachromatic granula upon toluidine blue staining; however, this staining was weaker 
compared to the staining of ex vivo isolated peritoneal MCs (data not shown). Thus, it is 
suggested that, even when the maturation of BMMCs is significantly enhanced by the 
addition of SCF in the culture, it remains weaker compared to MCs in vivo. The reduced 
maturation of in vitro-generated BMMCs is also proven by the fact that BMMCs, when 
transferred intracutaneously, intraperitoneally or intravenously into mice in vivo, require 5-10 
weeks for optimal maturation to be achieved (Nakano et al., 1985). However, although the 
maturation of BMMCs compared to MCs in vivo appears to be reduced, BMMCs display 
specific phenotypical and functional MC characteristics, such as intracellular storage of 
proteases, histamine, proteoglycans and heparin (Tsai et al., 1991a; Tsai et al., 1991b; Gurish 
et al., 1992), surface expression of c-kit (CD117) and FcεRI (Dvorak et al., 1994), and 
degranulation upon antigen/IgE-specific stimulation (Levi-Schaffer et al., 1993). For this 
reason, BMMCs generated according to the method used in this study, comprise a well-
accepted and widely-used model to study MC functions in vitro (Kawakami et al., 2006).  
 
4.2. Antigen-independent control of CD8+ T cell activities by MCs in 
vitro 
A potential interaction between MCs and CD8+ T cells in the absence of a specific 
antigen might be relevant for the homeostasis of the naïve CD8+ T cell pool. Therefore, the 
crosstalk between MCs and CD8+ T cell was initially studied in the absence of a specific 
antigen. MCs were found to promote the survival of CD8+ T cells in an antigen-independent 
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and cell-cell contact-dependent manner. Similar observations regarding DCs, demonstrate 
that in the absence of a specific antigen, DCs form functional synapses with T cells, induce 
tyrosine phosphorylation and a small Ca2+ response and promote the survival of naïve CD4+ 
and CD8+ T cells (Revy et al., 2001; Kondo et al., 2001). Consistent with the present 
findings, the increased survival of T cells was promoted by DCs only in a cell-cell contact-
dependent manner (Kondo et al., 2001). It is noteworthy that the tyrosine kinase Lck was 
suggested to be a central mediator of antigen-independent DC-T cell interactions, since 
inhibition of Lck activity reduces the formation of stable conjugates between DCs and T cells 
(Revy et al., 2001; Kondo et al., 2001). Although the signal transduction pathways that 
promote CD8+ T cell survival upon antigen-independent contact with MCs were not the focus 
of the present study, it would be interesting to examine whether this phenomenon is similarly 
dependent on Lck tyrosine kinase activation.  
However, MCs did not induce any antigen-independent activation of CD8+ T cells, as 
measured by surface expression of activation markers. Evidence that MCs interact with T 
cells in an antigen-independent manner was provided by Nakae et al. (2005). However, in 
their settings MCs facilitated the proliferation and cytokine production by T cells, only when 
T cells were simultaneously stimulated by sub-optimal doses of anti-CD3. In light of these 
findings, the present study suggests that MCs do not induce antigen-independent CD8+ T cell 
response de novo.  
In conclusion, MCs promote the survival of naïve CD8+ T cells, suggesting that in a 
physiological situation MCs contribute to the homeostasis of naïve CD8+ T cells without 
inducing their activation.  Thereby, MCs are possible key regulators of naïve CD8+ T cell 
homeostasis at peripheral tissues and may potentially modulate the dimension of CD8+ T 
cell-dependent processes.  
 
4.3. Antigen-dependent control of CD8+ T cell activities by MCs in vitro 
Several studies demonstrate the ability of MCs to induce antigen-specific CD4+ T cell 
responses in an MHC class II-dependent manner (Frandji, et al., 1993; Fox et al., 1994; 
Poncet et al., 1999). Despite the central role of antigen-specific CD8+ T cells in host defense 
mechanisms, the potential of MCs to also induce antigen-specific CD8+ T cell responses 
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remains inadequately studied. Therefore, this study attempted to investigate the antigen-
specific interaction between MCs and CD8+ T cells.  
 
4.3.1. MCs internalize the OVA protein 
An essential requirement for a cell type to be considered as APC is the ability to 
uptake, process and present antigenic proteins. Thus, it was initially examined whether MCs 
are able to uptake the OVA protein. Indeed, MCs internalized the OVA protein coupled with 
FITC, as shown by fluorescence microscopy and FACS, in a dose-dependent manner. The 
finding that MCs internalize an antigenic protein is in line with previous investigations 
reporting that MCs phagocytose bacteria after binding to FimH, a mannose-binding subunit 
expressed on Escherichia coli and other enterobacteria (Malaviya et al., 1994). In addition, 
MCs were recently reported to express the scavenger receptors SR-A and MARCO and 
internalize silica particles of size 1.5-2 μm (Brown et al., 2007). The fact that MCs internalize 
antigenic proteins and particles or phagocytose bacteria, supports the hypothesis that MCs 
may act efficiently as APCs for presentation of exogenous or bacterial proteins to T cells.  
Following protein uptake, intracellular processing should occur in order to present 
antigenic peptides to T cells. The ability of MCs to process the OVA protein for presentation 
of antigenic peptides to T cells was not the direct focus of the present study. However, in a 
pilot experiment where OVA-pulsed MCs were used to stimulate CD8+ T cells, no significant 
CD8+ T cell activation was detected (data not shown). This was attributed to the fact that 
either a) the CD8+ T cells used in this system (OT-I transgenic) were skewed for the 
recognition of only a specific peptide (OVA257-264), therefore the magnitude of the CD8+ T 
cell response against the whole protein was restricted, or b) the reduced maturation of 
BMMCs in vitro did not allow efficient processing of the OVA protein. However, previous 
investigations have suggested the ability of MCs to process antigenic proteins. Thus, the 
uptake of live bacteria resulted in the processing of bacterial-produced proteins and the 
presentation of antigenic peptides to peptide-specific T cell clones (Malaviya et al., 1996b). 
In addition, MCs apparently possess the required machinery to degrade foreign proteins, 
since they have non-secretory lysosomes, containing acid-hydrolases (Schwartz and Austen, 
1980), where the processing of the ingested proteins might occur. However, whether the 
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processing of proteins for presentation is a feature of mature MCs in vivo should be further 
elucidated.  
 
4.3.2. MCs induce antigen-specific CD8+ T cell responses 
The ability of MCs to induce antigen-specific CD8+ T cell responses in vitro was 
examined by the co-culture of antigen (OVA257-264) -pulsed MCs with TCR-transgenic (OT-I) 
CD8+ T cells. OVA257-264-pulsed MCs induced activation and proliferation of CD8+ T cells in 
a dose-dependent manner. The use of the OVA257-264 peptide for studying antigen presenting 
functions of different cell types in vitro has been widely used by various investigators (Met et 
al., 2003; Rückert et al., 2003; Winau et al., 2007).  A widely used APC:T cell ratio for in 
vitro antigen presentation experiments is 1:2 - 1:10 (Chefalo and Harding, 2001; Brandt et al., 
2003; Rückert et al., 2003; Setterblad et al., 2004; Castiglioni et al., 2005; Winau et al., 
2007). However, it was acknowledged that MCs are generally found at sites where low 
numbers of T cells are encountered (skin, lung, peritoneal cavity), although during a primary 
immune response MCs may migrate to the lymph nodes, where the encounter of high 
numbers of T cells occurs (Wang et al., 1998; Dabak et al., 2004). Thus, in order to reproduce 
a more physiological situation regarding the MC:CD8+ T cell ratio, successively reduced MC 
numbers as stimulators of CD8+ T cells were used. MCs were proven to be efficient 
activators of CD8+ T cells, even at the lowest ratio of MC:CD8 = 1:100, which was sufficient 
to induce activation and proliferation of approximately 50% of the CD8+ T cell population. 
This ratio is comparable to the one required for LPS-matured DCs to induce proliferation of 
heterologous T cells in vitro (Brandes et al., 2005) as well as for E.coli-infected DCs to 
induce proliferation of up to 15% of the CD8+ T cell population (Billard et al., 2007). Thus, 
MCs are suggested to act as highly potent inducers of antigen-specific CD8+ T cell responses 
in vitro. 
The antigen-specific CD8+ T cell response after contact with antigen-pulsed MCs was 
dependent on MHC class I-TCR-signalling, since neither MHC class I-deficient MCs (β2m-/- 
MCs) induced significant CD8+ T cell activation, nor did non-TCR-transgenic CD8+ T cells 
respond to the TCR-specific peptide (OT-I) presented. Thus, it is excluded that the here 
detected MC-mediated antigen-specific CD8+ T cell response was induced by contamination 
of the peptide (e.g. from LPS) or by any other artificial factor except for the active 
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presentation of the peptide from functional MHC class I on the MCs to functional TCR on the 
CD8+ T cells. β2m-/- mice represent a valuable model for studying MHC class I-dependent 
antigen presentation (Koller et al., 1989; Zijlstra et al., 1990). These mice do not express the 
β2m chain, therefore they lack functional MHC class I expression, and subsequently the 
ability to present MHC class I-restricted antigens. The minimal CD8+ T cell response 
observed after co-culture of OT-I CD8+ T cells with OVA257-264-pulsed β2m-/- MCs is 
attributed to the fact that minimal amounts of the peptide could remain in the culture even 
after extensive washings of the MCs and may be presented from CD8+ T cells to themselves. 
In support of this hypothesis, CD8+ T cells have been previously reported to present soluble 
peptides to other CD8+ T cells (Walden and Eisen, 1990; Su et al., 1993; Schott et al., 2002), 
thus suggesting that traces of free OVA257-264 peptide could be responsible for a minimal in 
vitro activation of OT-I specific CD8+ T cells. However, since this MHC class I-independent 
activation is considered minimal in comparison to the MHC class I-dependent (10% in 
comparison to 95%), MCs are suggested to act as efficient APCs of MHC class I-restricted 
antigens.  
In addition to the antigen-specific activation and proliferation of the CD8+ T cells, 
MCs induced also effector CD8+ T cell functions, such as cytokine production. IFN-γ, a 
cytokine known to be produced at high levels upon antigen-specific activation of CD8+ T 
cells (Harty et al., 2000), as well as IL-2, a major regulator of T cell-survival (Marrack and 
Kappler, 2004), were detected at high levels in the supernatants after antigen-specific, MC-
mediated CD8+ T cell stimulation. In order to prove that IFN-γ and IL-2 were secreted by the 
CD8+ T cells, intracellular cytokine staining was performed. Indeed, CD8+ T cells were the 
source of IL-2 and IFN-γ, without excluding the possibility that also MCs contribute 
additionally to the accumulation of these cytokines in the co-culture supernatant. The high 
levels of IFN-γ and IL-2 produced during antigen-dependent CD8+ T cell activation suggest 
that CD8+ T cells may actively regulate many immunological processes upon antigen-
dependent contact with MCs. First, IFN-γ is identified as a main cytokine with cytotoxic 
activities, since it enhances the anti-microbial activity and killing of intracellular pathogens 
by macrophages and neutrophils (Young and Hardy, 1995) and also mediates the cytotoxic 
activity of CTL by promoting the Fas-mediated target cell-lysis (Andersen et al., 2006). On 
the other hand, IL-2 is a growth factor for all subpopulations of T cells and stimulates 
proliferation of B and T lymphocytes at high efficiency (Murray, 1996). Both IFN-γ and IL-2 
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are characterized as Th1-associated cytokines, therefore promote inflammatory reactions 
(Abbas et al., 1996). Thus, it is suggested that upon MC-mediated antigen-presentation CD8+ 
T cells contribute to cytotoxic reactions and to the elimination of intracellular pathogens on 
one hand, and on the other hand contribute to the magnitude of an inflammatory response and 
support the survival of T and B lymphocytes.  
Moreover, the inflammatory cytokines TNF-α and GM-CSF were detected in the 
supernatants upon antigen-dependent MC-CD8+ T cell co-culture. The release of TNF-α and 
GM-CSF suggests that during the antigen-specific MC-CD8+ T cell contact, inflammatory 
cytokines are secreted, which promote neutrophil recruitment and inflammation (Thomas, 
2001; Broide et al., 2001; Shi et al., 2006) and modulate the adaptive immune response by 
regulating the maturation of DCs (Kimber and Cumberbatch, 1992; Jonuleit et al. 1996; 
Thomas and Lipsky, 1996). However, it would be interesting to determine by intracellular 
staining the source of TNF-α and GM-CSF, since both cytokines can be produced at high 
amounts by MCs (Galli et al., 2005b). Moreover, it is interesting to examine whether CD8+ T 
cells induced degranulation of MCs, since TNF-α can be released by MCs by secretion and 
also upon degranulation (Okayama, 2005).  
It is noteworthy that none of the Th-2-associated cytokines examined here (IL-4, IL-5, 
IL-10) (Abbas et al., 1996) were detected after the antigen-specific MC-mediated CD8+ T cell 
activation. Collectively, the cytokine detection after MC-mediated antigen-specific CD8+ T 
cell activation suggests that MCs mediate an antigen-specific activation of CD8+ T cells, 
which results in the production of cytokines favouring the Th1 responses, thus, promoting 
inflammatory reactions and the development of cytotoxic T cells. These findings support the 
proposal that MCs have a diverse, complex role in regulating the Th1/Th2 cytokine milieu 
(Gregory and Brown, 2006; Stelekati et al., 2007). Therefore, next to their traditional, well-
characterized role in inducing Th2 responses through the release of IL-4 (Huels et al., 1995; 
Mekori and Metcalfe, 1999), MCs can also favour the Th1 response via interacting with 
CD8+ T cells and inducing considerable production of IFN-γ and IL-2. Whether a 
degranulation of MCs is required for this function remains to be investigated.  
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4.3.3. MCs increase the cytotoxic potential of CD8+ T cells 
Given the central role of IFN-γ in the facilitation of cytolytic activity performed by 
CD8+ T cells (Andersen et al., 2006), the hypothesis that MCs modulated the cytolytic 
activities of the CD8+ T cells was examined. The intracellular content of granzyme B, a key 
component of the cytotoxic machinery of cytolytic CD8+ T cells, which induces the caspase-
dependent pathway of apoptosis in target cells (Talanian et al., 1997), was increased in CD8+ 
T cells after antigen-specific activation by MCs. Moreover, CD8+ T cell degranulation was 
induced by MCs upon MHC class I-dependent antigen presentation. These findings strongly 
suggest that MCs enhance the cytotoxic potential of CD8+ T cells upon antigen-specific 
activation.  
There has been little information obtained regarding the possible implication of MCs 
in directly inducing cytotoxicity. Human MCs (Strik et al., 2007) as well as mouse MCs 
(Kataoka et al., 2004; Pardo et al., 2007) express granzyme B, the release of which upon MC 
degranulation induces cell death in target cells by a perforin-independent way (Pardo et al., 
2007). The present study suggests that MCs participate in cytotoxic reactions by an additional 
mechanism; that is, by directly inducing cytotoxic CD8+ T cells upon antigen-specific 
activation. This suggestion is supported by the most recent findings of Heib et al. (2007), who 
reported that MC-deficient mice display a deficiency in initiating peptide-specific CTL 
responses upon TLR-7 activation in vivo. It would be interesting to examine whether the MCs 
are subsequently targets of the CD8+ T cell cytotoxicity, or they have mechanisms to prevent 
apoptosis upon contact with CTLs. It is possible that, in response to contact with CTLs, MC 
degranulation is induced in order to increase the release of cytotoxic mediators (such as 
granzyme B) and enhance the efficiency of cytotoxicity. However, the effect of such a 
contact with CTLs on MCs remains to be investigated.  
 
4.3.4. The antigen-dependent activation of CD8+ T cells by MCs requires 
direct cell-cell contact and the release of soluble mediators 
 The mechanism of the MC-induced CD8+ T cell activation was further investigated in 
this study. Thus, it was first demonstrated that inhibition of cell contact between MCs and 
CD8+ T cells blocks the antigen-specific MC-CD8+ T cell interaction. It is therefore 
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suggested that the presentation of MHC class I-antigen complexes on the surface of the MCs 
is the initiative and essential step for the antigen-specific interaction with CD8+ T cells. This 
is explained by the fact that physical APC-T cell contact is essential for the formation of the 
immunological synapse, for the MHC-TCR interaction and for the subsequent stimulation of 
the TCR signaling pathway, which results in the activation of the T cells. Thus, consistent 
with the present study, a similar requirement of direct cell-cell contact has been reported for 
DCs, in order to induce antigen-specific activation of CD8+ T cells (Gunzer et al., 2000; 
Mempel et al., 2004).  
MC-released cytokines were also found to contribute to the antigen-dependent 
interaction with CD8+ T cells, since blocking of cytokine synthesis or secretion by MCs 
significantly reduced their ability to induce antigen-specific CD8+ T cell activation. Thus, it 
is suggested that once direct presentation of the antigen via MHC class I-TCR interaction 
occurs, additional soluble mediators produced by MCs enhance the efficiency of antigen 
presentation. Consistent with this observation, the secretion of cytokines, such as IL-1, IL-6, 
TNF-α, IL-12 and IL-15, by APCs was found to be important for priming naïve T cells and 
promoting their differentiation (Roitt et al. 2002). MC-released cytokines among their diverse 
functions also contribute in the regulation of CD8+ T cell activities. For example, important 
mediators of naïve T cell homeostasis, such as IL-4 and IL-6 (Vella et al., 1997; Teague et 
al., 2000) are produced by MCs (Brown et al., 1987; Burd et al., 1989; Plaut et al., 1989). 
Interestingly, IL-15, which is characterized as the main survival factor for memory CD8+ T 
cells (Zhang et al., 1998), has been detected in MC intracellular granula (Orinska et al., 
2007), although stimuli inducing its release have not been characterized so far. Moreover, 
MC-derived TNF-α has been reported to mediate T cell activation in an antigen-independent 
way (Nakae et al., 2005). However, the identification of the MC-released soluble mediators 
that mediate the antigen-dependent CD8+ T cell activation, as observed in the present study, 
remains to be investigated.  
 
4.3.5. TLR-ligand exposure of MCs enhances their potential to activate 
CD8+ T cells 
In order to understand how an antigen-dependent interaction between MCs and CD8+ 
T cells can be further modulated, the effect of TLR-stimulation of MCs in this interaction was 
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investigated. It was shown that LPS- and, less potently, pIC-stimulated MCs exhibited an 
enhanced capacity to activate CD8+ T cells, due, at least partially, to their increased surface 
expression of MHC class I. Thus, it was demonstrated that the MC ability to induce antigen-
specific CD8+ T cell responses is modulated by TLR-stimulation.  
The effect of TLR-stimulation of MCs has been extensively studied so far in the 
context of enhanced cytokine production (Introduction, Table 1.1). Thus, TLR-4 mediated 
activation of MCs induces TNF-α and other pro-inflammatory cytokine production, without 
stimulating MC degranulation. Therefore, it is suggested that the enhanced activation of 
CD8+ T cells by MCs upon TLR-stimulation of MCs, described in this study, is mediated 
partially by the enhanced MHC class I expression on MCs and partially by cytokines, such as 
TNF-α, released by MCs upon TLR-activation.  
TLR-4-mediated stimulation of MCs by LPS has been identified as a key causal agent 
for the LPS-induced exacerbation of allergic inflammation in vivo, since it results in 
increased cellular infiltration in the lung and enhanced Th2 cytokine production (Nigo et al., 
2006; Murakami et al., 2007). The finding of the present study that LPS enhances also the 
ability of MCs to activate CD8+ T cells, proposes an additional effect of the LPS-exposure on 
MCs; upon TLR4-engagement, MCs additionally initiate an adaptive, CD8+ T cell-dependent 
immune response. Taking into consideration that TLR-3-mediated activation of MCs induces 
CD8+ T cell recruitment in vivo (Orinska et al., 2005), it is here proposed that MCs serve as 
key mediators between innate and adaptive immunity in peripheral tissues; upon encounter of 
pathogens and TLR-induced stimulation, they lead to an enhanced adaptive immune 
response, mediated by increased CD8+ T cell recruitment and subsequent activation.  
 
4.4. Antigen-dependent control of CD8+ T cells by MCs in vivo 
As soon as it was demonstrated that MCs efficiently induce primary CD8+ T cell 
responses in vitro, the necessity to investigate whether this phenomenon occurs also in vivo 
arose. For this reason, first the ability of MCs to induce antigen-dependent responses of 
primary CD8+ T cells in vivo was investigated. Following, the role of MCs in regulating the 
CD8+ T cell response during an allergic airway sensitization model was examined.  
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4.4.1. MCs induce antigen-dependent proliferation of CD8+ T cells in 
vivo  
In order to prove that this interesting MC-CD8+ T cell interaction occurs in vivo, 
adoptive transfer experiments were performed in wild-type and in β2m-/- mice. β2m-/- mice 
lack the expression of the β2m chain of MHC class I, therefore, exhibit a deficiency in 
generating CD8+ T cells and they are unable to efficiently present antigens in an MHC class 
I-dependent manner. For this reason, transfer of antigen-loaded, wild-type MCs and OT-I 
transgenic CD8+ T cells into β2m-/- mice provided a model that lacks endogenous MHC-I-
restricted antigen presentation. Interestingly, MCs induced a similar antigen-dependent CD8+ 
T cell proliferation in wild-type as well as in β2m-/- mice. This finding completely excludes 
the possibility that other resident APCs contributed to the antigen-dependent CD8+ T cell 
responses demonstrated in this study, thus underestimating the role of MCs in this 
phenomenon. The proof that MCs are able to induce antigen-specific proliferation of primary 
CD8+ T cells upon MHC class I-dependent antigen presentation in vivo is of central 
significance for the understanding of the role of MCs in the modulation of adaptive immune 
responses. Thus, this is the first report to demonstrate that MCs are able to induce 
proliferation of primary CD8+ T cells in an antigen-dependent manner in vivo, in mice. The 
investigation whether primary, freshly isolated MCs exhibit the same function, as well as 
whether a similar role for MCs in the human system exists, is considered to be of great 
interest.  
An interesting question arising upon the demonstration that MCs induce antigen-
specific CD8+ T cell responses in vivo is the physiological conditions under which the 
organism benefits by this function of MCs. MCs are mostly resident cells at peripheral sites. 
Therefore, it is possible that upon pathogen or allergen encounter they internalize antigens 
and preserve them in the periphery, thus comprising a reservoir of the antigen in the 
periphery. In support of this hypothesis, it was recently reported that latently HIV-infected 
MCs comprise a long-living, inducible reservoir of the virus at peripheral tissues in humans. 
The release of infectious virus from those latently infected MCs could be induced upon IgE 
crosslinking in vitro (Sundstrom et al., 2007). Thus, it is here hypothesized that MCs may 
have a central contribution in the establishment of memory CD8+ T cell compartment and the 
regulation of immune responses at the periphery. Although subpopulations of MCs have also 
been reported to migrate to the lymph nodes upon infection or inflammatory stimuli (Wang et 
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al., 1998; Dabak et al., 2004), the differences between MCs and DCs in the kinetics and 
degree of migration may highlight the individuality of these two different cell types as APCs. 
Taken together, all these attribute to the MCs the unique role of controlling the CD8+ T cell 
responses in the periphery, in contrast to DCs, which normally execute their antigen 
presenting function in the lymph nodes.  
Interesting evidence accumulate demonstrating that in addition to the “professional” 
APCs (DCs, B cells and macrophages), several other cell types may act as APCs in different 
organs and at different sites of the organism. The fact that endothelial cells (Marelli-Berg and 
Jarmin, 2004), fibroblasts (Kundig et al., 1995), MCs (Frandji et al., 1993), hepatic stellate 
cells (Winau et al., 2007) may act as APCs indicates that antigen presentation might be 
regulated in different ways at the various sites of the body. A possible meaning of the 
existence of several APCs at different sites was interestingly proposed in a recent report by 
Unanue, E. (2007); the antigen presentation in every microenvironment is dependent on 
anatomical and physiological considerations such as patterns of blood flow, barriers to 
vascular permeability, organization of connective tissue and expression of adhesion 
molecules and chemokines. Therefore, the existence of several APCs, next to the 
“professional” ones, is not redundancy; the “non-professional” APCs, such as MCs, are 
needed to mount optimal responses to antigens, meeting the requirements of the exact 
surrounding conditions and to perform the fine-tuning of the antigen presentation in the 
particular environment.  
 
4.4.2. MCs do not significantly influence CD8+ T cell responses in a 
murine model of allergic airway sensitization in vivo 
As soon as the ability of MCs to modulate antigen-specific CD8+ T cell responses in 
vivo was determined, the question of how this phenomenon is relevant for the function of the 
organism arose. Therefore, a pathological situation in which the MC-mediated antigen-
specific CD8+ T cell responses are potentially important was investigated. Since MCs are key 
mediators of the allergic immune reactions, it was hypothesized that their capacity to present 
antigens to CD8+ T cells may regulate the outcome of allergic responses. Increasing evidence 
in different models suggest that CD8+ T cells are important for the induction of allergic 
sensitization and atopic diseases (Haczku et al., 1995a, Haczku et al., 1995b). Interestingly, in 
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a murine model of allergic sensitization to OVA, the development of airway hyper-reactivity, 
eosinophil influx, and IL-5 production was absolutely dependent on the presence of CD8+ T 
cells (Hamelmann et al., 1996). For this reason, the role of MCs in the induction of antigen-
specific CD8+ T cell responses was studied using a well-established murine model of allergic 
sensitization against OVA, in which antigen-specific CD8+ T cell proliferation was observed 
(Rückert et al., 2005).  
An interesting observation arising from the analysis of naïve (control unimmunized) 
mice was that MC-deficient mice exhibit a reduced percentage and reduced total number of 
CD8+ T cells in the lung compared to their congeneic wild-type mice. An important role for 
MCs in regulating naïve CD8+ T cell homeostasis in the lung could be a possible explanation 
for this CD8+ T cell deficiency in MC-deficient mice. Such a role for MCs in promoting 
CD8+ T cell survival has been investigated earlier in this study and discussed in the paragraph 
4.2. However, it should be taken into consideration that Kit-W/Wv mice exhibit several 
developmental abnormalities such as macrocytic anemia, lack of melanocytes, intestinal 
TCRγδ intraepithelial lymphocytes and interstitial cells of Cajal (Galli and Kitamura, 1985; 
Grimbaldeston et al., 2005). Therefore, it is not excluded that the CD8+ T cell deficiency 
observed here is an additional defect caused by a dysregulated T cell development in the Kit-
W/Wv mice. In order to evaluate if MCs were the cause of this deficiency, the CD8+ T cell 
development in the lung of Kit-W/Wv mice reconstituted with MCs should be investigated.  
In contrast to the initial expectations, the CD8+ T cell activation or memory 
differentiation during this model was not significantly influenced by the presence of MCs, 
since MC-deficient mice developed comparable amounts of activated and memory CD8+ T 
cells after OVA-sensitization and challenge. This result suggests that, although MCs are 
capable of inducing antigen-specific CD8+ T cell responses in vivo, this MC-CD8+ T cell 
interaction is dispensable for the CD8+ T cell activation observed in the lung and its draining 
lymph nodes during an allergic airway inflammation. The reason why no significant 
differences were observed regarding the CD8+ T cell response could be attributed to the fact 
that only a small proportion of the CD8+ T cells would be OVA-specific. Thus, the use of 
general activation markers such as CD69 and CD25 and memory markers such as CD44 and 
CD62L, although provides an accurate evaluation of the overall CD8+ T cell response, 
however, does not focus on the antigen-specific CD8+ T cells. Therefore, if there were 
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significant differences only in the antigen-specific (OVA-specific) CD8+ T cells, those could 
be detected only with the use of OVA-specific tetramer staining.   
On the other hand, it is possible that MCs do not play a role in the induction of CD8+ 
T cell response in this model, because other APCs in the lung such as DCs or macrophages 
induce a sufficient CD8+ T cell response, therefore overtake the role of MCs in this model. 
Moreover, the total time period in which this sensitization- and challenge-phase occurred 
lasted for 29 days. It may be an explanation that during this time-period, the role of MCs in 
inducing CD8+ T cell responses is overtaken by professional APCs, while this would not be 
the case in a longer-lasting time-frame, since MCs are by far longer-living cells than other 
APCs. Indeed, some existing evidence suggests that MCs are central participants in late phase 
immune responses. Thus, MCs promote the development of chronic asthma, as demonstrated 
in a murine model of chronic asthma lasting for 10 weeks (Yu et al., 2006). Additionally, a 
recent report demonstrated that MCs are recruited and activated by Treg-produced IL-9 in 
tolerant allografts and that this interaction between Treg and MCs is essential for the long-
term allograft tolerance (Lu et al., 2006). It is therefore suggested that the role of MCs might 
be more important in the late phase of immune responses rather than in short-term immune 
reactions. Therefore, a potential physiological role of MC-mediated antigen-specific CD8+ T 
cell responses in long-term immune reaction should be further investigated.   
 
4.5. The effect of MCs on pre-activated CD8+ T cells 
MCs are long-lived, resident cells in the periphery (Marshall, 2004). Therefore, as 
speculated above, MCs may participate in late-phase immune reactions and in the outcome of 
a secondary immune response. During a secondary response, MCs encounter CD8+ T cells 
that have been already primed by the migrating DCs in the lymph nodes. For this reason, the 
effect of MCs on pre-activated CD8+ T cells was further investigated in this study. First, it 
was proven that MCs reduce the antigen-specific DC-induced activation of CD8+ T cells. 
Furthermore, MCs reduced the proliferation of pre-activated CD8+ T cells. These data 
suggest that MCs exhibit a dual modulatory role in priming CD8+ T cells; on encounter with 
naïve CD8+ T cells MCs induce antigen-specific activation and proliferation, while on 
encounter with pre-activated CD8+ T cells, MCs down-regulate the CD8+ T cell responses.  
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An interaction between MCs-DCs-CD8+ T cells could possibly happen in the lymph 
nodes, where all the three cell types may encounter each other. MCs have been reported to 
migrate to the lymph nodes upon infection or inflammatory processes in mice and rats (Wang 
et al., 1998; Dabak et al., 2004). Moreover, MCs have been detected at increasing 
concentrations in the lymph nodes in patients with tuberculous lymphadenitis or lung cancer 
(Tomita et al., 2003; Taweevisit and Poumsuk, 2007). Interestingly, during the progression of 
infection, MCs in the lymph nodes migrate mostly to the paracortical area and medullary 
sinuses, where T cells are found in higher proximity (Dabak et al., 2004). These evidence 
suggest that an interaction between MCs-DCs and CD8+ T cells is indeed a possible 
physiological phenomenon, that might be mostly relevant for the immune response during 
infection.  
The finding that MCs inhibit the antigen-specific response of DC-mediated primed 
CD8+ T cells, gives a hint of a role of MCs in participating in tolerance induction, by down-
regulating CD8+ T cell responses. Indeed, MCs have been reported to be necessary for the 
induction of systemic suppression of contact hypersensitivity responses by UVB radiation 
(Hart et al., 1998). In addition, as mentioned above, MCs were identified as essential 
mediators of the long-term allograft tolerance, by interacting with regulatory T cells (Lu et 
al., 2006). It is therefore tempting to hypothesize that the here demonstrated interaction 
between MCs and pre-activated CD8+ T cells may also play a role in the induction of 
tolerance in CD8+ T cell-mediated immune responses.  
 
4.6. Control of MC phenotype by CD8+ T cells 
The up to here presented results verify that MCs considerably affect CD8+ T cell 
responses. In order to investigate whether the MC-activated CD8+ T cells subsequently 
regulate the activities of their MC counterparts, the effects of CD8+ T cells on MCs in the 
presence and in the absence of antigen were investigated. Microarray analysis, as well as 
PCR analysis on MCs isolated after co-culture with CD8+ T cells revealed a differential gene 
expression profile of MCs after contact with CD8+ T cells. It was therefore concluded that the 
MC-CD8+ T cell interaction is a dialogue affecting both cell types, rather than a monologue 
inducing only CD8+ T cell responses. 
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4.6.1. CD8+ T cells control MC phenotype in an antigen-independent 
manner 
Interestingly, CD8+ T cells induced up-regulation of several genes in MCs in an 
antigen-independent manner, showing that CD8+ T cells are indeed able to modulate MC 
responses.  A great proportion of those genes are correlated with the signaling pathway of 
interferons (IFNs). Thus, the signal transducer and activator of transcription 1 (STAT1), 
which is correlated with IFN-γ production, as well as with IFN-α/β production (Leonard and 
O´Shea, 1998) was significantly up-regulated in an antigen-independent manner. Similarly, 
IFN regulatory factor (IRF) 7, which induces IFN-α and IFN-β production, as well as IRF1, 
responsible for IFN-γ and partially IFN-β  production (Taniguchi et al., 2001), were also up-
regulated in MCs after contact with CD8+ T cells in the absence of specific antigen. 
Moreover, molecules downstream of IFN-γ signaling, such as Rtp4, induced by IFN-γ, and 
Igtp, a GTPase induced also by IFN-γ, which regulates innate immune responses to 
intracellular pathogens (Taylor et al., 2004) displayed enhanced gene expression in MCs after 
contact with CD8+ T cells. These results suggest that CD8+ T cells stimulate the IFN-
signaling pathway in MCs upon antigen-independent contact. Given the central role of IFNs 
in the mechanism of host defense, the result that CD8+ T cells activate the IFN signaling 
pathway in MCs, supports the hypothesis that MC-CD8+ T cell crosstalk might be crucial in 
establishing an optimal antiviral response.  
Further evidence in the frame of this hypothesis is provided by the almost 10-times 
up-regulation of the radical S-adenosyl methionine domain containing 2 (Rsad2), an IFN-
inducible gene encoding for the antiviral protein viperin (Chin and Cresswell, 2001). Viperin 
(named for: virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) 
inhibits productive human cytomegalovirus (HCMV) infection in vitro, by down-regulating 
several HCMV structural proteins known to be indispensable for viral assembly and 
maturation (Chin and Cresswell, 2001). Consistent with the present study, Rivieccio et al. 
(2006) defined viperin as one of the most highly up-regulated genes on human astrocytes 
upon TLR-3 activation. Therefore, although the protein expression of viperin was not 
measured, the finding of up-regulated Rsad2 gene expression proposes that MCs induce 
antiviral responses upon activation by CD8+ T cells, as shown in a schematic representation 
in Fig. 4.1.  
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Fig. 4.1. CD8+ T cells stimulate the IFN-signaling pathway in MCs and the induction of an 
antiviral programme in an antigen-independent manner. Blue circles highlight the genes 
that were shown to be up-regulated in MCs after contact with CD8+ T cells in an antigen-
independent manner.   
 
Increasing evidence indicates that MCs can be infected by viruses and respond to viral 
signals. MCs can detect viral infections via TLR3 and TLR3-activated MCs contribute to host 
defense by expressing key antiviral response genes (IFN-β, ISG15) and recruiting CD8+ T 
cells (Orinska et al., 2005). MC activation followed by cytokine and chemokine production 
was demonstrated upon dengue virus, HIV and encephalomyocarditis virus infection 
(Bannert et al., 2001; Marone et al., 2001; King et al., 2002; Kitaura-Inenaga et al., 2003). 
However, the mechanism of MC infection and activation during viral infections as well as 
their contribution to the establishment of antiviral responses in vivo remain to be 
characterized in detail.  
 
4.6.2. CD8+ T cells control MC phenotype in an antigen-dependent 
manner 
Apart from the antigen-independent gene up-regulation in MC, several genes 
displayed enhanced expression upon antigen-dependent CD8+ T cell contact. The most 
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prominent of these appeared to be IFN-γ and IFN-related genes, revealing an enhanced 
stimulation of the IFN-related pathway. Moreover, molecules related to major 
histocompatibility complex (MHC) class I and II (Qa-2 antigen, H2-Q1, H2-Ab1 and H2-Q8) 
and the co-stimulatory molecule tumor necrosis factor receptor superfamily member 9 
(Tnfrsf9) were significantly up-regulated.  
The fact that several genes implicated in the IFN-signaling pathway, both upstream 
and downstream of IFN, were up-regulated in MCs upon antigen-dependent contact with 
CD8+ T cells, broadens the conclusions deduced in the previous paragraph. Thus, CD8+ T 
cells induce the IFN pathway in MCs in the absence of a specific antigen, but this effect is 
even more potently induced in the presence of an antigen. Moreover, the increased 
production of IFN-γ resulted in the up-regulation of SOCS-3, which subsequently suppressed 
TGF-β expression. Given the role of TGF-β as a suppressor factor for the induction of 
immune responses (Wan and Flavell, 2007), the down-regulation of its expression by MCs 
upon antigen-dependent contact with CD8+ T cells might provide an essential mechanism for 
MCs in order to mount the maximal of an antigen-specific CD8+ T cell response.  
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Fig. 4.2. CD8+ T cells stimulate the IFN-signaling pathway in MCs and the induction of an 
antiviral programme in an antigen-dependent manner. Blue circles highlight the genes that 
were shown to be up-regulated in MCs after contact with CD8+ T cells in an antigen-
independent manner. Red circles highlight the genes, which displayed increased up-
regulation in the presence of antigen. Green circle shows that TGF-β was down-regulated 
upon antigen-dependent contact with CD8+ T cells.  
The fact that MHC-related antigens were up-regulated on MCs upon antigen-
dependent interaction with CD8+ T cells, strongly suggests that MCs are indeed capable of 
acting as APCs, and this function is significantly promoted after antigen-dependent contact 
with CD8+ T cells. Thus, MCs initiate antigen-specific activation of CD8+ T cells, which in 
turn augment the tools for antigen presentation in MCs and therefore promote the ability of 
MCs to induce antigen-specific responses. It is noteworthy that also MHC class II-related 
molecules were up-regulated in MCs after antigen-specific contact with CD8+ T cells. This 
would provide the MCs an enhanced ability to interact also with CD4+ T cells. The ability of 
MCs to express MHC class II and induce antigen-specific activation of CD4+ T cells has been 
previously reported (Frandji, et al., 1993; Fox et al., 1994; Love et al., 1996; Poncet et al., 
1999). However, the enhanced expression of MHC class II on MCs upon activation by CD8+ 
T cells sheds additional light to this function: MCs present MHC class I-related antigens to 
CD8+ T cells, which results not only in CD8+ T cell responses, but also in enhanced MHC 
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class II expression on MCs. Subsequently, MCs possess an enhanced ability to activate CD4+ 
T cells in an antigen-dependent manner, therefore mediate the crosstalk between CD8+ and 
CD4+ T cells and regulate an optimal antigen-specific response.  
The up-regulation of Tnfrsf9 (also called CD137 antigen or 4-1BB) after antigen-
dependent contact with CD8+ T cells, provides evidence of a possible mechanism by which 
MCs induce CD8+ T cell responses. 4-1BB is a co-stimulatory molecule, promoting 
proliferation and effector function of T cells (Pollok et al., 1993; Hurtado et al., 1995). 
Moreover, 4-1BB stimulation induces cytokine production by DCs (Futagawa et al., 2002) 
and enhances cytokine production and degranulation upon FcεRI- and antigen-stimulation on 
MCs (Nishimoto et al., 2005). Therefore, the enhanced 4-1BB expression on MCs might be 
the reason not only for providing the necessary co-stimulation for CD8+ T cells, but also for 
enhancing the required cytokine and soluble factors production by MCs. Furthermore, the 
hypothesis of this study that MCs might be crucial regulators of viral defense mechanisms is 
highly supported by the findings that in vivo 4-1BB stimulation enhances and broadens the 
CD8+ T cell response to influenza virus and can restore the CD8+ T cell response when CD28 
co-stimulation is absent (Halstead et al., 2002). Finally, an exciting finding that there is a 
switch in co-stimulatory requirement from CD28 to 4-1BB during primary versus secondary 
responses of CD8+ T cells to influenza virus (Bertram et al., 2004), provides further hints that 
the MC-CD8+ T cell interactions might be more important in secondary immune responses.  
The analysis of MC gene expression after CD8+ T cell contact revealed that only 3 
genes were significantly down-regulated in MCs after contact with CD8+ T cells; except 
TGF-β, as discussed above, lysozyme and lipase were also down-regulated in an antigen-
independent manner. The fact that enzymes, such as lysozyme and lipase, localized in the 
granules of MCs were down-regulated provides evidence of a possible regulatory mechanism 
used by MCs; upon CD8+ T cell encounter, molecules related with adaptive immunity and a 
possible crosstalk with T cells become up-regulated, while the potential for degranulation 
becomes reduced. This would direct MCs to instruct specific responses to T cells, while the 
possible boost of inflammation through MC degranulation would be minimized.  
In conclusion, this study has demonstrated that there is a bi-directional crosstalk 
between MCs and CD8+ T cells, which on one hand enhances effector CD8+ T cell functions 
and on the other hand instructs MCs to regulate an adaptive immune response and mediate an 
anti-viral reaction. Such a role of MCs in inducing antiviral responses in vivo should be 
further investigated.  
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5. Conclusions and Perspectives 
n conclusion, this study demonstrated that MCs act as potent regulators of CD8+ T 
cell responses. Thus, it was shown that MCs are powerful antigen-presenting cells of 
MHC class I-related antigens in vitro and in vivo. On the other hand, the antigen-specific 
interaction between MCs and CD8+ T cells affects also MC activities. MCs increasingly 
express the antiviral genes as well as co-stimulatory molecules and MHC class I and class II 
molecules after contact with CD8+ T cells. Briefly, the findings of this study are summarized 
in Fig. 5.1. 
antigen
Mast cell
MHC class I 9 direct antigen
presentation (MHC-I)
9 cell-cell contact
9 cytokines
9 activation
9 proliferation
9 cytokines (IL-2, IFN-γ)
9cytotoxicity
9 IFN-γ
9 anti-viral response
9 co-stimulatory molecules
9MHC expression
TCR
CD8
CD8 CD8
CD8
 
Fig. 5.1. The main conclusions of the present study 
The here demonstrated ability of MCs to induce antigen-specific CD8+ T cell 
responses upon presentation of MHC class I-related antigens in vitro and in vivo supports the 
hypothesis that MCs are efficient antigen presenting cells (APCs). The MC-induced 
proliferation of naïve primary CD8+ T cells in vivo introduces further questions regarding the 
(patho)physiological situations in which this MC-CD8+ T cell interaction is relevant.  
The fact that MCs did not significantly influence the CD8+ T cell responses in an in 
vivo model of allergic airway sensitization should direct further research of MC-CD8+ T cell 
I 
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interactions to longer-term pathological situations. Since MCs are long living cells in 
peripheral tissues, it is highly speculated that their interaction with CD8+ T cells may 
contribute to the induction of memory CD8+ T cell differentiation at peripheral sites. 
Consistent with this hypothesis, the co-stimulatory molecule 4-1BB, which was highly up-
regulated in MCs after antigen-specific interaction with CD8+ T cells, is important in the 
induction of secondary rather than primary CD8+ T cell responses (Bertram et al., 2004). 
Consequently, the role of MCs as modulators of CD8+ T cell responses should be elaborated 
in secondary immune reactions, such as late phase allergic responses, memory cell 
differentiation or induction of peripheral tolerance.  
On the other hand, the MC-induced augmentation of the cytotoxic potential of CD8+ 
T cells introduces further topics to be investigated:  Do MCs contribute to the induction of 
cytotoxic CD8+ T cells upon MHC class I-dependent antigen presentation in vivo? And is this 
MC-CD8+ T cell interaction essential for host defense mechanisms? Very recent findings 
(Heib et al., 2007), support the requirement of MCs for the induction of CTL responses after 
TLR-7 activation in vivo. However, the significance of this cross-talk for an in vivo 
pathological situation has not yet been explored.  
Finally, a novel direction in MC research is innovated by the fact that several anti-
viral genes in MC were up-regulated after interaction with CD8+ T cells. In addition to the 
available evidence of MCs being activated upon different viral infections, this result proposes 
an important role of MCs for the outcome of viral infections. The investigation of the role of 
MCs in inducing anti-viral responses in vivo is regarded to be of great biological as well as 
medical interest and remains to be examined in detail.  
MCs remain enigmatic cells, despite the attempts of several investigators over the past 
decades to unravel their different roles in health and disease. The contribution of the present 
study further underline the biological importance of MCs in pathological situations. 
Biological research will always be splendid; we may keep on discovering exciting 
information about the cell and possibly unexpected functions of particular cell types, however 
the currently available information will always be a step towards understanding the biological 
functions and manipulate them for the human benefit.  
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                       Summary 
precisely regulated crosstalk between innate and adaptive immunity is a 
prerequisite for an optimal immune response and successful survival strategy. 
Important players of innate immunity are the mast cells (MCs). These are long-living cells at 
sites of host-environment interface and important effector players during allergic responses. 
Recently, MCs have been described as central regulatory cells not only in innate but also in 
adaptive immune responses. MCs interact with cells of the adaptive immune system and 
recruit CD8+ T cells upon different stimuli. The purpose of this study was to investigate the 
interaction between MCs and CD8+ T cells, identify the factors that modulate this interaction 
and examine its downstream effects.  
By using murine bone marrow-derived MCs, this study demonstrated that MCs 
promote the survival of naïve, primary CD8+ T cells in an antigen-independent and cell-cell 
contact-dependent manner. The investigation of the antigen-dependent interaction between 
MCs and CD8+ T cells showed that MCs induce antigen-specific activation, proliferation and 
cytokine secretion by TCR-transgenic CD8+ T cells in vitro. Furthermore, the increased 
intracellular content of granzyme B and enhanced CD8+ T cell degranulation indicated an 
increase in the cytotoxic potential of CD8+ T cells. This antigen-driven communication 
between MCs and CD8+ T cells required both direct cell-cell contact and the release of 
soluble factors by MCs. TLR-mediated activation of MCs augmented their capacity to 
activate CD8+ T cells, partially due to enhanced surface expression of MHC class I 
molecules. Remarkably, the adoptive transfer of antigen-pulsed MCs induced proliferation of 
antigen-specific CD8+ T cells in vivo, in wild-type as well as in β2-microglobulin-deficient 
mice, which lack functional MHC class I expression. Thus, MCs promote CD8+ T cell 
responses, inducing effector CD8+ T cells in vitro and in vivo.  
Furthermore, CD8+ T cells enhanced the expression of several genes in MCs, in an 
antigen-dependent as well as antigen-independent manner, as demonstrated by differential 
gene expression analysis of MCs. Many of these genes are implicated in the signal 
transduction pathway of interferons, suggesting that the MC-CD8+ T cell interaction may 
contribute significantly to host defense mechanisms. Additionally, upregulation of major 
histocompatibility complex-related molecules and of the co-stimulatory molecule 4-1BB 
suggests that the contact with CD8+ T cells enhances the potential of MCs to modulate 
adaptive immune responses.  
In conclusion, this study adds new insights into the physiological role of MCs in the 
context of adaptive immune responses, such as a CD8+ T cell-driven antiviral immune 
response. This novel understanding of MC biology foresees new promising approaches for a 
therapeutic manipulation of antiviral immunity.  
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                  Zusammenfassung 
in exakt regulierter Dialog zwischen angeborener und adaptiver Immunität ist eine 
wesentliche Voraussetzung für eine optimale Immunantwort und somit für eine 
erfolgreiche Überlebensstrategie. Zu den bedeutenden Zellen der angeborenen Immunität 
zählen unter anderen die Mastzellen (MZ). MZ sind langlebige Zellen, welche überwiegend 
an Umwelt-exponierten Körperflächen lokalisiert sind und wichtige Effektorzellen während 
einer allergischen Reaktion darstellen. Kürzlich wurden MZ als zentrale, regulatorische 
Zellen sowohl der angeborenen, als auch innerhalb der adaptiven Immunantwort beschrieben. 
MZ interagieren mit Zellen des angeborenen Immunsystems und vermögen nach 
unterschiedlicher Stimulation CD8+ T-Zellen zu rekrutieren. Absicht der vorliegenden Studie 
war es, die Interaktion zwischen MZ und CD8+ T-Zellen zu untersuchen, die diese 
Interaktion modulierenden Faktoren zu identifizieren und deren weiterführende 
Auswirkungen zu bestimmen. 
Unter Verwendung aus murinem Knochenmark generierter MZ zeigte diese Studie, 
dass MZ das Überleben naiver Primär-CD8+ T-Zellen Antigen-unabhängig und Zell-Zell-
Kontakt-abhängig unterstützen. Untersuchungen der Antigen-abhängigen Interaktionen 
zwischen MZ und CD8+ T-Zellen zeigten, dass MZ eine Antigen-spezifische Aktivierung, 
Proliferation und Zytokinproduktion TCR-transgener CD8+ T-Zellen in vitro induzieren. 
Desweiteren deuten ein erhöhter intrazellulärer Gehalt an Granzym B und ein Anstieg der 
CD8+ T-Zell-Degranulation auf ein gesteigertes zytotoxisches Potential der CD8+ T-Zellen 
hin. Diese Antigen-gesteuerte Kommunikation zwischen MZ und CD8+ T-Zellen benötigte 
sowohl Zell-Zell-Kontakt  als auch die Freisetzung löslicher Faktoren durch Mastzellen. Eine 
Aktivierung der MZ durch die Toll-like-Rezeptoren erhöhte deren Fähigkeit CD8+ T-Zellen 
zu aktivieren, teilweise vermittelt durch eine gesteigerte Zelloberflächenexpression der MHC 
Klasse I Molküle.  Bemerkenswerter Weise induzierte der direkte Transfer Antigen-
stimulierter MZ die Proliferation Antigen-spezifischer CD8+ T-Zellen in vivo, sowohl in 
wildtypischen als auch in β2-Mikroglobulin-defizienten Mäusen, welchen eine funktionale 
MHC Klasse I Expression fehlt. Somit wurde deutlich, dass MZ die CD8+ T-Zelle-Antwort 
fördern und dabei Effektor-CD8+ T-Zellen in vitro und in vivo induzieren. 
Zudem waren CD8+ T-Zellen in der Lage die Expression verschiedener Gene in MZ 
Antigen-abhängig als auch Antigen-unabhängig deutlich zu verstärken, wie mittels 
differentieller Genexpressionsanalyse gezeigt werden konnte. Viele dieser Gene haben eine 
wichtige Funktion innerhalb der Signaltransduktionswege von Interferonen, was zu der 
Annahme führte, dass die MZ-CD8+ T-Zell-Interaktion wesentlich zu Abwehrmechanismen 
beitragen könnte. Zusätzlich lässt die Hochregulation des Major Histocompatibility Complex-
verwandten Moleküls 4—1BB vermuten, dass der Kontakt mit CD8+ T-Zellen das Potential 
der MZ, die adaptive Immunantwort zu modulieren, erhöhen könnte. 
Zusammenfassend ist zu sagen, dass diese Studie neue Einsichten in die 
physiologische Rolle der MZ im Kontext der adaptiven, wie einer CD8+ T-Zelle-gesteuerten 
anti-viralen Immunantwort gibt. Dieses neue Verständnis der MZ-Biologie birgt 
vielversprechende Ansätze für eine Manipulation der anti-viralen Immunantwort im 
therapeutischen Sinne. 
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